{"chunk_type":"transcript_chunk","text":"# LM_GIT 1\n**Verification Dictation (0:00~0:30)**\n\"Welcome back to the deep dive. Today, we are stripping away all the noise. We're uh, locking the doors, turning off the wifi, and just focusing entirely on high-yield clinical reasoning. We are tackling a system that appears on every single board exam, usually in a way that's, you know, designed to trip you up: The Esophagus. That's right. And we aren't just casually browsing a textbook today; we are following the source of truth, which for this session is the Table of Contents...\"\n---\n# Section 1. Esophageal Disorders (Dysphagia, Achalasia, & GERD)\nì„ ìƒë‹˜, ì˜¤ëŠ˜ ë‚´ìš©ì€ **USMLE Step 2 CK**ì—ì„œ ì •ë§ ë°¥ ë¨¹ë“¯ì´ ë‚˜ì˜¤ëŠ” Esophagus íŒŒíŠ¸ì…ë‹ˆë‹¤.\nì˜¤ë””ì˜¤ì—ì„œë„ ê°•ì¡°í•˜ë“¯ì´, ë‹¨ìˆœíˆ ì§€ì‹ì„ ë‚˜ì—´í•˜ëŠ” ê²Œ ì•„ë‹ˆë¼ **\"Next Best Step\"**ì„ ê³ ë¥´ëŠ” Clinical Reasoning íë¦„ì„ ì¡ëŠ” ê²Œ í•µì‹¬ì…ë‹ˆë‹¤. í…ìŠ¤íŠ¸ë¶ ëª©ì°¨(TOC) ìˆœì„œëŒ€ë¡œ **Linear**í•˜ê²Œ ë½€ê°œë´…ì‹œë‹¤! ğŸš€\n---\n## 1. Evaluation of Dysphagia: The Decision Tree ğŸŒ³\ní™˜ìê°€ \"ì‚¼í‚¤ê¸° í˜ë“¤ì–´ìš”(Dysphagia)\"ë¼ê³  ì™”ì„ ë•Œ, ë¨¸ë¦¿ì†ì—ì„œ ê°€ì¥ ë¨¼ì € ê·¸ë ¤ì•¼ í•  ì•Œê³ ë¦¬ì¦˜ì…ë‹ˆë‹¤.\n```\nDysphagia (Difficulty Swallowing)\nâ”‚\nâ”œâ”€â”€ Question 1: ëª©ì—ì„œ ì•ˆ ë„˜ì–´ê°€ë‚˜ìš”? vs ê°€ìŠ´ì—ì„œ ê±¸ë¦¬ë‚˜ìš”?\nâ”‚   â”‚\nâ”‚   â”œâ”€â”€ \"Initiating(ì‹œì‘)ì´ í˜ë“¤ì–´ìš”, ê¸°ì¹¨ì´ ë‚˜ìš”, ì½”ë¡œ ì—­ë¥˜í•´ìš”\"\nâ”‚   â”‚   â””â”€â”€ Oropharyngeal Dysphagia (Top issue)\nâ”‚   â”‚       â”œâ”€â”€ Etiologies: Stroke, Dementia, Myasthenia Gravis, Zenker's\nâ”‚   â”‚       â””â”€â”€ Next Best Step: Video Fluoroscopic Swallowing Study (VFSS)\nâ”‚   â”‚\nâ”‚   â””â”€â”€ \"ì‚¼í‚¤ê¸´ í–ˆëŠ”ë° ê°€ìŠ´ ë’¤(Breastbone)ì— ê±¸ë ¤ìš”\"\nâ”‚       â””â”€â”€ Esophageal Dysphagia (Plumbing issue)\nâ”‚           â”‚\nâ”‚           â””â”€â”€ Question 2: Solids only? vs Solids & Liquids?\nâ”‚               â”‚\nâ”‚               â”œâ”€â”€ Solids Only (ì ì§„ì  ì§„í–‰) â†’ Mechanical Obstruction ğŸ§±\nâ”‚               â”‚   â”œâ”€â”€ Etiologies: Stricture, Web, Cancer (Tumor)\nâ”‚               â”‚   â””â”€â”€ History Check:\nâ”‚               â”‚       â”œâ”€â”€ Caustic injury/Radiation? â†’ Stricture\nâ”‚               â”‚       â”œâ”€â”€ Older age, Wt loss? â†’ Cancer\nâ”‚               â”‚   â””â”€â”€ Next Best Step: Barium Swallow â†’ Endoscopy\nâ”‚               â”‚\nâ”‚               â””â”€â”€ Solids & Liquids (ì²˜ìŒë¶€í„° ë‘˜ ë‹¤) â†’ Motility Disorder ğŸŒŠ\nâ”‚                   â”œâ”€â”€ Etiologies: Achalasia, Spasm, Scleroderma\nâ”‚                   â””â”€â”€ Next Best Step: Barium Swallow â†’ Manometry\n```\n- **Key Concept:** **Solids & Liquids**ê°€ ë™ì‹œì— ì•ˆ ë‚´ë ¤ê°€ë©´ ê¸°ëŠ¥ì ì¸ ë¬¸ì œ(Muscle failure), **Solid**ë¶€í„° ì‹œì‘í•´ì„œ ì§„í–‰ë˜ë©´ ë¬¼ë¦¬ì ì¸ ë§‰í˜(Mechanical block)ì„ ì˜ì‹¬í•´ì•¼ í•©ë‹ˆë‹¤.\n---\n## 2. Achalasia: The Prototype of Motility Disorders ğŸ¦…\n**Achalasia**ëŠ” Motility disorderì˜ ëŒ€í‘œ ì£¼ìì…ë‹ˆë‹¤.\n- **Pathophysiology:** Lower Esophageal Sphincter (LES)ê°€ ì´ì™„(Relaxation)ì„ ëª» í•¨. ê½‰ ë‹«í˜€ìˆëŠ” ìƒíƒœ.\n- **Clinical Presentation:** Solids & Liquids dysphagia from the start. (ë¬¼ë„ ì•ˆ ë„˜ì–´ê°)\n### ğŸ©º Diagnostic Workup (High Yield Order)\nUSMLEëŠ” \"ê°€ì¥ ì •í™•í•œ ê²€ì‚¬\"ì™€ \"ê°€ì¥ ë¨¼ì € í•  ê²€ì‚¬\"ë¥¼ êµ¬ë¶„í•´ì„œ ë¬¼ì–´ë´…ë‹ˆë‹¤. ì´ ìˆœì„œê°€ í‹€ë¦¬ë©´ ì˜¤ë‹µì…ë‹ˆë‹¤.\n1. **Best Initial Test:** **Barium Swallow**\n- **Finding:** **Bird's Beak appearance** (ìƒˆ ë¶€ë¦¬ ëª¨ì–‘). ì‹ë„ í•˜ë¶€ê°€ ë¾°ì¡±í•˜ê²Œ ì¢ì•„ì ¸ ìˆê³  ìœ„ìª½ì€ ëŠ˜ì–´ë‚˜ ìˆìŒ.\n- \n    1. **Most Accurate Test (Confirmatory):** **Manometry**\n- **Finding:** Aperistalsis (ì—°ë™ìš´ë™ ì†Œì‹¤) + Incomplete relaxation of LES. ì••ë ¥ì„ ì¬ì„œ ê·¼ìœ¡ì´ ì•ˆ ì›€ì§ì´ëŠ” ê±¸ ì¦ëª…í•´ì•¼ í™•ì§„ì…ë‹ˆë‹¤.\n1. **Mandatory Step (Rule out Cancer):** **Endoscopy (EGD)**\n- **Why?** **Pseudo-achalasia** ë•Œë¬¸ì…ë‹ˆë‹¤.\n- **Pseudo-achalasia:** ìœ„ì‹ë„ ì ‘í•©ë¶€(GE junction)ì— ìƒê¸´ **Tumor(Cancer)**ê°€ ì‹ ê²½ì„ ì¹¨ë²”í•´ì„œ Achalasiaì™€ ë˜‘ê°™ì€ ì¦ìƒ/ì†Œê²¬ì„ ë³´ì¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n- â˜… **Tip:** í™˜ìê°€ 60ì„¸ ì´ìƒì´ê±°ë‚˜, ì²´ì¤‘ ê°ì†Œê°€ ê¸‰ê²©í•˜ê³  ì‹¬í•˜ë‹¤ë©´(Significant weight loss) ë°˜ë“œì‹œ ì•”ì„ ì˜ì‹¬í•˜ê³  ë‚´ì‹œê²½ìœ¼ë¡œ í™•ì¸í•´ì•¼ í•©ë‹ˆë‹¤.\n---\n## 3. Medication-Induced Esophagitis (Pill Esophagitis) ğŸ’Š","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-1"}
{"chunk_type":"transcript_chunk","text":"ì Šê³  ê±´ê°•í•œ í™˜ìê°€ ê°‘ìê¸° ìê³  ì¼ì–´ë‚¬ëŠ”ë° ê°€ìŠ´ì´ íƒ€ëŠ” ë“¯ì´ ì•„í”„ë‹¤(Excruciating chest pain)? ë²”ì¸ì€ ë°”ë¡œ \"ì•½\"ì…ë‹ˆë‹¤.\n- **Vignette:** \"ìê¸° ì „ì— ì•½ ë¨¹ê³  ë¬¼ì„ ê±°ì˜ ì•ˆ ë§ˆì‹œê³  ë°”ë¡œ ëˆ„ì› ì–´ìš”.\" (The Dry Swallower)\n- **4 Major Culprits (ì™¸ì›Œì•¼ í•  ì•½ë¬¼ 4ê°€ì§€):**\n1. **Antibiotics:** Specifically **Tetracyclines** (Doxycycline ë“±). ì‚°ì„±ì´ ê°•í•´ ì‹ë„ë¥¼ ì§ì ‘ íƒœì›€.\n2. **Anti-inflammatories:** Aspirin & **NSAIDs**.\n3. **Bisphosphonates:** Alendronate, Risedronate (ê³¨ë‹¤ê³µì¦ ì•½). ë³µìš© ì§€ì¹¨(30ë¶„ê°„ ì„œ ìˆê¸°)ì´ ê¹Œë‹¤ë¡œìš´ ì´ìœ ì…ë‹ˆë‹¤.\n4. **Others:** Potassium chloride, Iron supplements.\n- **Treatment:** ì•½ì„ ì¤‘ë‹¨í•˜ë©´ í•´ê²°ë©ë‹ˆë‹¤. ì´ê±´ ì‹œìˆ ì´ í•„ìš”í•œ ë³‘ì´ ì•„ë‹™ë‹ˆë‹¤.\n---\n## 4. GERD (Gastroesophageal Reflux Disease) ğŸ”¥\nê°€ì¥ í”í•˜ì§€ë§Œ, ê·¸ë ‡ê¸° ë•Œë¬¸ì— í•¨ì •ì´ ë§ìŠµë‹ˆë‹¤. **\"Scope(ë‚´ì‹œê²½)ì„ í•  ê²ƒì¸ê°€, ë§ ê²ƒì¸ê°€?\"**ê°€ ì¶œì œ í¬ì¸íŠ¸ì…ë‹ˆë‹¤.\n### ğŸš¦ Management Algorithm\n1. **Typical Symptoms (Heartburn, Regurgitation) + No Alarm Features:**\n- **Diagnosis:** Clinical Diagnosis. ê²€ì‚¬ í•„ìš” ì—†ìŒ.\n- **Treatment:** **Lifestyle modification + PPI trial (Once daily) for 2 months.**\n- ë§Œì•½ ì¦ìƒì´ ì¢‹ì•„ì§€ë©´? Great. ë‚˜ì¤‘ì— ì¤„ì—¬ë´…ë‹ˆë‹¤.\n- ë§Œì•½ 2ë‹¬ ì¼ëŠ”ë°ë„ íš¨ê³¼ê°€ ì—†ìœ¼ë©´? (Refractory) â†’ PPIë¥¼ 2ë°°ë¡œ ì¦ëŸ‰(Twice daily)í•˜ê±°ë‚˜ ë‹¤ë¥¸ PPIë¡œ êµì²´. ê·¸ë˜ë„ ì•ˆ ë˜ë©´ **Endoscopy** ê³ ë ¤.\n1. **Alarm Features (Red Flags) ğŸš©:**\n- ì´ê²Œ ìˆìœ¼ë©´ PPI ì£¼ì§€ ë§ê³  **ë°”ë¡œ Endoscopy (EGD)** í•´ì•¼ í•©ë‹ˆë‹¤.\n- **Risk Factors:** **Men > 50yo + Symptoms > 5 years** (Barrett's/Cancer risk screening).\n- **Alarm Symptoms:**\n- Dysphagia (ì‚¼í‚´ ê³¤ë€) / Odynophagia (ì‚¼í‚¬ ë•Œ í†µì¦)\n- Weight loss (ì˜ë„ì¹˜ ì•Šì€ ì²´ì¤‘ ê°ì†Œ)\n- Anemia / GI Bleeding (Melena, Hematemesis)\n- Vomiting (Persistent)\n---\n## 5. Eosinophilic Esophagitis (EoE) ğŸŒ¸\n\"Asthma of the Esophagus\"ë¼ê³  ìƒê°í•˜ë©´ ë©ë‹ˆë‹¤.\n- **Patient:** ì Šì€ ë‚¨ì (20ëŒ€ í›„ë°˜), **Atopy History** (Asthma, Eczema, Allergies)ê°€ ìˆìŒ.\n- **Symptom:** ê³ ê¸°ë¥¼ ë¨¹ë‹¤ê°€ ê±¸ë¦¼ (**Food Impaction**). GERD ì¦ìƒ ê°™ì§€ë§Œ PPIì— ë°˜ì‘ ì•ˆ í•¨.\n- **Diagnosis:** **Biopsy** í•„ìˆ˜.\n- **Criteria:** **â‰¥ 15 Eosinophils / hpf** (High Power Field).\n- ë°˜ë“œì‹œ GERD(ì‚° ì—­ë¥˜ë¡œ ì¸í•œ í˜¸ì‚°êµ¬ ì¦ê°€)ì™€ ê°ë³„í•´ì•¼ í•¨.\n- **Treatment:**\n1. **Elimination Diet:** 6-food elimination (Dairy, Wheat, Soy, Eggs, etc.)\n2. **PPI:** í•­ì—¼ì¦ íš¨ê³¼ê°€ ìˆì–´ ì‹œë„í•´ë´„.\n3. **Topical Glucocorticoids:** **Swallowed Fluticasone/Budesonide**. (í¡ì…ì œë¥¼ ì…ì•ˆì— ë¿Œë¦¬ê³  ì‚¼í‚¤ê²Œ í•¨)\n---\n## 6. Stress Ulcer Prophylaxis (ICU Guideline) ğŸ¥\në³‘ì›ì— ì…ì›í•œ ëª¨ë“  í™˜ìì—ê²Œ PPIë¥¼ ì£¼ë©´ ì•ˆ ë©ë‹ˆë‹¤. (C.diff, Pneumonia ìœ„í—˜ ì¦ê°€).\n**Prophylaxis Indications (Major & Minor)**ë¥¼ ì•Œì•„ì•¼ í•©ë‹ˆë‹¤.\n- **One Major Factor (í•˜ë‚˜ë§Œ ìˆì–´ë„ PPI íˆ¬ì—¬):**\n1. **Coagulopathy:** Plt < 50k, INR > 1.5, PTT > 2x Normal.\n2. **Mechanical Ventilation > 48 hours.**\n3. **GI Bleed / Ulcer history** (last 12 months).\n4. **Severe Trauma:** Head trauma, Spinal cord injury, Major Burn.\n- **Two Minor Factors:** Sepsis, ICU stay > 1 week, Occult bleeding, High dose steroids ë“±. (ë³´í†µ Majorê°€ ì¤‘ìš”í•¨)\n---","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-21"}
{"chunk_type":"recap_summary","text":"## ğŸ”¥ Rapid Fire Recap (High Yield Summary)\n| Clinical Vignette (ìƒí™©) | Diagnosis (ì§„ë‹¨) | Key Action / Concept (í•µì‹¬) |\n| --- | --- | --- |\n| **Solid**ë¶€í„° ì‹œì‘í•´ì„œ **Liquid**ë¡œ ì§„í–‰ë˜ëŠ” ì‚¼í‚´ ê³¤ë€ | **Mechanical Obstruction** (Stricture/Cancer) | **Barium Swallow** ë¨¼ì € í•´ì„œ ìœ„ì¹˜/ëª¨ì–‘ í™•ì¸í•˜ê³  ë‚´ì‹œê²½(EGD). |\n| ì²˜ìŒë¶€í„° **Solid & Liquid** ë‘˜ ë‹¤ ì•ˆ ë„˜ì–´ê° | **Motility Disorder** (Achalasia/Spasm) | **Manometry**ê°€ Confirmatory test. (ì••ë ¥ ì¸¡ì • í•„ìˆ˜) |\n| Bariumì—ì„œ **Bird's beak** ì†Œê²¬ + ì²´ì¤‘ ê°ì†Œ ì‹¬í•¨ | **Pseudo-achalasia** (Cancer suspicion) | Achalasiaë¡œ ë‹¨ì • ê¸ˆì§€. ë°˜ë“œì‹œ **EGD**ë¡œ ì•”ì„ ë°°ì œí•  ê²ƒ(Rule out malignancy). |\n| ìê¸° ì „ ì•½ ë¨¹ê³  ë‚œ ë’¤ ê·¹ì‹¬í•œ í‰í†µ (Odynophagia) | **Pill-induced Esophagitis** | ì›ì¸: **Tetracycline, Bisphosphonates, NSAIDs**. ì¹˜ë£ŒëŠ” ì•½ ì¤‘ë‹¨/ë¬¼ ë§ì´ ë§ˆì‹œê¸°. |\n| 55ì„¸ ë‚¨ì„±, 10ë…„ ëœ ì†ì“°ë¦¼ (Heartburn) | **GERD** (Screening Candidate) | 50ì„¸ ì´ìƒ ë‚¨ì„± + 5ë…„ ì´ìƒ ì¦ìƒì€ **Barrett's** ìœ„í—˜êµ° â†’ **Endoscopy** ì‹œí–‰. |\n| ì Šì€ ì²œì‹ í™˜ì, ê³ ê¸° ë¨¹ë‹¤ ê±¸ë¦¼, PPI ë°˜ì‘ ì—†ìŒ | **Eosinophilic Esophagitis (EoE)** | Biopsyì—ì„œ **>15 Eosinophils**. ì¹˜ë£ŒëŠ” **Swallowed Steroid**. |\n| ICU í™˜ì, ì¸ê³µí˜¸í¡ê¸° 3ì¼ì§¸ ì ìš© ì¤‘ | **Stress Ulcer Risk** | Major risk factor(Vent > 48h) ìˆìŒ â†’ **PPI Prophylaxis** ì‹œì‘. |\n| ì•„ì¹¨ì— ê¹¨ë©´ ì…ì—ì„œ ì‹ ë§›ì´ ë‚¨, ê²½ê³  ì¦ìƒ ì—†ìŒ | **Uncomplicated GERD** | ê²€ì‚¬ ì—†ì´ **PPI 2ë‹¬** ì¹˜ë£Œ (Lifestyle + PPI trial). |\n| PPI ë¨¹ê³  ìˆëŠ”ë° ë°¤ì— ìë‹¤ê°€ ê°‘ìê¸° 3ì‹œì— ì†ì“°ë ¤ì„œ ê¹¸ | **Nocturnal Acid Breakthrough** | í™˜ìê°€ \"Refractory\"í•œì§€ í™•ì¸ í•„ìš”? ì•„ë‹ˆìš”, ì´ê±´ **Dosing** ë¬¸ì œì¼ ìˆ˜ë„. (ì˜¤ë””ì˜¤ì—ëŠ” ì—†ëŠ” ë‚´ìš©ì´ë‚˜ ì°¸ê³ : ì•¼ê°„ ì‚°ë¶„ë¹„ ê³ ë ¤) *ì˜¤ë””ì˜¤ ë‚´ìš© ê¸°ì¤€: 2ë‹¬ ì¹˜ë£Œ ì‹¤íŒ¨ ì‹œ ì¦ëŸ‰/êµì²´.* |\n---\n**[Next Step for User]**\nì„ ìƒë‹˜, Esophagus íŒŒíŠ¸ëŠ” **Algorithm** ì‹¸ì›€ì…ë‹ˆë‹¤. íŠ¹íˆ **\"Solid vs Liquid\"** êµ¬ë¶„ê³¼ **\"Alarm feature ìœ ë¬´ì— ë”°ë¥¸ Scope ê²°ì •\"** ì´ ë‘ ê°€ì§€ê°€ ì‹œí—˜ì˜ 70%ë¥¼ ì°¨ì§€í•©ë‹ˆë‹¤. ë‹¤ìŒ ì„¹ì…˜(Stomach/Small Bowel)ìœ¼ë¡œ ë„˜ì–´ê°€ê¸° ì „ì—, ìœ„ í‘œì˜ Rapid Fire ë‚´ìš©ì„ ê°€ë¦¬ê³  ë‹µí•  ìˆ˜ ìˆëŠ”ì§€ ìê°€ í…ŒìŠ¤íŠ¸ í•œë²ˆ í•´ë³´ì‹œê² ìŠµë‹ˆê¹Œ?\nHere is the comprehensive study guide based on the audio file provided.\n### ğŸ§ One Line Vibe & Summary\n**\"Stomach Pathology: From toxic erosions to paralyzed pumps â€“ distinguishing functional failure from mechanical blocks.\"**\nì´ë²ˆ ì—í”¼ì†Œë“œëŠ” ìœ„ì¥ê´€(Stomach)ì—ì„œ ë°œìƒí•  ìˆ˜ ìˆëŠ” ë³‘ë¦¬í•™ì  ìƒíƒœë¥¼ 3.1ë¶€í„° 3.5ê¹Œì§€ **Erosion(ë¯¸ë€), Motility(ìš´ë™ì„±), Obstruction(íì‡„)**ì˜ ê´€ì ì—ì„œ ì •ë¦¬í–ˆìŠµë‹ˆë‹¤. íŠ¹íˆ Functional disorderì™€ Mechanical obstructionì„ êµ¬ë¶„í•˜ëŠ” ê²ƒì´ í•µì‹¬ì…ë‹ˆë‹¤.\n---\n### ğŸ“ 0:00~0:30 Dictation (Verbatim Verification)","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-37"}
{"chunk_type":"transcript_chunk","text":"\"Welcome back to the deep dive. We have locked the doors to the study room, silenced our pagers, and we are getting strictly into board prep mode. Absolutely. If you are a learner getting ready for step 2 CK or just trying to survive your internal medicine rotation, you are in the right place. We are cutting through all the noise today. No fluff, just high yield concepts. We're gonna focus on the stomach. Right.\"\n---\n### ğŸŒ³ Top-down Classification (ASCII Text Tree)\nì˜í•™ì ì¸ Contextë¥¼ ì¡ê¸° ìœ„í•´ Stomach Pathologyë¥¼ **Toxic, Functional, Mechanical** ì„¸ ê°€ì§€ í° ì¤„ê¸°ë¡œ ë‚˜ëˆ„ì–´ êµ¬ì¡°í™”í–ˆìŠµë‹ˆë‹¤.\nPlaintext\n`STOMACH PATHOLOGY (USMLE Step 2 CK Focus)\nâ”‚\nâ”œâ”€â”€ 1. Toxic/Acute Injury (The \"Burn\")\nâ”‚   â””â”€â”€ Acute Erosive Gastropathy ğŸ©¸\nâ”‚       â”œâ”€â”€ Etiology: Alcohol + Cocaine + NSAIDs (Synergistic Attack)\nâ”‚       â””â”€â”€ Key Feature: Hematemesis, Hemorrhagic lesions\nâ”‚\nâ”œâ”€â”€ 2. Functional/Motility Disorders (The \"Paralysis\")\nâ”‚   â”œâ”€â”€ Cyclic Vomiting Syndrome ğŸ”„\nâ”‚   â”‚   â”œâ”€â”€ Link: Migraine equivalent\nâ”‚   â”‚   â””â”€â”€ Key: \"Stereotypical\" episodes + Asymptomatic intervals\nâ”‚   â”‚\nâ”‚   â”œâ”€â”€ Gastroparesis (Delayed Emptying) ğŸŒ\nâ”‚   â”‚   â”œâ”€â”€ Etiology: Diabetes (Autonomic Neuropathy)\nâ”‚   â”‚   â”œâ”€â”€ Dx: EGD (Rule out mech) â†’ Scintigraphy (Gold Std)\nâ”‚   â”‚   â””â”€â”€ Rx: Metoclopramide, Erythromycin\nâ”‚   â”‚\nâ”‚   â””â”€â”€ Constipation (Lower GI Motility) ğŸ›‘\nâ”‚       â””â”€â”€ Opioid Induced vs. Laxative Abuse (Bisacodyl toxicity)\nâ”‚\nâ””â”€â”€ 3. Mechanical Obstruction (The \"Blockage\")\n    â””â”€â”€ Gastric Outlet Obstruction (GOO) ğŸš§\n        â”œâ”€â”€ Etiology: PUD Stricture, Malignancy\n        â”œâ”€â”€ Key Feature: Projectile, Non-bilious vomiting\n        â””â”€â”€ Succussion Splash (+)`\n---\n# # Ep 3.1-3.5. Stomach Pathology: From Erosion to Obstruction\n## 3.1 Dyspepsia & Stomach Pathology: Acute Erosive Gastropathy ğŸ©¸\nìˆ ê³¼ ë§ˆì•½, ì§„í†µì œê°€ ìœ„ì ë§‰ì— ê°€í•˜ëŠ” **Synergistic Attack(ìƒìŠ¹ ì‘ìš©)**ì— ëŒ€í•œ ë‚´ìš©ì…ë‹ˆë‹¤. ë‹¨ìˆœí•œ ìœ„ì—¼(Gastritis)ì´ ì•„ë‹ˆë¼ ìœ„ì ë§‰ì´ ë²—ê²¨ì§€ëŠ” ìƒí™©(Erosive)ì„ì„ ëª…ì‹¬í•´ì•¼ í•©ë‹ˆë‹¤.\n- **Clinical Vignette:**\n    - ì‹¬í•œ ë³µí†µê³¼ **Hematemesis(í† í˜ˆ)**ë¡œ ë‚´ì›í•œ í™˜ì.\n    - **History:** Recent binge of **Alcohol + Cocaine**.\n- **Pathophysiology (The Perfect Storm):**\n    1. **Cocaine:** Potent Vasoconstrictor â†’ ìœ„ë²½ í˜ˆê´€ì„ ìˆ˜ì¶•ì‹œì¼œ **Ischemia(í—ˆí˜ˆ)** ìœ ë°œ. Oxygen supply ì°¨ë‹¨.\n    2. **Aspirin/NSAIDs:** Prostaglandin(ìœ„ì ë§‰ ë³´í˜¸ë§‰, Mucous shield) ìƒì„± ì–µì œ â†’ ë°©ì–´ë ¥ ê°ì†Œ.\n    3. **Alcohol:** Direct Toxin â†’ ìƒí”¼ì„¸í¬(Epithelial cells)ë¥¼ ì§ì ‘ íŒŒê´´.\n    - **Result:** ë°©ì–´ë§‰ì´ ì—†ê³ (NSAIDs), í”¼ë„ ì•ˆ í†µí•˜ëŠ”(Cocaine) ìœ„ë²½ì— ì•Œì½”ì˜¬ì„ ë¶“ëŠ” ê²© â†’ **Acute Erosive Gastropathy** ë°œìƒ.\n- **Management:**\n    - Supportive care. ì›ì¸ ë¬¼ì§ˆ ì¤‘ë‹¨ ì‹œ íšŒë³µ ê°€ëŠ¥.\n## 3.2 Vomiting & Diarrhea: Cyclic Vomiting Syndrome ğŸ”„\nì†Œì•„ë‚˜ ì Šì€ ì„±ì¸ì—ì„œ ë°œìƒí•˜ëŠ” **Functional disorder**ì…ë‹ˆë‹¤. ìœ„ì¥ê´€ì˜ ë¬¸ì œë¼ê¸°ë³´ë‹¤ëŠ” **Brain-Gut Axis**ì˜ ë¬¸ì œ, íŠ¹íˆ í¸ë‘í†µ(Migraine)ê³¼ì˜ ì—°ê´€ì„±ì´ ë†’ìŠµë‹ˆë‹¤.\n- **Diagnosis of Exclusion:** ê¸°ì§ˆì  ì›ì¸(Anatomy, Metabolic)ì„ ëª¨ë‘ ë°°ì œí•œ í›„ ì§„ë‹¨í•©ë‹ˆë‹¤.\n- **Key Diagnostic Criteria:**\n    1. **Disproportionate Intensity:** ì‹œê°„ë‹¹ 4íšŒ ì´ìƒì˜ ê²©ë ¬í•œ êµ¬í† . í™˜ìëŠ” ë§¤ìš° ë¹„ì°¸í•´ ë³´ì„(Miserable).\n    2. **Stereotypical Episodes:** ë§¤ë²ˆ ë°œì‘ì´ ë˜‘ê°™ì€ ì–‘ìƒ(ì‹œê°„, ì§€ì† ê¸°ê°„ ë“±)ì„ ë³´ì„. \"It follows a script.\"\n    3. **Asymptomatic Interval (â˜…Crucial):** ë°œì‘ ì‚¬ì´ì—ëŠ” **\"Totally fine\"** (ì™„ë²½í•˜ê²Œ ì •ìƒ). ë¶€ëª¨ë‹˜ì´ \"ì–´ì œê¹Œì§„ ì¶•êµ¬í•˜ê³  í”¼ì ë¨¹ê³  ë©€ì©¡í–ˆì–´ìš”\"ë¼ê³  ë§í•¨.\n- **Associations:**\n    - **Migraines:** ê°€ì¡±ë ¥ì´ ìˆê±°ë‚˜, í™˜ì ë³¸ì¸ì´ í¸ë‘í†µì´ ìˆì„ í™•ë¥ ì´ ë†’ìŒ. \"Migraine equivalent in the gut.\"\n    - ì¹˜ë£Œì œë„ í¸ë‘í†µì•½(Triptans, Amitriptyline)ì´ íš¨ê³¼ê°€ ìˆìŒ.\n- **âš ï¸ Warning:** ë°œì‘ ì‚¬ì´(Interval)ì— ë³µí†µì´ë‚˜ ë©”ìŠ¤êº¼ì›€ì´ ë‚¨ì•„ìˆë‹¤ë©´ ì´ ì§„ë‹¨ì€ í‹€ë¦° ê²ƒì…ë‹ˆë‹¤. ë‹¤ë¥¸ í•´ë¶€í•™ì  ë¬¸ì œë‚˜ ëŒ€ì‚¬ ì§ˆí™˜ì„ ì°¾ì•„ì•¼ í•©ë‹ˆë‹¤.\n## 3.3 Constipation: Opioids & Laxative Abuse ğŸ’Š\në³€ë¹„ íŒŒíŠ¸ì—ì„œëŠ” íŠ¹íˆ ì•½ë¬¼ ìœ ë°œì„± ë³€ë¹„ì™€ í•˜ì œ ë‚¨ìš©ì˜ ìœ„í—˜ì„±ì„ ë‹¤ë£¹ë‹ˆë‹¤.\n### A. Opioid Induced Constipation\n- **Mechanism:** OpioidëŠ” ì¥ì˜ Peristalsis(ì—°ë™ ìš´ë™)ë¥¼ ë§ˆë¹„ì‹œí‚´.\n- **Clinical Pearl:** ìˆ˜ìˆ  í›„ë‚˜ ë§Œì„± í†µì¦ í™˜ìì—ì„œ ê°€ì¥ í”í•˜ê²Œ ë†“ì¹˜ëŠ” ë¶€ì‘ìš©.\n### B. Laxative Abuse (Bisacodyl Warning)\n- **Problem:** **Stimulant Laxative (ì˜ˆ: Bisacodyl)**ì˜ ì¥ê¸° ì‚¬ìš©.\n- **Complication:** **Protein Losing Enteropathy.**\n    - ì¥ì„ ì–µì§€ë¡œ ì§œë‚´ë‹¤ ë³´ë‹ˆ(Whipping a tired horse), ì¥ ì ë§‰ì´ ì†ìƒë˜ê³  Leakyí•´ì§.\n- **Classic Lab Findings (The Board Question):**\n    - **Hypokalemia (Low K+):** ì„¤ì‚¬ë¡œ ì¸í•œ ì „í•´ì§ˆ ì†Œì‹¤.\n    - **Low Protein:** ë‹¨ë°±ì§ˆì´ ëŒ€ë³€ìœ¼ë¡œ ë¹ ì ¸ë‚˜ê°.\n    - **General Weakness:** ì €ì¹¼ë¥¨í˜ˆì¦ ë° ì˜ì–‘ ê²°í•.\n    - â†’ ìê°€ë©´ì—­ì§ˆí™˜ ë“±ì„ ì˜ì‹¬í•˜ê¸° ì „ì— í™˜ìê°€ ì•½êµ­ì—ì„œ ë³€ë¹„ì•½ì„ ì‚¬ ë¨¹ê³  ìˆëŠ”ì§€ í™•ì¸í•˜ì„¸ìš”.","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-47"}
{"chunk_type":"transcript_chunk","text":"## 3.4 Gastroparesis (Diabetic Gastroparesis) ğŸŒ\nìœ„ê°€ ê¸°ê³„ì ìœ¼ë¡œ ë§‰íŒ ê²Œ ì•„ë‹ˆë¼, ì‹ ê²½ë³‘ì¦ìœ¼ë¡œ ì¸í•´ **\"ê¸°ëŠ¥ì ìœ¼ë¡œ ë§ˆë¹„ëœ\"** ìƒíƒœì…ë‹ˆë‹¤. ë‹¹ë‡¨ë³‘ í™˜ì ë¬¸ì œì—ì„œ ë‹¨ê³¨ ì¶œì œë©ë‹ˆë‹¤.\n- **Pathophysiology:** Long-standing Diabetes â†’ **Autonomic Neuropathy** (Vagus nerve damage) â†’ Stomach fails to squeeze.\n- **Symptoms:**\n    - **Early Satiety (ì¡°ê¸° í¬ë§Œê°):** ì¡°ê¸ˆë§Œ ë¨¹ì–´ë„ ë°°ë¶€ë¦„.\n    - **Bloating & Vomiting:** ì‹ì‚¬ í›„ ìˆ˜ ì‹œê°„ ë’¤ì— **\"Undigested food(ì†Œí™” ì•ˆ ëœ ìŒì‹)\"**ë¥¼ í† í•¨.\n    - **Labile Glucose:** ì¸ìŠë¦°ì€ ë“¤ì–´ê°”ëŠ”ë° ìŒì‹ì€ ìœ„ì—ì„œ ì•ˆ ë‚´ë ¤ê°(Hypoglycemia) â†’ ë‚˜ì¤‘ì— ê°‘ìê¸° ìŒì‹ì´ ë‚´ë ¤ê°€ì„œ í¡ìˆ˜ë¨(Hyperglycemia). í˜ˆë‹¹ ì¡°ì ˆì´ ë„ë›°ê¸°í•¨.\n- **Physical Exam:**\n    - **Succussion Splash:** ì²­ì§„ê¸°ë¥¼ ëŒ€ê³  ë°°ë¥¼ í”ë“¤ì—ˆì„ ë•Œ \"ì°°ë‘ì°°ë‘\" ë¬¼ì†Œë¦¬ê°€ ë‚¨ (ì‹í›„ 3-4ì‹œê°„ì´ ì§€ë‚¬ëŠ”ë°ë„).\n- **Diagnosis (Step-by-Step):**\n    1. **Step 1: EGD (Upper Endoscopy):** ê¸°ê³„ì ì¸ íì‡„(Cancer, Ulcer Stricture)ë¥¼ **ë¨¼ì € ë°°ì œ(Rule out)**í•´ì•¼ í•¨.\n    2. **Step 2 (Gold Standard): Nuclear Gastric Emptying Study:** ë°©ì‚¬ì„  í‘œì§€ëœ ì‹ì‚¬(Scintigraphic meal)ë¥¼ í•˜ê³  4ì‹œê°„ ë’¤ì— ìœ„ ë°°ì¶œëŠ¥ì„ ì¸¡ì •.\n- **Treatment:**\n    - **Diet:** Small, frequent meals. **Low Fat** (ì§€ë°©ì€ ìœ„ ë°°ì¶œì„ ëŠë¦¬ê²Œ í•¨), **Low Fiber** (Bezoar í˜•ì„± ë°©ì§€).\n    - **Meds:**\n        - **Metoclopramide:** Dopamine antagonist (Pro-kinetic).\n        - **Erythromycin:** Motilin receptor agonist (íš¨ê³¼ëŠ” ì¢‹ìœ¼ë‚˜ Tachyphylaxis/ë‚´ì„± ë•Œë¬¸ì— ë‹¨ê¸° ì‚¬ìš©).\n## 3.5 Gastric Outlet Obstruction (GOO) ğŸš§\nGastroparesisì™€ ì¦ìƒì€ ë¹„ìŠ·í•˜ì§€ë§Œ, ì›ì¸ì€ **\"Physical Roadblock\"**ì…ë‹ˆë‹¤.\n- **Key Symptoms:**\n    - **Projectile Vomiting:** ì••ë ¥ì´ ì°¨ì˜¬ë¼ì„œ ë¶„ìˆ˜í† ë¥¼ í•¨.\n    - **Non-bilious:** ë‹´ì¦™(Bile)ì´ ì„ì´ì§€ ì•ŠìŒ. (íì‡„ ë¶€ìœ„ê°€ ë‹´ê´€ì´ í•©ë¥˜í•˜ëŠ” ì‹­ì´ì§€ì¥ë³´ë‹¤ ìœ„ìª½, ì¦‰ Pylorus ê·¼ì²˜ì´ê¸° ë•Œë¬¸).\n- **Etiologies:**\n    1. **Malignancy:** Antrumì´ë‚˜ Pylorusì˜ ì•”.\n    2. **Peptic Ulcer Disease (PUD):** ë°˜ë³µëœ ê¶¤ì–‘ê³¼ ì¹˜ìœ  ê³¼ì •ì—ì„œ ìƒê¸´ **Scarring/Stricture**.\n    3. **Crohn's Disease:** Duodenal stricture.\n    4. **Caustic Ingestion:** ë¶€ì‹ì„± ë¬¼ì§ˆ ì„­ì·¨ í›„ í‰í„°.\n- **Management:**\n    - **Initial:** NPO, NG tube suction (Decompression), IV fluids/Electrolytes correction.\n    - **âš ï¸ Absolute Contraindication:** **Pro-kinetic drugs** (Metoclopramide ë“±) ì ˆëŒ€ ê¸ˆì§€! ê¸¸ì´ ë§‰í˜€ìˆëŠ”ë° ìœ„ë¥¼ ì§œì£¼ë©´ **Perforation(ì²œê³µ)** ìœ„í—˜ì´ ìˆìŒ.\n    - **Definitive:** Endoscopic dilation or Surgery.\n---\n### ğŸ”¥ Rapid Fire Recap (High Yield Summary)\n| **Clinical Vignette (Keyword)** | **Suspected Diagnosis** | **Key Mechanism/Action** |\n| --- | --- | --- |\n| **Alcohol + Cocaine** binge, Hematemesis | **Acute Erosive Gastropathy** | Ischemia + Loss of protective prostaglandins. |\n| Child, **Stereotypical** vomiting, **Totally fine** between episodes | **Cyclic Vomiting Syndrome** | Related to **Migraine**. Rx: Triptans, Supportive. |\n| Chronic constipation, **Hypokalemia**, Low Protein, Weakness | **Laxative Abuse** (Bisacodyl) | **Protein Losing Enteropathy** due to stimulant laxative overuse. |\n| Diabetic, Early satiety, Vomiting **undigested food**, Glucose swings | **Gastroparesis** | **Autonomic Neuropathy**. Dx: Emptying Study. Rx: Metoclopramide. |\n| Projectile **Non-bilious** vomiting, Hx of PUD, **Succussion splash** | **Gastric Outlet Obstruction** | Mechanical blockage. **Never** give pro-kinetics! |\n---\n### ğŸ©º Tutor's Note for Step 2 CK\n**\"Mechanical vs. Functionalì„ êµ¬ë¶„í•˜ëŠ” ê²ƒì´ ìŠ¹ë¶€ì²˜ì…ë‹ˆë‹¤.\"**\nì‹œí—˜ ë¬¸ì œì—ì„œ í™˜ìê°€ \"ë°¥ ë¨¹ê³  í† í•œë‹¤\"ê³  í•  ë•Œ,\n1. **ë‹¹ë‡¨ë³‘** ë³‘ë ¥ì´ ê¸¸ê³  ì‹ ê²½í†µ(Neuropathy)ì´ ìˆë‹¤ë©´ â†’ **Gastroparesis** (ê¸°ëŠ¥ ë¬¸ì œ, Motility drug ì¤Œ).\n2. **ê¶¤ì–‘(Ulcer)** ë³‘ë ¥ì´ ìˆê±°ë‚˜ ì²´ì¤‘ ê°ì†Œ(Cancer)ê°€ ìˆê³  **Projectile** í•˜ë‹¤ë©´ â†’ **GOO** (êµ¬ì¡° ë¬¸ì œ, Motility drug ê¸ˆê¸°).\n    \n    ì´ ë‘ ê°€ì§€ë¥¼ ê°ë³„í•˜ëŠ” ê²ƒì´ ì†Œí™”ê¸° íŒŒíŠ¸ì˜ í•µì‹¬ ë©˜íƒˆ ëª¨ë¸ì…ë‹ˆë‹¤! ğŸ’ª\nHere are your high-quality lecture notes for USMLE Step 2 CK, based on the audio provided.\n---\n### ğŸ™ï¸ 0:00~0:30 Verbatim Dictation (Verification)\n\"Welcome back to the deep dive. I'm your host, and for this session, I'll be the resident. And I'm the attending. My job is to hold the map, to check the boxes, and make absolutely sure we don't miss a single line item on our study plan today. And my job is to take that map and tell you where the real world landmines are. We're not just here to memorize lists, we're building clinical intuition.\"\n---\n# ğŸ¥ Section 4: Diagnosing Jaundice, Liver Failure, and Cirrhosis","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-67"}
{"chunk_type":"transcript_chunk","text":"ì, ì˜¤ëŠ˜ì€ ìš°ë¦¬ ëª¸ì˜ Metabolic Engineì¸ **Liver**ë¥¼ ì™„ë²½í•˜ê²Œ í•´ë¶€í•´ ë´…ì‹œë‹¤! ğŸ§  ê°„ì€ ë§ê°€ì§€ë©´ ì¦ìƒì´ ì •ë§ ë‹¤ì–‘í•˜ê²Œ ë‚˜íƒ€ë‚˜ê¸° ë•Œë¬¸ì— Logicì„ ì¡ëŠ” ê²ƒì´ í•µì‹¬ì…ë‹ˆë‹¤.\n## 4.1 Jaundice (í™©ë‹¬) ğŸŸ¡\n**\"The Yellow Flag\"**\nJaundiceëŠ” ê°€ì¥ ëˆˆì— ë„ëŠ” ì‚¬ì¸ì´ì§€ë§Œ, Systemì´ ì—†ìœ¼ë©´ ì˜¤ì§„í•˜ê¸° ë”± ì¢‹ìŠµë‹ˆë‹¤.\n### ğŸšª The Doorway Thought (Clinical Vignette)\nê°€ì¥ ë¨¼ì € ë– ì˜¬ë ¤ì•¼ í•  Classic Case: **Painless Jaundice in an Elderly Patient.**\n- **Situation:** 70ì„¸ ë‚¨ì„±, í†µì¦ ì—†ì´ í¸ì•ˆí•´ ë³´ì„(Comfortable).\n- **Sign:** Skin is pumpkin yellow, Sclera is neon.\n- **Intuition:** Painì´ ì—†ëŠ”ë° Jaundiceê°€ ìˆë‹¤? ğŸš¨ ì´ê±´ **Ominous sign**ì…ë‹ˆë‹¤. Something is growing slowly and silently compressing the plumbing (Bile duct). â†’ **Cancer until proven otherwise.** (Gallstoneì€ ë³´í†µ *Hurts a lot*).\n### ğŸŒ³ Diagnostic Algorithm: The Forks in the Road\nJaundice í™˜ìê°€ ì˜¤ë©´ ë¬´ì¡°ê±´ **Bilirubin fractionation**ë¶€í„° ì‹œì‘í•©ë‹ˆë‹¤.\n### 1ï¸âƒ£ First Fork: Unconjugated (Indirect) Hyperbilirubinemia\n- **Mechanism:** Raw materialì´ ë„ˆë¬´ ë§ê±°ë‚˜(Overproduction), ê³µì¥ ì…êµ¬(Uptake) ë¬¸ì œ.\n- **Causes:**\n    - **Hemolysis:** RBCê°€ ê¹¨ì§€ë©´ì„œ Hemeì´ ìŸì•„ì ¸ ë‚˜ì˜´. (Anemia, High Reticulocyte count ë™ë°˜)\n    - **Reduced Uptake/Conjugation Defect:**\n        - **Gilbert Syndrome:** â˜… **High Yield!** \"Medical Student Syndrome\". Stress, Fasting, Sleep deprivation, Illness ì‹œì— mild unconjugated hyperbilirubinemia ë°œìƒ. Liver enzyme(AST/ALT)ì€ ì •ìƒ. **Treatment: Reassurance (Benign).**\n        - **Crigler-Najjar:** í›¨ì”¬ ì‹¬ê°í•œ íš¨ì†Œ ê²°í• (Step 1 ëƒ„ìƒˆê°€ ë‚˜ì§€ë§Œ ì•Œì•„ë‘˜ ê²ƒ).\n### 2ï¸âƒ£ Second Fork: Conjugated (Direct) Hyperbilirubinemia\n- **Mechanism:** ê°„ì´ Conjugationì€ í–ˆëŠ”ë° ë°°ì¶œì„ ëª» í•¨. (Backing up into blood).\n- **Key Question:** ê°„ ì„¸í¬ ìì²´ì˜ ë¬¸ì œì¸ê°€(Hepatocellular)? ì•„ë‹ˆë©´ ê¸¸ì´ ë§‰í˜”ë‚˜(Obstructive)? â†’ **Liver Enzyme (AST, ALT, Alkaline Phosphatase)** íŒ¨í„´ì„ ë´…ë‹ˆë‹¤.\n| **Scenario** | **Pattern** | **Diagnosis / Thinking Process** |\n| --- | --- | --- |\n| **Scenario A** | Normal AST/ALT/Alk Phos, High Direct Bili | **Dubin-Johnson** (Black Liver) or **Rotor Syndrome**. (Transport protein defect). Benign conditions. |\n| **Scenario B** | Elevated AST/ALT (Hepatocellular injury) | **Hepatitis** (Viral, Autoimmune, Tylenol, Ischemia, Alcohol). Cell death â†’ leaking contents. |\n| **Scenario C** | **Elevated Alkaline Phosphatase** (Cholestatic) | **Cholestasis**. Bile flow blocked somewhere. â†’ **Next Step: Imaging!** |\n---\n### ğŸ“· Imaging for Cholestasis (High Alk Phos)\nPlumbing problemì´ ì˜ì‹¬ë˜ë©´ ê·¸ë¦¼ì„ ë´ì•¼ì£ .\n- **First Move:** **RUQ Ultrasound (US)**. (Cheap, No radiation, Great for ducts).\n    - **Dilated Ducts:** ì•„ë˜ìª½ì´ ë§‰í˜”ë‹¤ëŠ” ëœ» (Obstructive). â†’ Stone or Tumor.\n    - **Non-dilated Ducts:** ë¬¸ì œì˜ ì›ì¸ì´ ê°„ ë‚´ë¶€ì˜ ë¯¸ì„¸í•œ ê´€ì— ìˆìŒ (Intrahepatic cholestasis). â†’ **AMA check** (PBC: Primary Biliary Cholangitis).\n- **Advanced Imaging (If US shows obstruction):**\n    - **CT Scan / MRI:** Mass(Tumor)ë¥¼ ì°¾ê¸° ìœ„í•´.\n    - **EUS (Endoscopic Ultrasound) / ERCP:** Biopsyí•˜ê±°ë‚˜ Stoneì„ ë¹¼ë‚´ê±°ë‚˜ Stentë¥¼ ë„£ì„ ë•Œ (Diagnostic & Therapeutic).\n### ğŸ§¬ Malignant Biliary Obstruction (The Scary Side)\n- **Courvoisierâ€™s Sign:** Palpable, **Non-tender** gallbladder in a jaundiced patient. (Tumorê°€ ì„œì„œíˆ ë§‰ì•„ì„œ GBê°€ í’ì„ ì²˜ëŸ¼ ëŠ˜ì–´ë‚¨, ì—¼ì¦ì´ ì—†ì–´ì„œ ì•ˆ ì•„í””).\n- **Key Symptoms:**\n    - **Pruritus (Itching):** Bile saltê°€ í”¼ë¶€ì— ì¹¨ì°©. í™˜ìê°€ ë¯¸ì¹œ ë“¯ì´ ê¸ìŒ.\n    - **Pale Stool (Acholic):** Bileì´ ì¥ìœ¼ë¡œ ëª» ê°€ì„œ ë˜¥ ìƒ‰ê¹”ì´ í•˜ì–—ê²Œ ë³€í•¨ (Clay-colored).\n    - **Dark Urine:** ë¹Œë¦¬ë£¨ë¹ˆì´ í˜ˆì•¡ìœ¼ë¡œ ì—­ë¥˜í•´ì„œ ì†Œë³€ìœ¼ë¡œ ë‚˜ì˜´ (Coca-Cola colored).\n- **Workup:** US â†’ CT â†’ ERCP (Biopsy/Stent).","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-87"}
{"chunk_type":"transcript_chunk","text":"### ğŸ”¨ Specific Etiologies (Cholestatic)\n- **Cholangiocarcinoma:** Bile duct cancer.\n- **Pancreatic Adenocarcinoma:** Head of pancreas tumor blocking the duct. (CA 19-9 marker).\n- **Ampullary Carcinoma:** Where duct enters bowel.\n---\n## 4.2 Acute Liver Failure (ALF) ğŸ’¥\n**\"The Bomb Going Off\"**\në§Œì„± ì§ˆí™˜ì´ ì•„ë‹™ë‹ˆë‹¤. ì´ì „ì— ê±´ê°•í•˜ë˜ ê°„ì´ ê°‘ìê¸°(Acute) ì…§ë‹¤ìš´ ë˜ëŠ” ê²ƒì…ë‹ˆë‹¤. ICU ìƒí™©ì…ë‹ˆë‹¤.\n### âš ï¸ The Diagnostic Triad (Must have ALL 3)\n1. **Severe Acute Liver Injury:** Massive enzyme elevation (AST/ALT > 1000~5000).\n2. **Synthetic Dysfunction:** ê°„ì´ ë‹¨ë°±ì§ˆì„ ëª» ë§Œë“¦. â†’ **INR â‰¥ 1.5** (Coagulopathy).\n3. **Hepatic Encephalopathy:** Altered Mental Status (Confusion, Asterixis). â˜… **Differentiator from Acute Hepatitis!**\n    - í™˜ìê°€ Alertí•˜ê³  ë©€ì©¡í•˜ë©´ ê·¸ëƒ¥ Severe Hepatitisì…ë‹ˆë‹¤.\n    - í™˜ìê°€ Confusedí•˜ê±°ë‚˜ Asterixis(Hand flap)ê°€ ë³´ì´ë©´ **Acute Liver Failure**ì…ë‹ˆë‹¤. â†’ **Transplant Center ì—°ë½!**\n- clinical manifestationìœ¼ë¡œ hypoglycemiaê°€ëŠ¥.\n### â˜ ï¸ Causes of ALF\n- **Viral:** Hep A, B, E (**Not C usually**), HSV, CMV.\n    - hep C: more chronic.\n- **Drugs:** **Acetaminophen (Tylenol)** is King. Also idiosyncratic reactions.\n- **Ischemia:** \"Shock Liver\". Hypotension, Cardiac arrest í›„. AST/ALTê°€ ìˆ˜ì²œê¹Œì§€ ì¹˜ì†Ÿì•˜ë‹¤ê°€ í˜ˆì•• ì¡íˆë©´ ëš ë–¨ì–´ì§ (Up fast, Down fast).\n- **Wilson Disease:** Young patient + Hemolysis + Psychosis/Movement d/o.\n- **Autoimmune Hepatitis.**\n### ğŸ’Š Acetaminophen Toxicity Management\n- **Antidote:** **N-acetylcysteine (NAC)**. Glutathioneì„ ë³´ì¶©í•´ ì¤Œ.\n    - alcoholicsëŠ” glutathioneì´ ë¶€ì¡±í•´ì„œ normal doseë¡œë„ toxicity  ê°€ëŠ¥\n- **Nomogram:** 4ì‹œê°„ì§¸ ë ˆë²¨ì„ ì°ì–´ì„œ Nomogramì— ëŒ€ì…í•´ ê²°ì •. (Rumack-Matthew).\n- **Timing:** ë¹¨ë¦¬ ì¤„ìˆ˜ë¡ ì¢‹ìŠµë‹ˆë‹¤.\n---\n## 4.2.1 & 4.2.2 Cirrhosis & Its Complications ğŸ¥¥\n**\"The Scarred Battlefield\"**\nê°„ì´ Fibrosisë¡œ ë”±ë”±í•´ì ¸ì„œ ê¸°ëŠ¥ë„ ëª»í•˜ê³  í”¼ë„ ëª» í†µí•˜ëŠ” ìƒíƒœì…ë‹ˆë‹¤.\n### Clinical Manifestations\n- Estrogen â†‘: dilates the capillaries.\n    - spider angiomata\n    - gynecomastia\n    - palmar erythema\n- Synthetic function â†“ ì„ ë´ì•¼ë¨!\n    - albumin â†“\n    - INR â†‘\n    - **platelet â†“** (portal hypertension â†’ spleen blood backup â†’ **splenomegaly** â†’ blood sequesteration â†’ platelet destruction)\n- ALT, ASTëŠ” ì •ìƒì¼ ìˆ˜ ìˆìŒ.\n### General Management Strategies","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-107"}
{"chunk_type":"transcript_chunk","text":"1. Step 1: Treat the baseline etiology conditions. (stop the alcohol..)\n2. Step 2: Preventive care: Vaccination. Hep A,B Vaccine.\n3. Step 3: Screening\n    1. Esophageal varices: EGD\n    2. HCC: AFP every 6mo.\n4. Step 4: Decompensated patients ì•„ë˜ ì°¸ê³ \n    1. variceal bleeding\n### ğŸ” Etiologies\n- **Alcohol:** AST:ALT ratio > 2:1 (\"A Scotch and Tonic\" = AST > ALT).\n    - note â˜… : NORMAL  AST, ALT ê°€ëŠ¥. NO healthy cells to die.\n- **Hepatitis C:** Chronic viral infection.\n- **NAFLD/NASH:** ë¹„ë§Œ, ë‹¹ë‡¨ ì¸êµ¬ ì¦ê°€ë¡œ ê¸‰ì¦ ì¤‘. (Diagnosis of exclusion).\n### ğŸš‘ Major Complications Breakdown\n### 1. Variceal Hemorrhage (í”¼ í† í•¨) ğŸ©¸\n- **Pathology:** Portal Hypertensionìœ¼ë¡œ ì‹ë„ ì •ë§¥ì´ ë¶€í’€ì–´ ì˜¤ë¦„. í„°ì§€ë©´ ëŒ€ëŸ‰ ì¶œí˜ˆ.\n- **Screening:** ëª¨ë“  Cirrhosis í™˜ìëŠ” ì§„ë‹¨ ì‹œ **EGD (Endoscopy)** í•´ì•¼ í•¨.\n- **Prophylaxis (ì˜ˆë°©):**\n    - Small varices: Beta-blocker (Nadolol, Propranolol) - Non-selective! (Beta 2 blockade â†’ Splanchnic vasoconstriction ìœ ë„). cf. metoprolol (Beta 1 selective ì‚¬ìš© ì•ˆí•¨)\n    - ì²œì‹ì´ ìˆì–´ì„œ BB ëª» ì“°ê±°ë‚˜ Large varices: **EVL (Endoscopic Variceal Ligation)** banding.\n- **Acute Bleed Management:**\n    1. **ABCs:** 2 large bore IVs, Fluid, Blood.\n    2. **Drugs:** **Octreotide** (Splanchnic vasoconstriction), **Antibiotics** (Ceftriaxone - SBP ì˜ˆë°©, ì‚¬ë§ë¥  ë‚®ì¶¤).\n    3. **Procedure:** Urgent EGD for Banding.\n    4. **Refractory:** TIPS (Transjugular Intrahepatic Portosystemic Shunt). *Warning: TIPS can worsen Encephalopathy (Bypasses the liver filter).*\n### 2. Ascites (ë³µìˆ˜) ğŸ’§\n- **Diagnosis:** Ultrasound.\n- **SAAG Score (Serum-Ascites Albumin Gradient):**\n    - `Serum Albumin - Ascites Albumin`\n    - High gradient = High water pressure\n    - Low gradient = Leaky vessels\n    - **SAAG â‰¥ 1.1:** Portal Hypertension (Cirrhosis, Heart Failure). (Hydrostatic pressureê°€ ë¬¼ì„ ë°€ì–´ëƒ„).\n    - **SAAG < 1.1:** Others (Cancer/Carcinomatosis, TB, Nephrotic syndrome). (Proteinì´ ê°™ì´ ìƒˆì–´ ë‚˜ì˜´).\n- **Management:**\n    - Salt restriction (<2g/day).\n    - Diuretics: **Spironolactone** (Aldosterone blocker) + **Furosemide** (Loop). Ratio 100:40 ìœ ì§€.\n        - Ascites = hyperaldosteronism\n        - ìœ íš¨í˜ˆë¥˜ëŸ‰ ë¶€ì¡±ìœ¼ë¡œ aldosterone ê³¼ë‹¤í•œ ìƒíƒœ â†’ spironolactone\n    - Refractory: Serial Paracentesis (LVP) + Albumin replacement.\n    - ê¸ˆì§€í•  ì•½ë¬¼:\n        - NSAIDs (cirrhotic kidneyëŠ” ë§Œì„±ì ìœ¼ë¡œ í˜ˆë¥˜ëŸ‰ì´ ë¶€ì¡±í•œ ìƒí™©ì¸ë° NSAIDë¡œ prostaglandin ì¤„ì—¬ë²„ë¦¬ë©´ í˜ˆë¥˜ëŸ‰ì´ ê°ì†Œí•´ì„œ ìœ„í—˜í•¨)\n### ğŸ¦  Spontaneous Bacterial Peritonitis (SBP)\n- ë³µìˆ˜ì— ê· ì´ ë“¤ì–´ê°„ ê²ƒ.\n- **Symptoms:** Fever, Abdominal pain, altered mental status in cirrhotic patient.\n    - Cirrhosis í™˜ìëŠ” baseline temp ê°€ ë‚®ìŒ\n    - ì‚´ì§ì´ë¼ë„ ë†’ì€ ë¯¸ì—´ì´ë¼ë„ full work up í•´ì•¼ë¨.\n- **Diagnosis:** Paracentesis. **Neutrophils (PMN) â‰¥ 250/mmÂ³.**\n- **Treatment:** **Ceftriaxone** (or similar 3rd gen Ceph). + **Albumin** (Renal failure ì˜ˆë°©).\n    - albuminì€ ê°ì—¼ë•Œë¬¸ì— ì£¼ëŠ”ê²Œ ì•„ë‹ˆë¼ Renal failureë•Œë¬¸ì— ì£¼ëŠ”ê²ƒì„.\n    - SBPê°€ ìƒê¸°ë©´ massive fluid shift!  â†’ Hepatorenal syndrome, renal failure ìœ ë°œ ê°€ëŠ¥\n    - albumin â†’ intravascular volume â†‘\n- **Prophylaxis:** ì´ì „ì— SBP ê±¸ë ¸ê±°ë‚˜ Ascites proteinì´ ë„ˆë¬´ ë‚®ìœ¼ë©´( <1.5) í‰ìƒ ì˜ˆë°©ì  í•­ìƒì œ (Fluoroquinolone) ë³µìš©.\n### 3. Hepatic Encephalopathy (ê°„ì„±í˜¼ìˆ˜) ğŸ§ \n- **Mechanism:** Ammonia ë“± ë…ì†Œê°€ ë‡Œë¡œ ê°.\n- **Triggers:** Infection (SBP, UTI), GI Bleed (Blood is protein load), Constipation, Hypokalemia, Alkalosis.\n- **Treatment:**\n    - **1st Line:** **Lactulose**.\n        - ì‚°ì„±í™” ê°ì˜¥ìœ¼ë¡œ ì ê¶ˆì„œ ë˜¥ìœ¼ë¡œ ì‹¸ë²„ë¦°ë‹¤.\n        - *â€œWe canâ€™t digest lactulose, but the bacteria in the colon canâ€ ë°•í…Œë¦¬ì•„ê°€ lactulose ë¨¹ê³  H+ë¥¼ ë§Œë“¦.*\n        - H+ë¥¼ ì œê³µí•´ì„œ NH3 â†’ NH4+ë¡œ ë°”ê¿”ì„œ ê°€ë‘¬ì§. positive ionì€ ì¥ì„ ê±´ë„ ìˆ˜ê°€ ì—†ê¸°ë–„ë¬¸. \"Ammonia Trap\"). Goal: 2-3 soft stools/day.\n    - **2nd Line:** **Rifaximin**. (Gut bacteriaë¥¼ ì£½ì—¬ì„œ ì•”ëª¨ë‹ˆì•„ ìƒì‚° ì¤„ì„).\n### NAFLD\n> ëŒ€ì‚¬ì¦í›„êµ° í”„ë¡œí•„ì˜ ë¹„ë§Œí™˜ìê°€ ë¬´ì¦ìƒì´ì§€ë§Œ ê±´ê°•ê²€ì§„ ë°›ìœ¼ëŸ¬ ì˜´. ê°„ìˆ˜ì¹˜ê°€ ì˜¬ë¼ê°€ ìˆë„¤.\n>\n- fatty liver no drinking history.\n- AST/ALT <1\n- Life style modification\n- ì§€ë°©ê»´ì„œ ì—¼ì¦ â†’ ê°„â€ì—¼â€ â†’ fibrosis â†’ cirrhosisâ€¦\n---\n### ğŸ“‰ Liver Scores\n- **Child-Pugh:** Prognosis ì˜ˆì¸¡ (Bilirubin, Albumin, PT/INR, Ascites, Encephalopathy). \"Pour Another Beer At Eleven\".\n- **MELD Score:** Transplant ëŒ€ê¸° ìˆœìœ„ ê²°ì • (Bilirubin, INR, Creatinine + Sodium). *Creatinineì´ ì¤‘ìš”í•¨! ì„¸ê°œ: ë…¸ë‘ìƒ‰, ë¹¨ê°„ìƒ‰, í¬ë ˆì•„í‹°ë‹Œ!*\n---","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-127"}
{"chunk_type":"recap_summary","text":"## ğŸ”¥ Rapid Fire Recap (High Yield Summary)\n1. **Clinical Vignette:** 70ì„¸ ë…¸ì¸, í†µì¦ ì—†ëŠ” í™©ë‹¬ (Painless Jaundice), Courvoisier's sign (ë§Œì ¸ì§€ëŠ” ë‹´ë‚­).\n    - **Diagnosis:** [Malignancy (Pancreatic head cancer, Cholangiocarcinoma)]\n    - **Key Action:** **CT Abdomen** or **US** first. **Do NOT** assume stones.\n2. **Clinical Vignette:** ì Šì€ í™˜ì, ìŠ¤íŠ¸ë ˆìŠ¤ ë°›ê±°ë‚˜ êµ¶ì—ˆë”ë‹ˆ ê²½ë¯¸í•œ í™©ë‹¬ (Mild unconjugated hyperbilirubinemia). ê°„ìˆ˜ì¹˜ ì •ìƒ.\n    - **Diagnosis:** [Gilbert Syndrome]\n    - **Key Action:** **Reassurance**. No treatment needed.\n3. **Clinical Vignette:** Cirrhosis í™˜ì, Confusion, Asterixis (Hand flapping).\n    - **Diagnosis:** [Hepatic Encephalopathy]\n    - **Key Action:** Check for triggers (Infection, GI bleed, Constipation). Start **Lactulose**.\n4. **Clinical Vignette:** Acute Liver Failure Triad?\n    - **Answer:** [Severe Liver Injury (High LFTs) + Coagulopathy (INR â‰¥ 1.5) + Encephalopathy]\n    - **Trap:** Mental statusê°€ ì •ìƒì´ë©´ Acute Hepatitisì´ì§€ ALFê°€ ì•„ë‹˜! â˜…\n    - Hep C ëŠ” ì›ì¸ì•„ë‹˜! íƒ€ì´ë ˆë†€ì€ ì›ì¸ì„\n5. SAAG >1.1 : High Hydrostatic portal Hypertension / SAAG <1.1 : Low Leaky albumin\n6. **Clinical Vignette:** Ascites í™˜ì, **ë¯¸ì—´ â˜…**  ë°œìƒ. Paracentesisì—ì„œ PMN > 250.\n    - **Diagnosis:** [Spontaneous Bacterial Peritonitis (SBP)]\n    - **Key Action:** Start **Ceftriaxone** immediately. Give **Albumin** to protect kidneys.\n## ğŸ“ Tutor's One-Liner\n\"JaundiceëŠ” **Pain**ì´ ìˆëŠ”ì§€ ë¨¼ì € ë³´ê³ , LFT íŒ¨í„´(**Hepatocellular vs Cholestatic**)ìœ¼ë¡œ ê¸¸ì„ ë‚˜ëˆˆ ë’¤, **Anatomy(Duct dilation)**ë¥¼ í™•ì¸í•˜ì„¸ìš”. CirrhosisëŠ” **Decompensated events**(Bleeding, Ascites, Encephalopathy)ë¥¼ ë§‰ê³  ê´€ë¦¬í•˜ëŠ” ê²ƒì´ ì „ë¶€ì…ë‹ˆë‹¤! íŒŒì´íŒ…! ğŸ’ª\"\n**Verbatim Dictation (0:00~0:30)**\n\"Welcome back to the deep dive. Today we are wading into the... the deep end of the GI block. We're strapping in for a real heavy hitter. We really are. We're talking about the metabolic engine of the body, the liver. And specifically we're looking at what happens when that engine, you know, just seizes up. It absolutely is the engine room. Yeah. You know I always tell the med students on rounds...\"\n---\n# ğŸ©º **Deep Dive: Liver Pathology (Cirrhosis & Complications)**\n**Section 4.2 - 4.7 Comprehensive Lecture Notes**\nì•ˆë…•í•˜ì„¸ìš”! ì˜¤ëŠ˜ ìš°ë¦¬ëŠ” ìš°ë¦¬ ëª¸ì˜ **Metabolic Engine**ì¸ **Liver**ê°€ ê³ ì¥ ë‚¬ì„ ë•Œ ì–´ë–¤ ì¼ì´ ë²Œì–´ì§€ëŠ”ì§€, ê·¸ë¦¬ê³  **USMLE Step 2 CK**ì—ì„œ ì–´ë–»ê²Œ ì¶œì œë˜ëŠ”ì§€ ì•„ì£¼ ê¹Šê²Œ íŒŒí—¤ì³ ë³¼ ê²ë‹ˆë‹¤. ì—”ì§„ì´ ë©ˆì¶”ë©´ ì‹œìŠ¤í…œ ì „ì²´ê°€ ë¶•ê´´ë˜ë“¯ì´, ê°„ì´ ë©ˆì¶”ë©´ Brain, Kidney, Lungê¹Œì§€ ëª¨ë‘ íƒ€ê²©ì„ ì…ìŠµë‹ˆë‹¤. ì, ì¤€ë¹„ë˜ì…¨ë‚˜ìš”? Let's dive in! ğŸ¤¿","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-146"}
{"chunk_type":"transcript_chunk","text":"---\n## ğŸ”¥ **Rapid Fire Recap (High Yield Summary)**\n| **Clinical Vignette (Korean Context)** | **Diagnosis** | **Key Action / Trap / Treatment** |\n| --- | --- | --- |\n| ìˆ  ë§ì´ ë§ˆì‹œëŠ” í™˜ì, ê°€ìŠ´ì— ê±°ë¯¸ì¤„ ëª¨ì–‘ í˜ˆê´€, ì†ë°”ë‹¥ ë¶‰ìŒ, ì—¬ì„±í˜• ìœ ë°© | **Cirrhosis (Stigmata)** | **Mechanism:** Hyperestrogenism (Liver fails to metabolize estrogen) |\n| ë³µìˆ˜ ì²œì(Paracentesis) í–ˆëŠ”ë° **SAAG > 1.1** | **Portal Hypertension** | **Etiology:** Cirrhosis, Heart Failure, Budd-Chiari\nProtein >2.5: CHF, BC\nProtein <2.5: Cirrhosis |\n| ë³µìˆ˜ ì²œì ê²°ê³¼ **Neutrophils (PMN) > 250** | **Spontaneous Bacterial Peritonitis (SBP)** | **Tx:** Ceftriaxone (or Cefotaxime) + **IV Albumin** (Kidney protection!) |\n| ê°„ê²½ë³€ í™˜ì, Creatinine ìƒìŠ¹, ìˆ˜ì•¡ ì¤˜ë„ í˜¸ì „ ì—†ìŒ (FeNa < 1%) | **Hepatorenal Syndrome** | **Tx:** Midodrine + Octreotide + Albumin (Vasoconstrictors!) |\n| ê°„ê²½ë³€ í™˜ì, ê°‘ìê¸° ë©í•´ì§(Confusion), ì†ì„ í„ëŸ­ì„(**Asterixis**) | **Hepatic Encephalopathy** | **Tx:** Lactulose (1st line), Rifaximin (Add-on) |\n| ê°„ê²½ë³€ í™˜ì, ì¼ì–´ë‚˜ ì•‰ìœ¼ë©´ ìˆ¨ì´ ì°¸ (**Platypnea**) | **Hepatopulmonary Syndrome** | **Mechanism:** Pulmonary vasodilation â†’ Shunt |\n| ì Šì€ ì—¬ì„±/Hypercoagulable state, ê¸‰ì„± ë³µí†µ, ë³µìˆ˜, ê°„ë¹„ëŒ€ | **Budd-Chiari Syndrome** | **Dx:** Doppler US (Hepatic vein thrombosis) |\n| ë©•ì‹œì½” ì—¬í–‰ ë‹¤ë…€ì˜´, RUQ pain, Anchovy paste pus, í˜ˆë³€ | **Amebic Liver Abscess** | **Tx:** Metronidazole (**Do NOT drain!**) |\n---\n## 4.2.1 Cirrhosis: The Scarred Engine ğŸ§±\n**Concept:** ê°„ì´ ë§ë‘ë§ë‘í•œ **Sponge**ì—ì„œ ë”±ë”±í•œ **Brick**ìœ¼ë¡œ ë³€í•˜ëŠ” ê³¼ì •ì…ë‹ˆë‹¤. Fibrosisê°€ ì§„í–‰ë˜ë©´ì„œ ê°„ì˜ ëŒ€ì‚¬ ê¸°ëŠ¥(Metabolic function)ê³¼ êµ¬ì¡°ì  ê¸°ëŠ¥(Plumbing)ì´ ëª¨ë‘ ë§ê°€ì§‘ë‹ˆë‹¤.\n### 1. Stigmata of Chronic Liver Disease (Physical Exam)\ní™˜ìê°€ ë¬¸ì„ ì—´ê³  ë“¤ì–´ì˜¬ ë•Œë¶€í„° ì§„ë‹¨ì´ ì‹œì‘ë©ë‹ˆë‹¤. ì™œ ì´ëŸ° ì¦ìƒì´ ìƒê¸°ëŠ”ì§€ **Pathophysiology**ë¥¼ ì´í•´í•˜ì„¸ìš”.\n- **Hyperestrogenism (Estrogen ê³¼ë‹¤)**: ê°„ì´ Sex hormoneì„ ëŒ€ì‚¬í•˜ì§€ ëª»í•´ Estrogenì´ ìŒ“ì…ë‹ˆë‹¤.\n    - **Spider Angioma:** ìƒì²´(SVC distribution)ì— ì£¼ë¡œ ë°œìƒ. ëˆ„ë¥´ë©´ ì‚¬ë¼ì§.\n    - **Palmar Erythema:** ì†ë°”ë‹¥ì´ ë¶‰ì–´ì§. (Vasodilation)\n    - **Gynecomastia & Testicular Atrophy:** ë‚¨ì„± í™˜ìì˜ ì—¬ì„±í™”. ğŸ˜¢\n- **Other Signs:**\n    - **Caput Medusae:** ë°°ê¼½ ì£¼ë³€ ì •ë§¥ í™•ì¥ (Portal HTN).\n    - **Dupuytren's Contracture:** ì†ë°”ë‹¥ ê·¼ë§‰ ë¹„í›„.\n### 2. The Plumbing Problem: Portal Hypertension ğŸš°\nê°„ì´ ë²½ëŒì²˜ëŸ¼ ë”±ë”±í•´ì§€ë‹ˆ í˜ˆì•¡ì´ ê°„ì„ í†µê³¼í•˜ì§€ ëª»í•©ë‹ˆë‹¤. ì••ë ¥ì´ ë’¤ë¡œ ê±¸ë¦¬ê² ì£ ? (Back pressure).\n- **Splenomegaly:** ë¹„ì¥ì´ ì»¤ì§€ë©´ì„œ Plateletì„ íŒŒê´´í•¨ â†’ **Thrombocytopenia**.\n- **Varices:** Esophageal, Gastric varices (ì¶œí˜ˆ ìœ„í—˜!).\n- **Ascites:** ë°°ì— ë¬¼ì´ ì°¸.\n- **Drugs to Avoid**! ìœ íš¨í˜ˆë¥˜ëŸ‰ì„ ì§€í‚¬ë ¤ë©´ ì•ë¬¸ì€ ì—´ê³  ë‚˜ê°€ëŠ” ë¬¸ì€ ì¢ê²Œí•´ì•¼ë¨ (ê·¸ë˜ì„œ ê°„ê²½í™”ì—ì„œ RAASí•­ì§„)\n    - Closing the front door: NSAID\n    - Opening the exit door too wide: ACEi ARB\n> [!WARNING] USMLE Trap: Temperature ğŸŒ¡ï¸\n> \n> \n> Cirrhosis í™˜ìëŠ” ì›ë˜ ì²´ì˜¨ì´ ë‚®ìŠµë‹ˆë‹¤ (Hypothermic baseline).\n> \n> ë§Œì•½ ì²´ì˜¨ì´ **100Â°F (37.8Â°C)** ë¼ë©´? ì¼ë°˜ì¸ì—ê² ë¯¸ì—´ì´ì§€ë§Œ, **Cirrhotic patientì—ê² Significant Fever**ì…ë‹ˆë‹¤! ì¦‰ì‹œ SBP ë“± ê°ì—¼ì„ ì˜ì‹¬í•˜ê³  Workup í•´ì•¼ í•©ë‹ˆë‹¤. (Pan-culture í•„ìˆ˜!)\n>\n---\n## 4.2.2 Ascites & SBP (The Fluid Problem) ğŸ’§\n### 1. Diagnosis: SAAG Score (Serum-Ascites Albumin Gradient)\nìˆ˜í•™ ê³µì‹ì´ ì•„ë‹™ë‹ˆë‹¤. **Physics(ë¬¼ë¦¬)**ì…ë‹ˆë‹¤! \"Starling Forces\"ë¥¼ ìƒê°í•˜ì„¸ìš”.\n$$SAAG = Serum Albumin - Ascites Albumin$$\n- **Interpretation:** SAAGëŠ” \"í”¼ ì†ì— Albuminì´ ë¬¼ì„ ì–¼ë§ˆë‚˜ ê½‰ ì¡ê³  ìˆëŠ”ê°€(Oncotic pressure)\"ì™€ \"í˜ˆê´€ ì••ë ¥ì´ ë¬¼ì„ ì–¼ë§ˆë‚˜ ë°€ì–´ë‚´ëŠ”ê°€(Hydrostatic pressure)\"ì˜ ì‹¸ì›€ì…ë‹ˆë‹¤.\n    - **SAAG â‰¥ 1.1 (High Gradient):** **Portal Hypertension**. í˜ˆê´€ ì••ë ¥ì´ ë„ˆë¬´ ì„¸ì„œ ë¬¼(Water)ë§Œ ì‚ì ¸ë‚˜ì˜¨ ê²ë‹ˆë‹¤. (Albuminì€ í˜ˆê´€ ì•ˆì— ë‚¨ìŒ).\n        - Causes: **Cirrhosis**, Heart Failure (Right-sided), Budd-Chiari.\n    - **SAAG < 1.1 (Low Gradient):** **No** Portal Hypertension. í˜ˆê´€ì´ í—ê±°ì›Œì ¸ì„œ ë‹¨ë°±ì§ˆë„ ê°™ì´ ì¤„ì¤„ ìƒŒ ê²ë‹ˆë‹¤. (Leaky capillaries).\n        - Causes: Cancer (Peritoneal carcinomatosis), TB, Nephrotic syndrome, Pancreatitis.","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-156"}
{"chunk_type":"transcript_chunk","text":"> One Step Further: SAAG â‰¥ 1.1 ì¸ë° Heart Failureì™€ Cirrhosisë¥¼ ì–´ë–»ê²Œ êµ¬ë¶„í•˜ì£ ?\n> \n> - **Ascites Total Protein**ì„ ë´…ë‹ˆë‹¤.\n>     - High Protein (>2.5 g/dL): **Heart Failure** (ê°„ì€ ì •ìƒì´ë¼ ë‹¨ë°±ì§ˆì„ ì¢€ í˜ë ¤ë³´ëƒ„).\n>     - Low Protein (<2.5 g/dL): **Cirrhosis** (ê°„ì´ í‰í„°íˆ¬ì„±ì´ë¼ Sinusoidê°€ ë§‰í˜€ì„œ ë‹¨ë°±ì§ˆì´ ëª» ë‚˜ì˜´).\n### 2. Treatment of Ascites\n- **1st Line:** Sodium Restriction (<2g/day).\n- **Diuretics:** **Spironolactone : Furosemide = 100 : 40 mg ratio**.\n    - ì´ ë¹„ìœ¨ì„ ìœ ì§€í•´ì•¼ **Potassium (K+) balance**ê°€ ë§ìŠµë‹ˆë‹¤ (Spironolactoneì€ K+ ì¡ê³ , FurosemideëŠ” K+ ë²„ë¦¼).\n- **Refractory Ascites:** Large Volume Paracentesis (LVP) or TIPS.\n    - [Note] LVP ì‹œ 5L ì´ìƒ ë½‘ìœ¼ë©´ ë°˜ë“œì‹œ **Albumin**ì„ ë³´ì¶©í•´ì¤˜ì•¼ í•©ë‹ˆë‹¤. (ì•ˆ ê·¸ëŸ¬ë©´ Circulatory collapse ì˜´).\n### 3. Spontaneous Bacterial Peritonitis (SBP) ğŸ¦ \në°°ì— ê³ ì¸ ë¬¼(Ascites)ì€ ì„¸ê· ì—ê²Œ ë”°ëœ»í•œ **Petri Dish**ì…ë‹ˆë‹¤. ì¥ë‚´ ì„¸ê· (E. coli, Klebsiella)ì´ ì¥ë²½ì„ ëš«ê³  ë„˜ì–´ì˜µë‹ˆë‹¤ (Translocation).\n- **Diagnosis:** Paracentesis is Mandatory!\n    - **Neutrophils (PMN) â‰¥ 250/mmÂ³** â†’ **Diagnostic!** (Culture ê²°ê³¼ ê¸°ë‹¤ë¦¬ì§€ ë§ê³  ì¹˜ë£Œ ì‹œì‘).\n- Clinical Manifestation: AMS â˜… (SBP infectionâ†’ HE), ë¯¸ì—´, tenderness, acute AKI.. ì¦ìƒì´ ì• ë§¤í•¨\n- **Treatment:**\n    1. **Antibiotics:** 3rd Gen Cephalosporin (**Ceftriaxone** or Cefotaxime).\n    2. **IV Albumin:** â˜… **CRITICAL STEP**. SBP í™˜ìì—ì„œ **Hepatorenal Syndrome**ì„ ì˜ˆë°©í•˜ê³  ìƒì¡´ìœ¨ì„ ë†’ì…ë‹ˆë‹¤. (í˜ˆê´€ ë‚´ ìœ íš¨ í˜ˆì¥ëŸ‰ì„ ìœ ì§€).\n- **Prophylaxis:** SBP ë³‘ë ¥ì´ ìˆê±°ë‚˜, Ascites proteinì´ ë„ˆë¬´ ë‚®ìœ¼ë©´(<1.5) ì˜ˆë°©ì  í•­ìƒì œ (**Fluoroquinolone**)ë¥¼ ì”ë‹ˆë‹¤.\n---\n## 4.5 Hepatorenal Syndrome (HRS) â˜ ï¸\nê°„ì´ ë§ê°€ì ¸ì„œ ì½©íŒ¥ì´ ì£½ëŠ” ë³‘ì…ë‹ˆë‹¤. **The Kidneys are Innocent bystanders!** ì½©íŒ¥ ìì²´ëŠ” ë©€ì©¡í•©ë‹ˆë‹¤.\nThey are being starved!\n- **Pathophysiology:**\n    1. Portal HTN â†’ Splanchnic Vasodilation (ì¥ ìª½ í˜ˆê´€ì´ ì—„ì²­ ëŠ˜ì–´ë‚¨).\n    2. Effective Arterial Blood Volume (EABV) ê°ì†Œ (í”¼ê°€ ì¥ ìª½ì— ë‹¤ ì ë¦¼).\n    3. KidneyëŠ” \"ì•—! í”¼ê°€ ì•ˆ ì˜¤ë„¤? ì‡¼í¬ì¸ê°€?\"ë¼ê³  ì°©ê°.\n    4. RAAS System í’€ê°€ë™ â†’ **Renal Vasoconstriction** (ì½©íŒ¥ í˜ˆê´€ì„ ê½‰ ì ê¸ˆ).\n    5. ìŠ¤ìŠ¤ë¡œ choke themselves â†’ commit suicide to save the systemic blood pressure.\n    6. ê²°êµ­ ì½©íŒ¥ìœ¼ë¡œ í”¼ê°€ ì•ˆ ê°€ì„œ **Renal Failure** ë°œìƒ.\n- **Trigger:** SBP, ê³¼ë„í•œ ì´ë‡¨ì œ ì‚¬ìš©, GI Bleeding.\n- **Diagnosis:**\n    - Cirrhosis + Cr ìƒìŠ¹.\n    - **Prerenalê³¼ ë¹„ìŠ·í•´ë³´ì´ì§€ë§Œ êµ¬ë¶„í•˜ëŠ” ë²• : Volume Challenge (Albumin)ì— ë°˜ì‘ ì—†ìŒ**.\n    - Urine Na < 10, FeNa < 1% (Pre-renal ì–‘ìƒ).\n- **Treatment: Splanchnic vasoconstrictionì„ ì¹˜ë£Œ!**\n    - Goal: Splanchnic vasoconstrictionì„ ìœ ë„í•´ì„œ í”¼ë¥¼ ì½©íŒ¥ìœ¼ë¡œ ë³´ë‚´ì•¼ í•¨.\n    - **Triple Therapy:** **Midodrine** (Systemic vasoconstrictor alpha 1 agonist) + **Octreotide** (Splanchnic vasoconstrictor) + **Albumin** (Volume expander).\n    - **Definitive Tx:** **Liver Transplant**. (ê°„ì„ ë°”ê¿”ì•¼ ì½©íŒ¥ì´ ì‚°ë‹¤).\n---\n## 4.3 Hepatic Encephalopathy (HE) ğŸ§ \nê°„ì´ í•´ë… ëª»í•œ **Ammonia (NH3)**ê°€ ë‡Œë¡œ ê°€ì„œ Neurotoxinìœ¼ë¡œ ì‘ìš©í•©ë‹ˆë‹¤.\n- **Triggers (Precipitating Factors):** ì´ê±¸ ì°¾ì•„ì„œ êµì •í•˜ëŠ” ê²Œ ì¹˜ë£Œì˜ í•µì‹¬!\n    - **Drugs:** Sedatives, Narcotics.\n    - Hypovolemia: Diarrhea, over diuresis. Decreased renal clearance of ammonia\n    - **Infection:** SBP, Pneumonia, UTI. (Catabolism ì¦ê°€).\n    - **GI Bleeding:** í”¼(Blood) = ê³ ë‹¨ë°± ì‹ì‚¬(Protein load) â†’ ì•”ëª¨ë‹ˆì•„ í­ë°œ.\n    - **Constipation:** ë³€ì´ ì¥ì— ì˜¤ë˜ ë¨¸ë¬¼ë©´ ì•”ëª¨ë‹ˆì•„ í¡ìˆ˜ ì¦ê°€.\n    - **Hypokalemia:** Kidneyì—ì„œ Ammonia ìƒì„±ì„ ì¦ê°€ì‹œí‚´. (ì˜¤ë””ì˜¤ì—ì„œ ê°•ì¡°í•œ ë¶€ë¶„! K+ê°€ ë‚®ìœ¼ë©´ ì½©íŒ¥ì´ H+ë¥¼ ì•„ë¼ë ¤ê³  NH3ë¥¼ ë” ë§ì´ ë§Œë“¦).\n    - TIPS ìˆ˜ìˆ \n- **Symptoms:** Confusion, Sleep-wake cycle reversal, **Asterixis** (Flapping tremor).\n- **Treatment:**\n    - 1st Line: **Lactulose**. (ì¥ë‚´ ì‚°ë„(pH)ë¥¼ ë‚®ì¶°ì„œ NH3(í¡ìˆ˜ë¨)ë¥¼ NH4+(ë°°ì„¤ë¨)ë¡œ ë°”ê¿ˆ + ë³€ìœ¼ë¡œ ë°°ì¶œ). \"Poop it out!\"\n    - Add-on: **Rifaximin**. (ì¥ë‚´ ì„¸ê· ì„ ì£½ì—¬ì„œ ì•”ëª¨ë‹ˆì•„ ìƒì„± ê°ì†Œ).\n---\n## 4.4 Hepatopulmonary Syndrome (HPS) ğŸ«\nê°„ê²½ë³€ í™˜ìì˜ í í˜ˆê´€ì´ ë¹„ì •ìƒì ìœ¼ë¡œ í™•ì¥(Vasodilation)ë˜ì–´ ìƒê¸°ëŠ” ì €ì‚°ì†Œì¦.\n- ë§Œì„±ì ì¸ Splanchnic vasodilation â†’ í í˜ˆê´€ë„ í™•ì¥ â†’ í í•˜ë¶€ëŠ” ê³ ì†ë„ë¡œê°€ ë„“ì–´ì ¸ì„œ ê°€ìŠ¤ êµí™˜ ì•ˆí•˜ê³  í”¼ê°€ ì‘¹ ì‘¹ ë‹¤ë‹˜\n- 100ì°¨ì„  ê³ ì†ë„ë¡œì—ì„œ ì‹œì† 200ìœ¼ë¡œ ë‹¬ë¦¬ëŠ” ìŠˆí¼ì¹´ë“¤ì´ ì£¼ìœ ì†Œ ëª»ë“¤ë¦¬ê³  ì£¼ìœ ì†Œë¥¼ ì§€ë‚˜ì¹¨.\n- **Classic Symptom:** **Platypnea** (ì¼ì–´ë‚˜ë©´ ìˆ¨ì°¸) & **Orthodeoxia** (ì¼ì–´ë‚˜ë©´ SpO2 ë–¨ì–´ì§).\n    - **Mechanism:** íì˜ ê¸°ì €ë¶€(Base) í˜ˆê´€ì´ í™•ì¥ë˜ì–´ ìˆìŠµë‹ˆë‹¤. ì„œ ìˆìœ¼ë©´ ì¤‘ë ¥ ë•Œë¬¸ì— í”¼ê°€ ì•„ë˜ë¡œ ì ë¦¬ëŠ”ë°, í™•ì¥ëœ í˜ˆê´€ ë•Œë¬¸ì— ì‚°ì†Œ êµí™˜ ì—†ì´ ê·¸ëƒ¥ ì§€ë‚˜ê°€ ë²„ë¦¼ (**V/Q Mismatch & Shunt**).\n- **Diagnosis:** Contrast Echocardiography (Bubble study) - ë²„ë¸”ì´ íë¥¼ í†µê³¼í•´ì„œ ì¢Œì‹¬ë°©ìœ¼ë¡œ ë„˜ì–´ì˜´.\n- **Tx:** Oxygen, **Liver Transplant** (Only cure).\n---","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-176"}
{"chunk_type":"transcript_chunk","text":"## 4.6 Budd-Chiari Syndrome ğŸš«\n**Hepatic Vein Thrombosis** (ê°„ ì •ë§¥ì´ ë§‰í˜). í”¼ê°€ ê°„ì—ì„œ ë¹ ì ¸ë‚˜ê°€ì§€ ëª»í•˜ë‹ˆ ê°„ì´ í„°ì§ˆ ë“¯ì´ ë¶“ê³  ë³µìˆ˜ê°€ ì°¹ë‹ˆë‹¤.\n- **Patient Profile:** Hypercoagulable state (ì Šì€ ì—¬ì„± + OCP, ì„ì‹ ) ë˜ëŠ” **Polycythemia Vera** (JAK2 mutation).\n- **Symptoms:** ê¸‰ì„± ë³µí†µ(RUQ pain), ê¸‰ê²©í•œ ë³µìˆ˜, ê°„ë¹„ëŒ€, í™©ë‹¬.\n- SAAG >1.1, Protein content >2.5 (ê°„ì´ ì•„ì§ fibrosisëŠ” ì•ˆì™œì„œ í”„ë¡œí‹´ì€ ìˆìŒ. CHFë‘ ê°™ì€ì–‘ìƒ)\n- **Diagnosis:**\n    - Screening: **Doppler Ultrasound** (í˜ˆë¥˜ê°€ ì—†ëŠ” ê²ƒ í™•ì¸).\n    - Gold Standard: Venography.\n- **Treatment:** Anticoagulation, Thrombolysis, TIPS, or Transplant.\n    - Underlying cause ì¹˜ë£Œ (PV)\n---\n## 4.7 Liver Abscess: Pyogenic vs. Amebic ğŸ¦  vs ğŸ›\n> High fever, RUQ pain\n>\nì´ ë‘˜ì„ êµ¬ë³„í•˜ëŠ” ê²ƒì´ ì‹œí—˜ì˜ í•µì‹¬ì…ë‹ˆë‹¤. ì¹˜ë£Œë²•ì´ ì •ë°˜ëŒ€ê±°ë“ ìš”!\n| **Feature** | **Pyogenic Abscess (Bacteria)** | **Amebic Abscess (Parasite)** |\n| --- | --- | --- |\n| **Pathogen** | E. coli, Klebsiella, Bacteroides | *Entamoeba histolytica* |\n| **Route** | Cholangitis (Biliary tree íƒ€ê³  ì˜¬ë¼ì˜´) | Fecal-oral (ì—¬í–‰ë ¥, ë©•ì‹œì½”/ì¸ë„ ë“±) |\n| **Patient** | ê³ ë ¹, ë‹¹ë‡¨, ë‹´ë„ ì§ˆí™˜ | ì Šì€ ë‚¨ì„±, ì—¬í–‰ì, ì´ë¯¼ì |\n| **Characteristics** | Multiple lesions often | Solitary, Right Lobe usually\n+bloody diarrhea |\n| **Aspirate** | Purulent (ê³ ë¦„) | **\"Anchovy Paste\"** (ë©¸ì¹˜ì “ê°ˆìƒ‰) ğŸŸ |\n| **Treatment** | **Drainage + Antibiotics** | **Metronidazole** (**Drainage ê¸ˆì§€!**) |\n> [!TIP] Why no drain for Amebic?\n> \n> \n> Metronidazole(Flagyl) í•œ ë°©ì´ë©´ ê¸°ìƒì¶©ì´ ë…¹ì•„ ì—†ì–´ì§‘ë‹ˆë‹¤. êµ³ì´ ë°”ëŠ˜ ì°”ëŸ¬ì„œ Superinfection ë§Œë“¤ ì´ìœ ê°€ ì—†ìŠµë‹ˆë‹¤. ì•½ë§Œ ì¤˜ë„ ë“œë¼ë§ˆí‹±í•˜ê²Œ ì¢‹ì•„ì§!\n>\n---\n**Next Step for User:**\nì´ ê°•ì˜ ë…¸íŠ¸ëŠ” ì˜¤ë””ì˜¤ì˜ í•µì‹¬ ë‚´ìš©ì„ ì™„ë²½í•˜ê²Œ ì»¤ë²„í–ˆìŠµë‹ˆë‹¤. ì´ì œ ê´€ë ¨ëœ **UWorld ë¬¸ì œ(GI/Hepatology)**ë¥¼ í’€ë©´ì„œ ì´ ê°œë…ë“¤ì„ ì ìš©í•´ë³´ì„¸ìš”. íŠ¹íˆ **SAAG ê³„ì‚°**ê³¼ **HRS ì¹˜ë£Œ í”„ë¡œí† ì½œ**ì€ ê¼­ ì•”ê¸°í•´ì•¼ í•©ë‹ˆë‹¤! í™”ì´íŒ…! ğŸ’ªğŸ‘¨â€âš•ï¸\n**Verification Dictation (0:00~0:30)**\n\"Welcome back to the deep dive. Today we are clearing the decks. We are turning off the pagers, metaphorically at least, and we are locking ourselves in a room to master one of the absolute pillars of general medicine and surgery. We are talking about the biliary tract. It is the bread and butter. You cannot walk through a hospital ward without bumping into a gallbladder issue. It is everywhere. But, and this is the crucial part, it is also a minefield.\"\n---\n## [5-5.6] ğŸ¥ **Biliary Tract Stones & Emergencies: The Ultimate Field Manual**\n**One Line Vibe:** ğŸš ë§ˆì¹˜ êµ°ì˜ê´€ì´ ì‘ê¸‰ì‹¤ ë‹¹ì§ ì„¤ ë•Œì²˜ëŸ¼, ì–¸ì œ ì¹¼ì„ ëŒ€ê³ (Surgery), ì–¸ì œ ê´€ì„ ëš«ê³ (Drainage), ì–¸ì œ ì§€ì¼œë´ì•¼(Observe) í•˜ëŠ”ì§€ ê²°ì •í•˜ëŠ” \"Timing & Triage\" ì‹¸ì›€ì…ë‹ˆë‹¤.\n---\n### ğŸŒ³ **Big Picture: Top-Down Classification (ASCII Tree)**\nì˜í•™ ê³µë¶€í•  ë•Œ ê°€ì¥ ì¤‘ìš”í•œ ê±´ ë‚´ê°€ ì§€ê¸ˆ ìˆ²ì˜ ì–´ë””ì— ìˆëŠ”ì§€ ì•„ëŠ” ê±°ì•¼. Biliary tract ì§ˆí™˜ì€ í¬ê²Œ **Stones(ëŒ)**ì´ëƒ ì•„ë‹ˆë©´ **Stricture/Inflammation(í˜‘ì°©/ì—¼ì¦)**ì´ëƒë¡œ ë‚˜ë‰˜ê³ , ìœ„ì¹˜ì— ë”°ë¼ ì ‘ê·¼ë²•ì´ ë‹¬ë¼ì ¸.","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-196"}
{"chunk_type":"transcript_chunk","text":"Plaintext\n`BILIARY TRACT PATHOLOGY\nâ”‚\nâ”œâ”€â”€ 1. Diagnostic Framework (The Fork in the Road)\nâ”‚   â”œâ”€â”€ Lab: Elevated Alk Phos (Alkaline Phosphatase)\nâ”‚   â”‚   â”œâ”€â”€ GGT Normal â†’ Bone origin\nâ”‚   â”‚   â””â”€â”€ GGT Elevated â†’ Hepatobiliary origin (CONFIRMED)\nâ”‚   â”‚\nâ”‚   â””â”€â”€ Imaging: RUQ Ultrasound (The Workhorse)\nâ”‚       â”œâ”€â”€ Dilated Ducts â†’ Extrahepatic Obstruction (Stone, Tumor)\nâ”‚       â””â”€â”€ Normal Ducts â†’ Intrahepatic Pathology (Medical issue)\nâ”‚\nâ”œâ”€â”€ 2. Stone Disease (Gallstones)\nâ”‚   â”œâ”€â”€ Asymptomatic â†’ Do Nothing (Category 1)\nâ”‚   â”œâ”€â”€ Biliary Colic â†’ Elective Cholecystectomy (Category 2)\nâ”‚   â””â”€â”€ Complicated Disease (Category 3)\nâ”‚       â”œâ”€â”€ Cystic Duct Obstruction â†’ Acute Cholecystitis\nâ”‚       â”œâ”€â”€ Common Bile Duct (CBD) Obstruction â†’ Choledocholithiasis\nâ”‚       â””â”€â”€ CBD Infection â†’ Acute Cholangitis (EMERGENCY!)\nâ”‚\nâ”œâ”€â”€ 3. Special Critical Care Situations\nâ”‚   â”œâ”€â”€ Acalculous Cholecystitis (ICU patient, no stones)\nâ”‚   â””â”€â”€ Emphysematous Cholecystitis (Diabetic male, gas in wall)\nâ”‚\nâ””â”€â”€ 4. Chronic/Autoimmune Conditions\n    â”œâ”€â”€ PSC (Primary Sclerosing Cholangitis) â†’ Men, UC, \"Beads on string\"\n    â””â”€â”€ PBC (Primary Biliary Cholangitis) â†’ Women, Itching, AMA+`\n---\n### ğŸ§ª **1. General Evaluation & Labs**\nì—¬ê¸°ê°€ ì²« ë²ˆì§¸ í•¨ì •(Trap)ì´ì•¼. **Alk Phos**ê°€ ë–´ë‹¤ê³  ë¬´ì¡°ê±´ ê°„/ë‹´ë„ ë¬¸ì œë¼ê³  ë‹¨ì • ì§“ì§€ ë§ˆ.\n- **The Tie-Breaker:** **GGT (Gamma-glutamyl transferase)**\n    - Alk Phosê°€ ë†’ì€ë° GGTê°€ ì •ìƒì´ë‹¤? â†’ **Bone** issue (Paget's, Mets).\n    - Alk Phos + GGT ë‘˜ ë‹¤ ë†’ë‹¤? â†’ **Hepatobiliary** origin í™•ì •! ğŸ¯\n    - **Pearl:** ì•Œì½”ì˜¬ ì„­ì·¨ë§Œìœ¼ë¡œë„ GGTëŠ” ì˜¤ë¥¼ ìˆ˜ ìˆìœ¼ë‹ˆ History í™•ì¸ í•„ìˆ˜.\n- **Imaging Workhorse:** **RUQ Ultrasound**\n    - ê°€ì„±ë¹„ ìµœê³ , ë°©ì‚¬ì„  ì—†ìŒ. ë‹´ë„ê³„ì˜ **First-line test**.\n    - ì—¬ê¸°ì„œ **Duct Dilation** ìœ ë¬´ê°€ managementì˜ ê°ˆë¦¼ê¸¸(Fork in the road)ì´ ë¨.\n        - **Dilated:** ê¸¸ì´ ë§‰í˜”ë‹¤ (Mechanical Obstruction) â†’ **ERCP** ê°ì„ ë´ì•¼ í•¨.\n        - **Normal Ducts:** ê°„ ë‚´ë¶€ì˜ ë¬¸ì œë‹¤ (Intrahepatic medical issue) â†’ **Biopsy**ë‚˜ í•­ì²´ ê²€ì‚¬ ê³ ë ¤. (ë‚´ê³¼ì ì‚¬ê³ ) (ERCPí•˜ì§€ ì•ŠëŠ”ë‹¤.)\n---\n### ğŸª¨ **2. Management of Gallstones (The 3 Categories)**\nëŒì´ ìˆë‹¤ê³  ë‹¤ ê°™ì€ ëŒì´ ì•„ë‹˜! í™˜ìê°€ ì–´ë–¤ ìƒíƒœëƒì— ë”°ë¼ ëŒ€ì²˜ê°€ ì™„ì „íˆ ë‹¬ë¼ì§.\n### **Category 1: Asymptomatic Cholelithiasis (ìš°ì—°íˆ ë°œê²¬ëœ ëŒ)**\n- **Scenario:** ë”´ ê±° ê²€ì‚¬í•˜ë‹¤ê°€ ë°œê²¬ë¨. ì¦ìƒ ì—†ìŒ. í”¼ì ë¨¹ì–´ë„ ì•ˆ ì•„í””.\n- **Action:** **No Treatment (Observation).**\n    - ê±´ë“œë ¤ë´¤ì ìˆ˜ìˆ  ë¦¬ìŠ¤í¬ê°€ ì´ë“ë³´ë‹¤ í¼. ê·¸ëƒ¥ ë†”ë‘ì„¸ìš”.\n### **Category 2: Biliary Colic (ë‹´ë„ ì‚°í†µ)**\n- **Scenario:** ê¸°ë¦„ì§„ ê±°(Fatty meal) ë¨¹ê³  30ë¶„ ë’¤ì— ëª…ì¹˜ë‚˜ RUQê°€ ì¥ì–´ì§œë“¯ ì•„í””. í†µì¦ì´ **Right Scapula**ë¡œ ë»—ì¹¨ (Boas sign).\n- **Pathophysiology:** ëŒì´ ë‹´ë‚­ ì…êµ¬(Cystic duct)ë¥¼ ì ê¹ ë§‰ì•˜ë‹¤ê°€ ë‹¤ì‹œ ë–¨ì–´ì§.\n- **Action:** **Elective Laparoscopic Cholecystectomy.**\n    - ì‘ê¸‰ì€ ì•„ë‹˜. í•˜ì§€ë§Œ ë†”ë‘ë©´ ì–¸ì  ê°€ ë§‰í˜€ì„œ ë¬¸ì œ ìƒê¸°ë‹ˆê¹Œ ìŠ¤ì¼€ì¤„ ì¡ê³  ìˆ˜ìˆ .\n    - **Alternative:** ìˆ˜ìˆ  ì ˆëŒ€ ëª» í•˜ëŠ” í• ë¨¸ë‹ˆ(Grandma with 10% EF)? â†’ **Ursodeoxycholic acid** (ëŒ ë…¹ì´ëŠ” ì•½, íš¨ê³¼ëŠ” ë³„ë¡œì„).\n### **Category 3: Complicated Gallstone Disease**\nì—¬ê¸°ê°€ ì‹œí—˜ ë¬¸ì œ ë°­(Minefield)ì„ ğŸ’£.\n**A. Acute Cholecystitis (ê¸‰ì„± ë‹´ë‚­ì—¼)**\n- **Def:** ëŒì´ Cystic ductì— **ê½‰ ë¼ì–´ì„œ ì•ˆ ë¹ ì§** â†’ ì—¼ì¦ ë°œìƒ.\n- **Sxs:** 6ì‹œê°„ ì´ìƒ ì§€ì†ë˜ëŠ” í†µì¦, ì—´(Fever), Leukocytosis.\n- **Key Sign:** **Murphy's Sign** (ìˆ¨ ë“¤ì´ë§ˆì‹œê²Œ í•˜ê³  RUQ ëˆ„ë¥´ë©´ 'ì–µ!' í•˜ê³  ìˆ¨ ë©ˆì¶¤).\n- **Dx:** US (Wall thickening, pericholecystic fluid). ë§Œì•½ USê°€ ì• ë§¤í•˜ë©´? â†’ **HIDA scan** (Gold standard for diagnosis).\n- **Tx:**\n    1. NPO, IV Fluids, Antibiotics.\n    2. **Cholecystectomy within 72 hours** (ì—¼ì¦ì´ ë–¡ì§€ê¸° ì „ì— ë¹¨ë¦¬ ë–¼ëŠ” ê²Œ ë‚˜ìŒ).\n**B. Choledocholithiasis (ì´ë‹´ê´€ ê²°ì„)**\n- **Def:** ëŒì´ ë‹´ë‚­ì„ íƒˆì¶œí•´ì„œ **Common Bile Duct (CBD)**ë¥¼ ë§‰ìŒ.\n- **Lab:** Alk Phos â†‘, Direct Bilirubin â†‘ (Jaundice), LFT â†‘.\n- **Imaging:** USì—ì„œ **Dilated CBD** ë³´ì„.\n- **Tx:**\n    - **ERCP** (ë‚´ì‹œê²½ìœ¼ë¡œ ëŒ ë¨¼ì € ëºŒ) â†’ ë‚˜ì¤‘ì— **Cholecystectomy** (ì¬ë°œ ë°©ì§€).\n**C. Acute Cholangitis (ê¸‰ì„± ë‹´ê´€ì—¼) - â˜…MEDICAL EMERGENCYâ˜…**","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-216"}
{"chunk_type":"transcript_chunk","text":"> Toxic looking. High fever, chills, jaundice.\n> \n- **Def:** CBDê°€ ë§‰íŒ ìƒíƒœì—ì„œ **ê°ì—¼(Infection)**ê¹Œì§€ ë¨. ê³ ì¸ ë¬¼ì€ ì©ëŠ”ë‹¤!\n- Etiology: ascending infection due to biliary obstruction.\n- Labs: cholestatic pattern (high direct bilirubin, high ALP), anion gap metabolic acidosis (septic â†’ organ oxygenation ì•ˆë¨ â†’ lactate)\n- **Sxs:**\n    - **Charcotâ€™s Triad:** Fever + RUQ Pain + Jaundice.\n    - **Reynoldsâ€™ Pentad (bacteriaê°€ í”¼ë„ ì¹¨ë²”, decompensated):** Triad + **Hypotension (Shock)** + **Confusion**.\n- **Tx:** ì‹œê°„ ì‹¸ì›€! â³\n    1. **Resuscitate:** ìˆ˜ì•¡ ì½¸ì½¸, í˜ˆì•• ì¡ì•„.\n    2. **Antibiotics:** Broad-spectrum (e.g., Piperacillin-Tazobactam).\n    3. **Biliary Drainage (Life-saving):** **Emergent ERCP**ë¡œ ë§‰íŒ ê³³ ëš«ê³  ë†(Pus)ì„ ë¹¼ì¤˜ì•¼ í•¨.\n        1. Charcotâ€™s triadë©´ í•­ìƒì œ ì£¼ê³  1-2ì¼ í›„ì— ì•„ì¹¨ì— í•œë‹¤.\n        2. Reynoldâ€™s pentad (AMS, shock) ìˆìœ¼ë©´ ìƒˆë²½ 2ì‹œì—ë¼ë„ í•œë‹¤.\n---\n### ğŸš¨ **3. Special Critical Care Situations (The Silent Killers)**\nì¼ë°˜ì ì¸ ëŒ í™˜ìê°€ ì•„ë‹˜. ICUë‚˜ ì‘ê¸‰ì‹¤ì—ì„œ ë§ˆì£¼ì¹  ìµœì•…ì˜ ì‹œë‚˜ë¦¬ì˜¤ë“¤.\n### **â‘  Acalculous Cholecystitis (ë¬´ê²°ì„ ë‹´ë‚­ì—¼)**\n- **Who:** ICUì— ì˜¤ë˜ ëˆ„ì›ŒìˆëŠ” ì¤‘í™˜ì (Trauma, Burn, Sepsis). ë§ë„ ëª» í•˜ê³  ì¸ê³µí˜¸í¡ê¸° ë‹¬ê³  ìˆìŒ.\n- **Patho:** **Stasis & Ischemia**. ëŒì€ ì—†ëŠ”ë°, ì•ˆ ë¨¹ìœ¼ë‹ˆê¹Œ ë‹´ì¦™ì´ ì•ˆ íë¥´ê³  ì©ì–´ì„œ ë‹´ë‚­ì´ ì©ì–´ë“¤ì–´ê°.\n- **Biles are meant to move**\n- **Diagnosis:** ì„¤ëª… ì•ˆ ë˜ëŠ” Sepsis/Feverê°€ ìˆì„ ë•Œ ì˜ì‹¬í•´ì•¼ í•¨.\n- **Tx:** ì´ í™˜ìë“¤ì€ ìˆ˜ìˆ ë°© ê°€ë©´ ì£½ìŒ.\n    - **Percutaneous Cholecystostomy (PCN):** ì˜ìƒ ì˜í•™ê³¼ ë¶ˆëŸ¬ì„œ íŠœë¸Œ ê½‚ê³  ë°°ì•¡(Drain)ë§Œ ë¨¼ì € í•´ì¤Œ. ìˆ˜ìˆ ì€ ë‚˜ì¤‘ì— í™˜ì ì‚´ì•„ë‚˜ë©´ ê³ ë¯¼.\n### **â‘¡ Emphysematous Cholecystitis (ê¸°ì¢…ì„± ë‹´ë‚­ì—¼)**\n- **Who:** **Diabetic Male**. (í• ì•„ë²„ì§€ ë‹¹ë‡¨ í™˜ì).\n- **Patho:** ê°€ìŠ¤ í˜•ì„± ê· (**Clostridium**, E. coli) ê°ì—¼ â†’ ë‹´ë‚­ ë²½ì— ê³µê¸°(Air)ê°€ ë³´ì„.\n- **Imaging:** X-rayë‚˜ CTì—ì„œ ë‹´ë‚­ ë²½ì— **Air-fluid level** ë³´ì„. Air in the wall!\n- **Tx:** **Emergency Cholecystectomy.**\n    - ê¸°ë‹¤ë¦¬ë©´ í„°ì§(Perforation). í•­ìƒì œ(Zosyn) ì“°ë©´ì„œ ë°”ë¡œ ìˆ˜ìˆ ë°© ë“¤ì–´ê°€ì•¼ í•¨.\n- Cf. Pneumobilia: Biliary ductì™€ ì¥ê´€ê³¼ fistula ìƒì„± â†’ ê´€ì— ê³µê¸°ê°€ ë“¤ì–´ê°.\n---\n### ğŸ§¬ **4. Autoimmune: PSC vs. PBC (The Classic Showdown)**\nì´ê±° ì¡±ë³´(USMLE favorite) ë¹„êµ ë¬¸ì œì„. ë¬´ì¡°ê±´ ë‚˜ì˜´.\n| **Feature** | **PSC (Primary Sclerosing Cholangitis)** | **PBC (Primary Biliary Cholangitis)** |\n| --- | --- | --- |\n| **Demographics** | **Men** (30-50s) | **Women** (Middle-aged) |\n| **Association** | **Ulcerative Colitis (UC)** (90%ê°€ UC ë™ë°˜) | Autoimmune disease (Sjogren's, Hashimoto's) |\n| **Pathology** | Intra & Extrahepatic ducts ë‹¤ ì¹¨ë²” | Intrahepatic ducts (ì‘ì€ ë‹´ê´€)ë§Œ ì¹¨ë²” |\n| **Imaging (ERCP/MRCP)** | **\"Beads on a String\"** (ì¢ì•„ì¡Œë‹¤ ë„“ì–´ì¡Œë‹¤ í•¨) | Normal extrahepatic ducts |\n| **Antibody** | p-ANCA (+) (not specific) | **Anti-Mitochondrial Antibody (AMA) (+)** |\n| **Symptoms** | Jaundice, Pruritus, Fatigue | **Severe Pruritus (ê°€ë ¤ì›€)**, Xanthelasma (ëˆˆê°€ ì§€ë°©) |\n| **Risk** | **Cholangiocarcinoma**, Colon Cancer | Cirrhosis |\n| **Treatment** | Transplant (ìœ ì¼í•œ ì™„ì¹˜), ERCP (ì¦ìƒ ì™„í™”) | **Ursodeoxycholic Acid (Ursodiol)** |\n---\n### ğŸ¤• **5. Post-Cholecystectomy Syndrome (ìˆ˜ìˆ í–ˆëŠ”ë° ì™œ ì•„íŒŒìš”?)**\n- **Scenario:** ë‹´ë‚­ ì ˆì œìˆ  ë°›ì•˜ëŠ”ë° ëª‡ ì£¼/ëª‡ ë‹¬ ë’¤ì— ë˜‘ê°™ì´ ì•„í””.\n- **Causes:**\n    1. **Retained Stone:** ìˆ˜ìˆ í•˜ë‹¤ê°€ CBDì— ëŒ í•˜ë‚˜ í˜ë¦¬ê³  ì˜´.\n    2. **Sphincter of Oddi Dysfunction (SOD):** ê´„ì•½ê·¼ì´ ê³¼í•˜ê²Œ ìˆ˜ì¶•í•¨.\n    note: morphinerê³¼ ê°™ì€ ì§„í†µì œê°€ ì˜¤íˆë ¤ ì˜¤ë””ê·¼ ìˆ˜ì¶•ì„ ì¼ìœ¼í‚´.\n    3. **Non-biliary:** ìœ„ì—¼, ê¶¤ì–‘ ë“± ë‹¤ë¥¸ ì›ì¸.\n- **Workup:** US/CT ë¨¼ì € â†’ Dilated duct ìˆìœ¼ë©´ **ERCP**.\n---","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-236"}
{"chunk_type":"recap_summary","text":"## ğŸ”¥ **Rapid Fire Recap (High Yield Summary)**\nì˜¤ë””ì˜¤ì—ì„œ ê°•ì¡°í•œ í•µì‹¬ ì‹œë‚˜ë¦¬ì˜¤ ì •ë¦¬í‘œ!\n| **Clinical Vignette (ìƒí™©)** | **Diagnosis (ì§„ë‹¨)** | **Key Action / Trap (í•µì‹¬)** |\n| --- | --- | --- |\n| **Fatty meal** í›„ 30ë¶„ ë’¤ í†µì¦, 6ì‹œê°„ ë‚´ ì†Œì‹¤ | **Biliary Colic** | **Elective Lap Chole**. (ì‘ê¸‰ ì•„ë‹˜) |\n| RUQ pain, **Fever**, **Murphy's sign (+)** | **Acute Cholecystitis** | **HIDA scan** if US equivocal. **Surgery within 72h**. |\n| **Jaundice**, Alk Phos â†‘, Dilated CBD on US | **Choledocholithiasis** | **ERCP** first (Remove stone) â†’ then Cholecystectomy. |\n| **Fever + Jaundice + RUQ Pain** (Charcot) | **Acute Cholangitis** | **Emergent ERCP** (Drainage) + IV Abx + Fluids. |\n| **ICU Patient**, Sepsis, No stones on US | **Acalculous Cholecystitis** | **Cholecystostomy Tube** (Do NOT operate yet). |\n| **Diabetic Male**, Air in GB wall | **Emphysematous Cholecystitis** | **Emergency Surgery** (High risk of perforation). |\n| **Male with UC**, Jaundice, Itching | **PSC** | Screen for **Cholangiocarcinoma**. Look for \"Beads on string\". |\n| **Middle-aged Woman**, Itching, Fatigue | **PBC** | Check **Anti-Mitochondrial Ab (AMA)**. Tx: Ursodiol. |\n---\n**[Next Step for User]**\nWould you like me to generate specific Anki card content for the **\"PSC vs PBC\"** differentiation or the **\"Management Hierarchy of Cholangitis\"** to help you lock this into your long-term memory?\n**Verification Dictation (0:00~0:30)**\n\"Welcome back to the deep dive. Today we are strapping in for a serious session. We're opening the abdominal cavity but uh, we are staying out of the hollow viscus for a moment. Oh yeah. We are focusing on the solid organs that really define those upper quadrants. We have a lot of ground to cover specifically two organs that often get bundled together but have, well very different personalities. The pancreas and the spleen.\"\n---\n# ğŸ¥ USMLE Step 2 CK: The Angry Pancreas & The Silent Spleen","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-252"}
{"chunk_type":"transcript_chunk","text":"## ğŸ“‹ Overview: A Tale of Two Organs\nì—¬ê¸° ë‘ ê°€ì§€ ìƒë°˜ëœ ì„±ê²©ì„ ê°€ì§„ ì¥ê¸°ê°€ ìˆìŠµë‹ˆë‹¤. USMLEëŠ” ì´ë“¤ì˜ \"Personality\"ë¥¼ ì´í•´í•˜ëŠ” ê²ƒì„ ì¢‹ì•„í•©ë‹ˆë‹¤.\n- **The Angry Pancreas ğŸ˜¡:** Retroperitoneum ê¹Šìˆ™ì´ ìˆ¨ì–´ìˆëŠ” \"ì„±ë‚œ ì¥ê¸°\". í•œë²ˆ í™”ë‚˜ë©´(Inflammation) ì˜¨ëª¸ì— systemic chaosë¥¼ ì¼ìœ¼í‚µë‹ˆë‹¤. ë‹¤ë£¨ê¸°ê°€ ë§¤ìš° ê¹Œë‹¤ë¡­ìŠµë‹ˆë‹¤.\n- **The Silent Spleen ğŸ¤«:** ì¡°ìš©í•œ í¬ìƒì(Silent victim). Systemic debrisë¥¼ ê±¸ëŸ¬ì£¼ëŠ” í•„í„° ì—­í• ì„ í•˜ë‹¤ê°€, ê²°êµ­ì—” ì¡°ìš©íˆ ì°¢ì–´ì§€ê±°ë‚˜(Rupture) ë†ì–‘(Abscess)ì„ ë§Œë“­ë‹ˆë‹¤.\n---\n## 6.0 Pancreas Overview & Acute Etiologies\n### 1. Clinical Presentation: The \"Boring\" Pain\ní™˜ìê°€ ë°°ë¥¼ ì›€ì¼œì¥ê³  ë“¤ì–´ì˜µë‹ˆë‹¤. ë‹¨ìˆœí•œ ë°°íƒˆ(IBS)ì´ ì•„ë‹™ë‹ˆë‹¤.\n- **Symptom:** Acute, Severe Epigastric Pain radiating to the **Back**.\n- **Anatomy:** PancreasëŠ” **Retroperitoneal organ**ì…ë‹ˆë‹¤. ì²™ì¶”(Spine)ì™€ ëŒ€ë™ë§¥(Aorta) ë°”ë¡œ ì•ì— ë”± ë¶™ì–´ ìˆì£ . ê·¸ë˜ì„œ ì—¼ì¦ì´ ìƒê¸°ë©´ ë“± ë’¤ì˜ Somatic nerveë¥¼ ìê·¹í•´ì„œ í†µì¦ì´ ë“± ë’¤ë¡œ ëš«ê³  ë‚˜ê°€ëŠ” ë“¯í•œ(**Boring through to the back**) ì–‘ìƒì„ ë³´ì…ë‹ˆë‹¤.\n### 2. Diagnosis: Rule of 2 out of 3\nì§„ë‹¨ì„ ìœ„í•´ ë‹¤ìŒ 3ê°€ì§€ ì¤‘ **2ê°€ì§€**ê°€ í•„ìš”í•©ë‹ˆë‹¤. (USMLEëŠ” ë¶ˆí•„ìš”í•œ í…ŒìŠ¤íŒ…ì„ ì‹«ì–´í•©ë‹ˆë‹¤!)\n1. **Clinical Presentation:** ì „í˜•ì ì¸ Epigastric pain radiating to the back.\n2. **Biochemical Evidence:** Amylase or **Lipase** > 3x Upper limit of normal.\n3. **Imaging:** CT, MRI, or Ultrasound evidence of pancreatitis.\n    1. gallstone pancreatitis ì˜ì‹¬ë ë•ŒëŠ” sono ì°ìŒ\n    2. sonoëŠ” ductë¥¼ ë³´ë©´ì„œ stoneìˆëŠ”ì§€ í‰ê°€í• ë•ŒëŠ” ì¢‹ì§€ë§Œ, ì·Œì¥ ê·¸ ìì²´ëŠ” ì˜ ëª»ë´„ (ì·Œì¥ì€ í›„ë³µë§‰ ì¥ê¸°)\n    ë”°ë¼ì„œ ì·Œì¥ì´ ì©ì—ˆëŠ”ì§€ ë“±, ì·Œì¥ì„ ì§ì ‘ ë³´ë ¤ë©´ CTë¥¼ ì°ëŠ” ê²ƒì´ ì¢‹ìŒ.\n    ë¬¼ë¡ , ì•„ë˜ tipì²˜ëŸ¼ ë³‘ ì´ˆë°˜ì— ì§„ë‹¨ìš©ìœ¼ë¡œ CTë¥¼ ì´¬ì˜í•  í•„ìš”ëŠ” ì—†ìŒ.\n> ğŸ’¡ Tutor's Tip:\n> \n> - **Lipase is the Money ğŸ’°:** AmylaseëŠ” ì¹¨ìƒ˜(Salivary gland)ì—ì„œë„ ë‚˜ì˜¤ê³  ë°˜ê°ê¸°ê°€ ì§§ì•„(24ì‹œê°„ ë‚´ ì •ìƒí™” ê°€ëŠ¥) ìœ„ìŒì„±ì´ ë‚˜ì˜¬ ìˆ˜ ìˆìŠµë‹ˆë‹¤. **Lipase**ê°€ í›¨ì”¬ **Specific**í•˜ê³  ì˜¤ë˜ ì§€ì†ë©ë‹ˆë‹¤. ë‘˜ ì¤‘ í•˜ë‚˜ë¥¼ ê³¨ë¼ì•¼ í•œë‹¤ë©´ ë¬´ì¡°ê±´ Lipase!\n> - **Do NOT order CT immediately if typical:** ì „í˜•ì ì¸ í†µì¦ + Lipase ìƒìŠ¹ì´ë©´ ì§„ë‹¨ ëì…ë‹ˆë‹¤. ì´ˆê¸°ì— CT ì°ì–´ë´¤ì ì—¼ì¦ ë³€í™”ë‚˜ NecrosisëŠ” 48-72ì‹œê°„ ë’¤ì—ë‚˜ ë³´ì…ë‹ˆë‹¤. ì´ˆê¸° CTëŠ” í™˜ìì—ê²Œ ë°©ì‚¬ì„ ê³¼ ì¡°ì˜ì œ(Nephrotoxic)ë§Œ ì¤„ ë¿ì…ë‹ˆë‹¤. ì• ë§¤í•˜ë©´ CT ì°ìŒ. ë¬¼ë¡ , ë‹¤ë¥¸ ì§ˆí™˜ ê°ë³„í•´ì•¼ë˜ë©´ CT ì°ì–´ì•¼ë¨.\n### 3. Etiologies: \"GET SMASHED\" ğŸºğŸª¨\nì›ì¸ì€ ë§ì§€ë§Œ **Gallstones**ì™€ **Alcohol**ì´ 80%ë¥¼ ì°¨ì§€í•©ë‹ˆë‹¤.\n| **Etiology** | **Clue / Specifics** |\n| --- | --- |\n| **G**allstones (40%) | **ALT > 150 U/L** (PPV 95%). ë‹´ì„ì´ ë‚´ë ¤ì˜¤ë‹¤ê°€ ê°„ì„¸í¬ë¥¼ ìê·¹í•´ì„œ ALTê°€ íŒ íŠ‘ë‹ˆë‹¤. |\n| **E**thanol (40%) | History of heavy drinking. Macrocytosis (MCV > 100). |\n| **T**rauma | **Handlebar Injury** ğŸš² (ì•„ì´ë“¤ì´ ìì „ê±° ì†ì¡ì´ì— ëª…ì¹˜ë¥¼ ì°§ìŒ). ì²™ì¶”ì™€ ì†ì¡ì´ ì‚¬ì´ì—ì„œ Pancreasê°€ ìœ¼ê¹¨ì§. |\n| **S**teroids | ë“œë¬¼ì§€ë§Œ ê°€ëŠ¥. |\n| **M**umps | Viral cause. |\n| **A**utoimmune | IgG4 related disease. |\n| **S**corpion sting | ì‹œí—˜ìš© í¬ê·€ ì¼€ì´ìŠ¤. |\n| **H**ypertriglyceridemia | **TG > 1,000 mg/dL**. í”¼ë¥¼ ë½‘ìœ¼ë©´ ë”¸ê¸° ì‰ì´í¬(Strawberry milkshake)ì²˜ëŸ¼ ë³´ì…ë‹ˆë‹¤. |\n| **H**ypercalcemia | Calciumì´ íš¨ì†Œë¥¼ ì¡°ê¸° í™œì„±í™”(Premature activation) ì‹œí‚´ â†’ ê´€ì„ ë§‰ìŒ â†’ ì·Œì¥ì—¼\nì·Œì¥ì—¼ â†’ fat necrosis â†’ sponification â†’ calcium ì†Œëª¨ â†’ hypocalcemia ìœ ë°œí•¨. |\n| **E**RCP (Iatrogenic) | ì‹œìˆ  í›„ 5%ì—ì„œ ë°œìƒ. Contrast dyeë‚˜ Papilla manipulation ë•Œë¬¸. |\n| **D**rugs | **Diuretics (Thiazide/Furosemide)**, Valproic acid, Didanosine, Pentamidine, Azathioprine/6-MP. |\n---\n## 6.1 Severe Acute Pancreatitis\n### 1. Definition & Pathophysiology\në‹¨ìˆœí•œ ì—¼ì¦ì´ ì•„ë‹ˆë¼ **Organ Failure**ê°€ 48ì‹œê°„ ì´ìƒ ì§€ì†ë˜ëŠ” ìƒíƒœì…ë‹ˆë‹¤.","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-262"}
{"chunk_type":"transcript_chunk","text":"- **Mechanism:** \"Cytokine Storm\" ğŸŒªï¸. ì·Œì¥ì´ ìì‹ ì„ ì†Œí™”ì‹œí‚¤ë©°(Autodigestion) ì—¼ì¦ ë§¤ê°œë¬¼ì§ˆ(TNF-alpha, Interleukins)ì„ ì „ì‹ ìœ¼ë¡œ ë¿Œë¦½ë‹ˆë‹¤.\n- **Result:** ì „ì‹  í˜ˆê´€ì´ í™•ì¥(Vasodilation)ë˜ê³  **í˜ˆê´€ íˆ¬ê³¼ì„±ì´ ì¦ê°€**í•˜ì—¬ í˜ˆì¥ì´ ì¡°ì§ìœ¼ë¡œ ë¹ ì ¸ë‚˜ê°‘ë‹ˆë‹¤(**Third Spacing**). ê²°êµ­ **Hypovolemic Shock**ê³¼ ìœ ì‚¬í•œ ìƒíƒœê°€ ë©ë‹ˆë‹¤.\n### 2. Predictors of Severity (Who needs ICU?)\në‹¤ìŒ ì§€í‘œë“¤ì´ ë³´ì´ë©´ ê¸´ì¥í•´ì•¼ í•©ë‹ˆë‹¤.\n- **Patient Factors:** Age > 55, **Obesity (BMI > 30)** â˜… (ì§€ë°©ì„¸í¬ ê´´ì‚¬ëŠ” ë…ì„±ì´ ê°•í•¨).\n- **Labs:**\n    - **HCT > 44%**: íƒˆìˆ˜(Hemoconcentration)ê°€ ì‹¬í•˜ë‹¤ëŠ” ì¦ê±°. í˜ˆê´€ì—ì„œ ë¬¼ì´ ë‹¤ ë¹ ì ¸ë‚˜ê°”ë‹¤ëŠ” ëœ».\n    - **BUN > 20 mg/dL (Rising BUN): ê°€ì¥ ë¬´ì„œìš´ ì‚¬ì¸ ğŸ’€. ìˆ˜ì•¡ì„ ì¤¬ëŠ”ë°ë„ BUNì´ ì˜¤ë¥¸ë‹¤ë©´ ì‚¬ë§ë¥ ì´ ê¸‰ì¦í•©ë‹ˆë‹¤.**\n    - **CRP > 150**: ì‹¬í•œ ì—¼ì¦.\n- **Physical Exam:**\n    - **Cullen's Sign:** ë°°ê¼½ ì£¼ìœ„ ë© (Periumbilical ecchymosis).\n    - **Grey Turner's Sign:** ì˜†êµ¬ë¦¬ ë© (Flank ecchymosis).\n    - *Note: ì´ ì‚¬ì¸ë“¤ì€ í›„ë³µë§‰ ì¶œí˜ˆì„ ì˜ë¯¸í•˜ë©°, ì˜ˆí›„ê°€ ë§¤ìš° ë‚˜ì©ë‹ˆë‹¤(Grim prognosis).*\n### 3. Management: The 3 Pillars ğŸ›ï¸\n1. **Fluids (Aggressive Hydration) ğŸ’§:** ê°€ì¥ ì¤‘ìš”í•©ë‹ˆë‹¤! **Lactated Ringer's (LR)**ê°€ Normal Salineë³´ë‹¤ ì„ í˜¸ë©ë‹ˆë‹¤ (ì‚°ì¦ ì˜ˆë°© ë° í•­ì—¼ì¦ íš¨ê³¼).\n2. **Analgesia ğŸ’Š:** ì•„í”ˆ ê±´ ì°¸ê²Œ í•˜ì§€ ë§ˆì„¸ìš”. **Opioids** (Fentanyl, Hydromorphone) ì‚¬ìš© ê°€ëŠ¥í•©ë‹ˆë‹¤. (ê³¼ê±°ì˜ 'Morphineì´ Sphincter of Oddië¥¼ ìˆ˜ì¶•ì‹œí‚¨ë‹¤'ëŠ” ì´ë¡ ì€ ì„ìƒì ìœ¼ë¡œ ë¬´ì‹œë©ë‹ˆë‹¤).\n3. **Nutrition ğŸ:** **Enteral Nutrition (Early feeding)**ì´ TPN(ì •ë§¥ ì˜ì–‘)ë³´ë‹¤ ì¢‹ìŠµë‹ˆë‹¤. ì¥ ì ë§‰ ì¥ë²½(Gut mucosal barrier)ì„ ìœ ì§€í•´ì„œ ë°•í…Œë¦¬ì•„ ì´ë™(Translocation)ì„ ë§‰ì•„ì•¼ í•©ë‹ˆë‹¤.\n### 4. Controversies & Pitfalls ğŸš«\n- **Antibiotics:** **Do NOT give prophylactic antibiotics.** ì—´ì´ ë‚˜ë„ ì´ˆë°˜ì—” ì—¼ì¦ ë•Œë¬¸ì…ë‹ˆë‹¤.\n    - **When to give Abx?** CTì—ì„œ ê¸°í¬(Gas)ê°€ ë³´ì´ê±°ë‚˜, ìƒê²€(Biopsy)ì—ì„œ ê°ì—¼ì´ í™•ì¸ëœ **Infected Necrosis**ì¼ ë•Œë§Œ Carbapenem ë“±ì„ ì”ë‹ˆë‹¤.\n- **Timing of CT:** ì…ì› ì´ˆê¸°ì—ëŠ” ë„ì›€ ì•ˆ ë¨. 48-72ì‹œê°„ í›„ì—ë„ ìƒíƒœê°€ ì•…í™”ë˜ê±°ë‚˜ í•©ë³‘ì¦(Necrosis, Abscess)ì´ ì˜ì‹¬ë  ë•Œ ì°ìŠµë‹ˆë‹¤.\n- **Gallstone Pancreatitis:**\n    - Mild: ì´ë²ˆ ì…ì› ê¸°ê°„ ë‚´ì— **Cholecystectomy** (ì§‘ì— ë³´ë‚´ë©´ ì¬ë°œë¥  ë†’ìŒ).\n    - Severe: ì—¼ì¦ì´ ê°€ë¼ì•‰ì„ ë•Œê¹Œì§€ ê¸°ë‹¤ë ¸ë‹¤ê°€ ìˆ˜ìˆ  (Interval cholecystectomy).\n    - gallstone pancreatitisì˜ ê²½ìš°ì—ëŠ” routine ECRP í•˜ì§€ì•ŠìŒ.\n    unless, persisted obstruction/dilation, concurrent cholangitis\n---\n## 6.2 & 6.3 Pancreatic Complications (Cysts)\n### 1. Pancreatic Pseudocyst (ê°€ì„±ë‚­ì¢…)\n> ì·Œì¥ì—¼ í•œë‹¬ì „ì— ê±¸ë ¸ëŠ”ë° ì¢‹ì•„ì§€ê¸´í–ˆëŠ”ë°, ì§€ì†ë˜ëŠ” ì–¼ì–¼í•œ ìœ—ë°° í†µì¦ì´ ìˆê³ , ë°°ê°€ ê¸ˆë°© ë¶€ë¦„..\n>\n- **Definition:** ì·Œì¥ íš¨ì†Œê°€ í˜ëŸ¬ë‚˜ì™€ ì„¬ìœ í™”ëœ ë²½(Fibrous tissue)ì— ê°‡íŒ ê²ƒ. **Epithelial liningì´ ì—†ìŠµë‹ˆë‹¤** (ê·¸ë˜ì„œ \"Pseudo\").\n- **Timing:** ê¸‰ì„± ì·Œì¥ì—¼ ì•“ê³  **4ì£¼ ì´í›„**ì— ë°œìƒ.\n- **Diagnosis:** CT Scan.\n- **Management:**\n    - **Asymptomatic / Small:** **Observation**. (ëŒ€ë¶€ë¶„ ì €ì ˆë¡œ ì‚¬ë¼ì§).\n    - **Symptomatic (Pain, Early satiety) / Infected / Growing:** **Drainage**. (ë‚´ì‹œê²½ì  Cystogastrostomyê°€ ì„ í˜¸ë¨).\n### 2. Pancreatic Cysts (Neoplasms)\nìš°ì—°íˆ ë°œê²¬ë˜ëŠ” ê²½ìš°ê°€ ë§ìŠµë‹ˆë‹¤ (Incidentaloma).\n- **Serous Cystadenoma:** ì–‘ì„±(Benign). ë²Œì§‘ ëª¨ì–‘(Honeycomb). ê´€ì°°.\n- **Mucinous Cystadenoma:** **Pre-malignant** (ì•”ì´ ë  ìˆ˜ ìˆìŒ). ì—¬ì„±ì—ì„œ í˜¸ë°œ. ê¼¬ë¦¬(Tail) ìª½. ìˆ˜ìˆ ì  ì ˆì œ ê³ ë ¤.\n- **IPMN (Intraductal Papillary Mucinous Neoplasm):** ì·Œê´€ê³¼ ì—°ê²°ë¨. ì•…ì„± ê°€ëŠ¥ì„± ìˆìŒ.\n- **Next Best Step for Suspicious Cysts:** **EUS (Endoscopic Ultrasound) + Biopsy (FNA)**. (í¬ê¸° > 3cm, Solid component, Pancreatic duct í™•ì¥ ì‹œ).\n---\n## 6.4 Chronic Pancreatitis\n### 1. Concept: \"Burned Out Gland\" ğŸ”¥â¡ï¸ğŸŒ‘\nê¸‰ì„± ì—¼ì¦ì´ ë°˜ë³µë˜ì–´ ì·Œì¥ì´ ëŒì²˜ëŸ¼ êµ³ê³ (Fibrosis, Calcification) ê¸°ëŠ¥ì„ ìƒì‹¤í•œ ìƒíƒœì…ë‹ˆë‹¤.","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-282"}
{"chunk_type":"transcript_chunk","text":"- **Etiology:** **Alcohol** (ì„±ì¸), **Cystic Fibrosis** (ì†Œì•„).\n- **Pathophysiology:** ë°¥ë¨¹ìœ¼ë©´ CCKê°€ ë‚˜ì˜¤ê³  CCKê°€ ì·Œì¥ ìê·¹í•˜ê³  ì·Œì¥ì—ì„œ íš¨ì†Œ ë‚´ë³´ëƒ„. ê·¼ë° ì·Œì¥ì—¼ì—ì„œ, íš¨ì†Œê°€ ì‹­ì´ì§€ì¥ìœ¼ë¡œ ì•ˆ ë‚˜ì˜¤ë‹ˆ, CCK(Cholecystokinin) ë¶„ë¹„ë¥¼ ì–µì œí•˜ëŠ” Negative feedbackì´ ê¹¨ì§‘ë‹ˆë‹¤. CCKê°€ ê³„ì† ë‚˜ì™€ ì·Œì¥ì„ ì¥ì–´ì§œë‹ˆ ì•„í”•ë‹ˆë‹¤.\n### 2. Clinical Triad\n1. **Chronic Pain:** ì‹í›„ ì•…í™”.\n2. **Exocrine Failure:** **Steatorrhea** (ì§€ë°©ë³€ - ë³€ê¸° ë¬¼ì— ê¸°ë¦„ ë‘¥ë‘¥, ëƒ„ìƒˆ ê³ ì•½í•¨). ì†Œí™”íš¨ì†Œ(Lipase) ë¶€ì¡±.\n3. **Endocrine Failure:** **Diabetes** (Type 3c). ì¸ìŠë¦° ë¶„ë¹„ ì„¸í¬ íŒŒê´´.\n### 3. Diagnosis & Management\n- **Diagnosis:** Amylase/LipaseëŠ” **ì •ìƒ**ì¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤ (ë§Œë“¤ ì„¸í¬ê°€ ë‹¤ ì£½ì–´ì„œ). **CT**ì—ì„œ ì·Œì¥ ì„íšŒí™”(Calcifications) í™•ì¸.\n- **Management:**\n    - **Lifestyle:** ê¸ˆì£¼(Stop Alcohol), ê¸ˆì—°(Stop Smoking). ì†ŒëŸ‰ì˜ ì €ì§€ë°© ì‹ì‚¬(Small frequent low-fat meals).\n    - **Enzyme Replacement:** **Lipase/Amylase/Protease supplements**. (CCK ë¶„ë¹„ë¥¼ ì¤„ì—¬ í†µì¦ë„ ì™„í™”ì‹œí‚´).\n    - **Diabetes:** Insulin í•„ìš”.\n- **Complication:**\n    - ì·Œì¥ì•”\n    - **Splenic Vein Thrombosis:** ì·Œì¥ ë°”ë¡œ ë’¤ì˜ ë¹„ì¥ì •ë§¥(Splenic vein)ì´ ì—¼ì¦ìœ¼ë¡œ ë§‰í˜. -> ë¹„ì¥ì´ ì»¤ì§€ê³ (Splenomegaly) -> **Gastric Varices** (ìœ„ ì •ë§¥ë¥˜)ë§Œ ìƒê¹€ (Esophageal varices ì—†ìŒ). ì¹˜ë£ŒëŠ” **Splenectomy**.\n---\n## 7.0 The Spleen\n### 1. Splenic Abscess ğŸ¦ \n- **Scenario:** ë°œì—´, ë°±í˜ˆêµ¬ ì¦ê°€, **LUQ Pain**.\n- **Cause:** **Infective Endocarditis** (ì‹¬ì¥ì˜ Septic emboliê°€ ë¹„ì¥ìœ¼ë¡œ ë‚ ì•„ê°).\n- **Management:** í•­ìƒì œë§Œìœ¼ë¡œ ì¹¨íˆ¬ê°€ ì–´ë ¤ì›€. **Splenectomy** + Antibioticsê°€ ë‹µ.\n### 2. Splenic Rupture ğŸ’¥\n- **Traumatic:** êµí†µì‚¬ê³ (MVA), ê°ˆë¹„ë¼ˆ ê³¨ì ˆ ë“±.\n- **Atraumatic:** **Epstein-Barr Virus (Infectious Mononucleosis)**. ë¹„ì¥ì´ ë¹„ëŒ€í•´ì ¸ì„œ(Splenomegaly) ì‚´ì§ë§Œ ë¶€ë”ªí˜€ë„ í„°ì§.\n- **Kehr's Sign:** **Left Shoulder Pain**. í„°ì§„ ë¹„ì¥ì˜ í”¼ê°€ íš¡ê²©ë§‰(Diaphragm)ì„ ìê·¹ -> Phrenic nerve (C3,4,5) -> ì–´ê¹¨ í†µì¦.\n### 3. Management of Splenic Trauma\n- **Hemodynamically Unstable:** ì‘ê¸‰ ìˆ˜ìˆ  (**Exploratory Laparotomy / Splenectomy**).\n- **Hemodynamically Stable:** **CT Scan** with contrast. -> ë“±ê¸‰ì— ë”°ë¼ Angiographic embolization ë˜ëŠ” Observation.\n> âš ï¸ Patient Education for Mono:\n> \n> \n> Contact Sports(ì¶•êµ¬, ëŸ­ë¹„ ë“±)ëŠ” ì¦ìƒ ì‹œì‘ í›„ **ìµœì†Œ 3-4ì£¼ (ë˜ëŠ” 21ì¼)** ê¸ˆì§€! ë¹„ì¥ì´ ì •ìƒ í¬ê¸°ë¡œ ëŒì•„ì˜¬ ë•Œê¹Œì§€ ê¸°ë‹¤ë ¤ì•¼ í•©ë‹ˆë‹¤.\n>\n---","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-302"}
{"chunk_type":"recap_summary","text":"## ğŸ”¥ Rapid Fire Recap (High Yield Summary)\n1. **Epigastric pain radiating to back + Lipase > 3x** â†’ **Acute Pancreatitis** â†’ **Next Step:** Fluids (LR), Pain control, NPO. (Do NOT order CT first).\n2. **Acute Pancreatitis + ALT > 150** â†’ **Gallstone Pancreatitis** â†’ **Next Step:** RUQ Ultrasound.\n3. **Pancreatitis patient + Fever/Hypotension after 10 days + CT shows gas** â†’ **Infected Necrosis** â†’ **Next Step:** Antibiotics (Carbapenem) + Step-up drainage.\n4. **4 weeks after Pancreatitis + Early Satiety + Abdominal Mass** â†’ **Pancreatic Pseudocyst** â†’ **Next Step:** Symptomatic? Drainage (Cystogastrostomy). Asymptomatic? Observation.\n5. **Chronic Pancreatitis + Isolated Gastric Varices** â†’ **Splenic Vein Thrombosis** â†’ **Tx:** Splenectomy.\n6. **Sore throat (Mono) + Sudden LUQ pain/Shoulder pain** â†’ **Splenic Rupture** â†’ **Next Step:** Stable? CT. Unstable? OR.\n## ğŸ§ 0:00~0:30 Verbatim Dictation\n\"Welcome back to the deep dive. Today we are... uh, not just reading a textbook. No, definitely not. We are putting on our long white coats, we're grabbing our stethoscopes, and we are stepping directly onto the wards. I like it. We are tackling a veritable beast of a topic for the USMLE Step 2 CK: Gastroenterology. Mm-hm. And specifically we are zooming in on the small intestine. We're looking strictly at sections 8.0 through 8.6 of our table of contents.\"\n---\n# ğŸ¥ USMLE Step 2 CK: GI Deep Dive (Small Intestine)\n**Topic:** Malabsorption, IBS, IBD, Celiac, SIBO\nì•ˆë…•í•˜ì„¸ìš” ì„ ìƒë‹˜! USMLE Step 2 CK ì¤€ë¹„ë¥¼ ìœ„í•œ GI íŒŒíŠ¸ Deep Diveì…ë‹ˆë‹¤.\nì˜¤ëŠ˜ì˜ ì£¼ì œëŠ” ì†Œì¥(Small Intestine) íŒŒíŠ¸ì…ë‹ˆë‹¤. ì¦ìƒì€ ë¹„ìŠ·í•´ ë³´ì´ì§€ë§Œ(ì„¤ì‚¬, ë³µí†µ, bloating), ê´€ë¦¬ëŠ” ì²œì§€ì°¨ì´ì¸ ì§ˆí™˜ë“¤ì„ í™•ì‹¤í•˜ê²Œ êµ¬ë¶„í•˜ëŠ” ê²ƒì´ í•µì‹¬ì…ë‹ˆë‹¤.\në¨¼ì € ì „ì²´ì ì¸ ê·¸ë¦¼ì„ **Big Picture**ë¡œ ì¡ê³  ë“¤ì–´ê°€ê² ìŠµë‹ˆë‹¤.","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-317"}
{"chunk_type":"transcript_chunk","text":"## ğŸŒ³ Big Picture: The \"Bloating & Diarrhea\" Differential\nì´ íŒŒíŠ¸ì˜ í•µì‹¬ì€ **\"ë°° ì•„í”„ê³  ì„¤ì‚¬í•˜ëŠ”ë°, ë„ëŒ€ì²´ ì›ì¸ì´ ë­ëƒ?\"**ë¥¼ ê°ë³„í•˜ëŠ” ê²ƒì…ë‹ˆë‹¤.\nPlaintext\n`GI Symptoms (Pain, Diarrhea, Bloating)\nâ”‚\nâ”œâ”€â”€ Systemic Signs? (Weight loss, Blood, Anemia, Nocturnal Sx)\nâ”‚   â”œâ”€â”€ YES (Alarm Features) ğŸš¨ \nâ”‚   â”‚   â”œâ”€â”€ Inflammation visible? \nâ”‚   â”‚   â”‚   â”œâ”€â”€ YES â†’ IBD (Crohn's / UC) [Sec 8.4]\nâ”‚   â”‚   â”‚   â””â”€â”€ NO â†’ Malignancy, Celiac, etc.\nâ”‚   â”‚   â””â”€â”€ Malabsorption signs? (Steatorrhea, Fat soluble vit def)\nâ”‚   â”‚       â”œâ”€â”€ Anatomy/Motility issue? â†’ SIBO [Sec 8.6]\nâ”‚   â”‚       â”œâ”€â”€ Gluten trigger? â†’ Celiac Disease [Sec 8.5]\nâ”‚   â”‚       â””â”€â”€ Bile issue? â†’ Malabsorption/Cholestasis [Sec 8.1]\nâ”‚   â”‚\nâ”‚   â””â”€â”€ NO (Functional)\nâ”‚       â””â”€â”€ Rome IV Criteria met? â†’ IBS (Irritable Bowel Syndrome) [Sec 8.3]`\n---\n## 1. Malabsorption (í¡ìˆ˜ì¥ì• ) [Sec 8.1]\n**Concept:** ë‹¨ìˆœíˆ \"ëª» ë¨¹ì–´ì„œ ë§ˆë¥¸ ê²ƒ\"ì´ ì•„ë‹ˆë¼, ìš°ë¦¬ ëª¸ì˜ ì—°ë£Œ íƒ±í¬ì— êµ¬ë©ì´ ë‚œ ìƒíƒœì…ë‹ˆë‹¤.\n### ğŸ”‘ Key Pathophysiology: The Liver-Bone Connection\nStep 2ì—ì„œ ì •ë§ ì¢‹ì•„í•˜ëŠ” ì—°ê²°ê³ ë¦¬ì…ë‹ˆë‹¤.\n- **Cholestasis (ë‹´ì¦™ ì •ì²´)** â†’ Bile acidê°€ ì‹­ì´ì§€ì¥ìœ¼ë¡œ ëª» ë‚˜ê°.\n- **No Bile** â†’ ì§€ë°©(Fat)ì„ ìœ í™”(Emulsify)ì‹œí‚¤ì§€ ëª»í•¨.\n- **Steatorrhea (ì§€ë°©ë³€)** ë°œìƒ (Greasy, foul-smelling, floating stool).\n- **Fat Soluble Vitamin (A, D, E, K) í¡ìˆ˜ ë¶ˆê°€.**\n- **â˜… Vitamin D ê²°í•** â†’ Calcium í¡ìˆ˜ ì €í•˜ â†’ **Osteoporosis / Osteomalacia (ê³¨ë‹¤ê³µì¦/ê³¨ì—°í™”ì¦)**.\n> ğŸ’¡ Clinical Pearl: > ë§Œì•½ ë¬¸ì œì—ì„œ **PBC(Primary Biliary Cholangitis)**ë‚˜ PSC í™˜ìê°€ ê³¨ì ˆì´ ìƒê¸°ê±°ë‚˜ ë¼ˆê°€ ì•„í”„ë‹¤ê³  í•˜ë©´?\n> \n> \n> ë‹¨ìˆœíˆ \"ë„˜ì–´ì¡Œë‚˜?\"ê°€ ì•„ë‹ˆë¼ **Fat malabsorption â†’ Vit D deficiency**ë¥¼ ë– ì˜¬ë ¤ì•¼ í•©ë‹ˆë‹¤.\n> â†’ DEXA scan\n>\n---\n## 2. Irritable Bowel Syndrome (IBS, ê³¼ë¯¼ì„± ëŒ€ì¥ ì¦í›„êµ°) [Sec 8.3]\n**Vibe:** ê²€ì‚¬ ìƒ ì´ìƒì€ ì—†ëŠ”ë° í™˜ìëŠ” ë¯¸ì¹˜ë„ë¡ ë¶ˆí¸í•œ ìƒíƒœ. í•˜ì§€ë§Œ \"ê¾€ë³‘\" ì·¨ê¸‰í•˜ë©´ ì•ˆ ë©ë‹ˆë‹¤! ë‡Œ-ì¥ ì¶•(Gut-Brain Axis)ì˜ ë¬¸ì œì…ë‹ˆë‹¤.\n### ğŸ›‘ Diagnosis: Rome IV Criteria (í•„ìˆ˜ ì•”ê¸°!)\nIBSëŠ” ë” ì´ìƒ \"Diagnosis of exclusion(ë°°ì œ ì§„ë‹¨)\"ì´ ì•„ë‹™ë‹ˆë‹¤. **Positive Diagnosis**ì…ë‹ˆë‹¤.\n- **Recurrent Abdominal Pain:** ìµœì†Œ **1ì£¼ì¼ì— 1ì¼ ì´ìƒ**, ì§€ë‚œ 3ê°œì›” ë™ì•ˆ.\n- **Associated with 2+ of the following:**\n    1. **Defecation:** ë°°ë³€ê³¼ ì—°ê´€ë¨ (ì‹¸ê³  ë‚˜ë©´ í¸í•´ì§€ê±°ë‚˜ ë” ì•„í”„ê±°ë‚˜).\n    2. **Frequency:** ë°°ë³€ íšŸìˆ˜ì˜ ë³€í™”.\n    3. **Form:** ëŒ€ë³€ í˜•íƒœì˜ ë³€í™” (ë¬¼ë˜¥ vs ì—¼ì†Œë˜¥).\n- ë°‘ì— í‘œì—ìˆëŠ” work upì„ í•˜ê³  ì„ìƒì  ì§„ë‹¨ì„ ë‚´ë¦¬ëŠ”ê²ƒì„ â˜…\n### ğŸš© Red Flags (Alarm Features) - IBSê°€ **ì•„ë‹Œ** ì‹ í˜¸\nì´ëŸ° ì¦ìƒì´ ë³´ì´ë©´ IBSë¼ê³  ë‹¨ì • ì§“ì§€ ë§ê³  ì¶”ê°€ ê²€ì‚¬(Colonoscopy ë“±)ë¥¼ í•´ì•¼ í•©ë‹ˆë‹¤.\n- Weight loss (ì²´ì¤‘ ê°ì†Œ)\n- Blood in stool (í˜ˆë³€)\n- Nocturnal symptoms (ìë‹¤ê°€ ê¹° ì •ë„ì˜ ì„¤ì‚¬/ë³µí†µ - IBSëŠ” ë³´í†µ ìëŠ” ë™ì•ˆì€ ê´œì°®ìŒ)\n- Family Hx of Colon cancer / IBD\n- Onset age > 50 (50ì„¸ ì´í›„ ê°‘ìê¸° ìƒê¸´ ì¦ìƒ)","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-327"}
{"chunk_type":"transcript_chunk","text":"### ğŸ’Š Management Ladder / Work up (Step-up approach)\nì¦ìƒ(ë³€ë¹„í˜• vs ì„¤ì‚¬í˜•)ì— ë”°ë¼ ì¹˜ë£Œê°€ ì™„ì „íˆ ê°ˆë¦½ë‹ˆë‹¤.\n| **Type** | Workup | **1st Line (Lifestyle/OTC)** | **2nd Line (Targeted)** | **3rd Line / Special** |\n| --- | --- | --- | --- | --- |\n| **IBS-C** (ë³€ë¹„í˜•) | CBC(anemia). CBCì •ìƒì´ë©´ ë‚´ì‹œê²½ì•ˆí•¨ | Soluble Fiber (Psyllium)\nOsmotic Laxatives (PEG) | **Lubiprostone** (Cl- channel activator)\n**Linaclotide** (Guanylate cyclase-C agonist) | **Tenapanor** (NHE3 inhibitor)\n*(Na+ í¡ìˆ˜ ë§‰ì•„ ë¬¼ì„ ì¥ë‚´ë¡œ ëŒì–´ë“¤ì„)* |\n| **IBS-D** (ì„¤ì‚¬í˜•) | IBS-Cë³´ë‹¤ëŠ” ë³µì¡.\n  â€¢ CBC\n  â€¢ stool culture (infection)\n  â€¢ Celiac testing\n  â€¢ CRP, fecal calprotectin/lactoferrin (DDX IBD) | **Loperamide** (Imodium) | **Bile Acid Sequestrants** (Cholestyramine)\n*(íŠ¹íˆ ë‹´ë‚­ì ˆì œìˆ  í›„ bile acid ê³¼í•˜ê²Œ ë¶„ë¹„ë˜ì–´ ì„¤ì‚¬í•˜ëŠ” í™˜ìì—ê²Œ íš¨ê³¼ì )* | \n**Alosetron** *(ì—¬ì„±, ë‚œì¹˜ì„± ì„¤ì‚¬ì—ë§Œ ì‚¬ìš© - Ischemic colitis ë¶€ì‘ìš© ì£¼ì˜)* |\n| **Pain** Predominant |  | Antispasmodics\n(Hyoscyamine, Dicyclomine)\n(anticholinergic ë°¥ë¨¹ê¸° 30ë¶„ì „ì— ë¨¹ëŠ”ë‹¤.) | **TCAs** (Amitriptyline)\n*(Low doseë¡œ visceral nerve ê³¼ë¯¼ì„± ì¡°ì ˆ)\nnote: TCA anticholinergic: constipation í™˜ìì—ê² ì£¼ë©´ì•ˆë¨. í•­ì½œë¦°ì„±ì´ë©´ ë‚´ì¥ìš´ë™ì„± ë‚®ì¶”ë‹ˆê¹Œ.* |  |\n> ğŸ§ª Pathophysiology Note: IBS í™˜ìëŠ” ì‹ì‚¬ í›„ ë¶„ë¹„ë˜ëŠ” **CCK (Cholecystokinin)**ì— ëŒ€í•´ Smooth muscleì´ Hypersensitivityë¥¼ ë³´ì…ë‹ˆë‹¤. ê·¸ë˜ì„œ ë°¥ë§Œ ë¨¹ìœ¼ë©´ ë°°ê°€ ì•„í”ˆ ê²ƒ! (\"Gastrocolic reflex\"ê°€ ê³¼í•­ì§„ë¨).\n>\n---\n## 3. Inflammatory Bowel Disease (IBD, ì—¼ì¦ì„± ì¥ì§ˆí™˜) [Sec 8.4]\n**Vibe:** ì§„ì§œ ì—¼ì¦ì´ ìˆëŠ” ìƒíƒœ. ë©´ì—­ê³„ê°€ ì¥ì„ ê³µê²©í•¨.\n### âš”ï¸ UC vs Crohn's Disease (Battle of the Bowels)\n| **Feature** | **Ulcerative Colitis (UC)** | **Crohn's Disease (CD)** |\n| --- | --- | --- |\n| **Location** | Rectumì—ì„œ ì‹œì‘í•´ ìœ„ë¡œ ì˜¬ë¼ê° (Continuous). **Colon only.** | Mouth to Anus ì–´ë””ë“  ê°€ëŠ¥. **Skip lesions** (ë„ì—„ë„ì—„). |\n| **Depth** | Mucosa & Submucosa (ì–•ìŒ). | **Transmural** (ë²½ ì „ì²´ ëš«ìŒ). |\n| **Symptoms** | **Bloody Diarrhea** (ê±°ì˜ í•­ìƒ). | ë³µí†µ, ì„¤ì‚¬ (í˜ˆë³€ì€ ëœ í”í•¨), ì˜ì–‘ë¶ˆëŸ‰. |\n| **Appearance** | **Lead pipe** (Haustra ì†Œì‹¤), Pseudopolyps. | **Cobblestone** mucosa, **Creeping fat**, Fistula/Stricture. |\n| **Histology** | **Crypt Abscesses**. | **Non-caseating Granulomas**. |\n| **Extra-intestinal** | **PSC (Primary Sclerosing Cholangitis)** - p-ANCA (+) | Kidney stones (Oxalate), Gallstones. |\n### ğŸ›¡ï¸ Treatment Strategy\n1. **Mild:** **5-ASA (Mesalamine)** - ì£¼ë¡œ UCì— íš¨ê³¼ì  (Topical anti-inflammatory).\n    1. MILD UC\n        1. <4 diarrhea/day\n        2. hemotochezia rare or intermittent\n        3. NO anemia, NORMAL ESR, CRP\n2. **Acute Flare:** **Steroids** (Prednisone, Budesonide) - ë¶ˆ ë„ê¸° ìš©. ì¥ê¸° ì‚¬ìš© X.\n3. **Moderate/Severe:** **Biologics** (Anti-TNF agents: Infliximab, Adalimumab).\n4. **Complications:** Fistula(ëˆ„ê³µ) ìƒê¸°ë©´ ë°”ë¡œ Biologicsë‚˜ ìˆ˜ìˆ  ê³ ë ¤.\n> âš ï¸ Cancer Screening Rule:\n> \n> \n> IBD ì§„ë‹¨ í›„ **8ë…„**ì´ ì§€ë‚˜ë©´ Screening Colonoscopyë¥¼ ì‹œì‘í•©ë‹ˆë‹¤. ê·¸ í›„ ë§¤ **1-2ë…„**ë§ˆë‹¤ ë°˜ë³µ. (ì¼ë°˜ì¸ì€ 45ì„¸ë¶€í„°ì§€ë§Œ, ì´ë“¤ì€ í›¨ì”¬ ê³ ìœ„í—˜êµ°!) ë˜í•œ í´ë¦½ì´ì•„ë‹ˆë”ë¼ë„ ë©€ì©¡í•´ë³´ì´ëŠ” ì¡°ì§ë“¤ë„ ëœë¤í•˜ê²Œ ì¶”ì¶œí•´ì„œ ì¡°ì§ê²€ì‚¬ ëŒë¦¼. (ë§Œì„±ì—¼ì¦ìƒíƒœë¼ í´ë¦½í˜•íƒœê°€ ì•„ë‹Œ ì•”ë³‘ë³€ì´ ìˆì„ ìˆ˜ ìˆë‹¤)\n>\n---\n## 4. Celiac Disease (ì…€ë¦¬ì•…ë³‘) [Sec 8.5]\n**Concept:** ê¸€ë£¨í…(ë°€, ë³´ë¦¬, í˜¸ë°€)ì— ëŒ€í•œ ìê°€ë©´ì—­ ë°˜ì‘.\n### ğŸ•µï¸ Diagnosis Flow\n1. **Suspicion:** ë§Œì„± ì„¤ì‚¬, ì²´ì¤‘ ê°ì†Œ, ì² ë¶„ ê²°í• ë¹ˆí˜ˆ(Duodenumì—ì„œ ì² ë¶„ í¡ìˆ˜í•˜ë¯€ë¡œ).\n2. **Skin Sign:** **Dermatitis Herpetiformis** (íŒ”ê¿ˆì¹˜, ë¬´ë¦ì— ìƒê¸°ëŠ” ë§¤ìš° ê°€ë ¤ìš´ ìˆ˜í¬ì„± ë°œì§„). *ì´ê²Œ ìˆìœ¼ë©´ ê±°ì˜ 100% Celiac.*\n    1. Management: Dapsone (í•­ìƒì œì§€ë§Œ í•­ì—¼ì¦ íš¨ê³¼ê°€ìˆìŒ)\n3. **Screening:** **Tissue Transglutaminase IgA (tTG-IgA)** antibody.\n    - *Trap:* í™˜ìê°€ **IgA Deficiency**ê°€ ìˆìœ¼ë©´ ìœ„ìŒì„±(False negative) ë‚˜ì˜¬ ìˆ˜ ìˆìŒ. ë°˜ë“œì‹œ **Total IgA** ë ˆë²¨ë„ ê°™ì´ í™•ì¸!\n4. **Confirmation (Gold Standard):** **Duodenal Biopsy**.\n    - Findings: **Villous Atrophy** (ìœµëª¨ê°€ ê¹ì„), Crypt Hyperplasia, Intraepithelial Lymphocytes.\n---\n## 5. SIBO (Small Intestinal Bacterial Overgrowth) [Sec 8.6]","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-347"}
{"chunk_type":"transcript_chunk","text":"**Concept:** ëŒ€ì¥ì— ìˆì–´ì•¼ í•  ì„¸ê· ë“¤ì´ ì†Œì¥ìœ¼ë¡œ ì—­ë¥˜í•´ì„œ íŒŒí‹°ë¥¼ ë²Œì´ëŠ” ìƒíƒœ.\n### Clinical\n- general malabsorption\n- **AHA moment: B12 def! high Folate (ë°•í…Œë¦¬ì•„ê°€ B12ë¨¹ê³  ê²°ê³¼ë¬¼ë¡œ B9 ë°©ê·€ë¥¼ ë€ë‹¤.)**\n### ğŸŒªï¸ Why does it happen? (Risk Factors)\n- **Motility Disorder:** ë‹¹ë‡¨ë³‘ì„± ìœ„ë¬´ë ¥ì¦(Gastroparesis), í”¼ë¶€ê²½í™”ì¦(Scleroderma) - ì¥ì´ ì•ˆ ì›€ì§ì´ë‹ˆ ê· ì´ ì•ˆ ì”»ê²¨ ë‚´ë ¤ê°. **Opioid use**\n- **Anatomical:** ìˆ˜ìˆ ë¡œ ì¸í•œ Blind loop, ì†Œì¥-ëŒ€ì¥ ì—°ê²°ë¶€ìœ„ ë¬¸ì œ. í¬ë¡  stricture.\n- NO chemical (acid, enzymeì´ ìˆì–´ì•¼ ê· ë“¤ì„ ì£½ì„): chronic pancreatitis, gastric hydrochloria, **PPI use**\n- Immune: IgA def.\n### ğŸ“‰ Pathophysiology & Diagnosis\n- **Bacteria's Action:** ì„¸ê· ì´ ì˜ì–‘ë¶„ì„ ë¨¼ì € ë¨¹ì–´ì¹˜ì›€ â†’ ê°€ìŠ¤ ìƒì„± (Bloating) & **Vitamin B12 ê²°í•** ìœ ë°œ. (ë°˜ëŒ€ë¡œ ì„¸ê· ì´ **Folate**ëŠ” ìƒì„±í•´ì„œ ìˆ˜ì¹˜ê°€ ë†’ì„ ìˆ˜ ìˆìŒ!).\n- Bloatingì´ ìˆì–´ë„, Bowel movement ì´ìƒì—†ìœ¼ë©´ SIBO ì˜ì‹¬í•˜ì§€ë§ˆì„¸ìš”!\n- **Diagnosis:** **Carbohydrate Breath Test** (Lactulose or Glucose).\n    - ì¸ê°„ì€ ì €ê±° ë§ˆì‹œê³ ìˆ˜ì†Œë¥¼ ë§Œë“¤ì§€ ì•ŠëŠ”ë° ë°•í…Œë¦¬ì•„ëŠ” ê¸°ì²´ë¥¼ ë§Œë“¦.\n    - ì •ìƒë³´ë‹¤ í›¨ì”¬ ë¹¨ë¦¬ ìˆ˜ì†Œ(H2)ë‚˜ ë©”íƒ„ ê°€ìŠ¤ ìˆ˜ì¹˜ê°€ ìƒìŠ¹í•˜ë©´ ì–‘ì„± (ì†Œì¥ì— ê· ì´ ìˆë‹¤ëŠ” ì¦ê±°).\n- **Treatment:** **Rifaximin** (ì¥ë‚´ì—ë§Œ ì‘ìš©í•˜ëŠ” í•­ìƒì œ).\n---\n## ğŸ”¥ Rapid Fire Recap (High Yield Summary)\n1. **Vignette:** 42ì„¸ ì—¬ì„±, ë‹´ì¦™ ì •ì²´ ì§ˆí™˜(PBC) ìˆìŒ, ìµœê·¼ í—ˆë¦¬ í†µì¦ê³¼ ê³¨ì ˆ.\n    - **Diagnosis:** Osteomalacia due to Vitamin D malabsorption.\n    - **Action:** Fat soluble vitamin ë³´ì¶© í•„ìš”.\n2. **Vignette:** 25ì„¸ ë‚¨ì„±, ìŠ¤íŠ¸ë ˆìŠ¤ ë°›ìœ¼ë©´ ë°° ì•„í”„ê³  ì„¤ì‚¬. ìë‹¤ê°€ ê¹¬ ì ì€ ì—†ìŒ. ì²´ì¤‘ ê°ì†Œ ì—†ìŒ. ë‚´ì‹œê²½ ì •ìƒ.\n    - **Diagnosis:** IBS-D (Irritable Bowel Syndrome - Diarrhea type).\n    - **Action:** Loperamide (1st), Rifaximin (refractory). **Rome IV criteria** ì ìš©.\n3. **Vignette:** 30ì„¸ ì—¬ì„±, í”¼ ì„ì¸ ì„¤ì‚¬, p-ANCA ì–‘ì„±, ë‹´ê´€ ì¡°ì˜ìˆ ìƒ \"beading\" ì†Œê²¬.\n    - **Diagnosis:** Ulcerative Colitis (UC) + Primary Sclerosing Cholangitis (PSC).\n    - **Action:** Colonoscopy (Cancer risk â†‘), Ursodeoxycholic acid (for liver), Mesalamine/Biologics (for gut).\n4. **Vignette:** ë‹¹ë‡¨ë³‘ í™˜ì, ë³µë¶€ íŒ½ë§Œê°, ì„¤ì‚¬. ì—½ì‚°(Folate) ìˆ˜ì¹˜ëŠ” ë†’ì€ë° B12ëŠ” ë‚®ìŒ.\n    - **Diagnosis:** SIBO (Small Intestinal Bacterial Overgrowth).\n    - **Action:** Carbohydrate Breath Test (Dx) â†’ Rifaximin (Tx).\n5. **Vignette:** íŒ”ê¿ˆì¹˜ì— ì—„ì²­ ê°€ë ¤ìš´ ë¬¼ì§‘. ì„¤ì‚¬.\n    - **Diagnosis:** Dermatitis Herpetiformis (Celiac Disease).\n    - **Action:** Gluten-free diet. Biopsy showing villous atrophy.\n---\n**Next Step for You:**\nì„ ìƒë‹˜, ìœ„ì¥ê´€ íŒŒíŠ¸ëŠ” ì¦ìƒì´ ê²¹ì³ì„œ í—·ê°ˆë¦¬ê¸° ì‰½ìŠµë‹ˆë‹¤. ì˜¤ëŠ˜ ê³µë¶€í•œ ë‚´ìš© ì¤‘ **\"Alarm Features\"**ê°€ ì—†ëŠ” ì Šì€ ì—¬ì„±ì˜ ë³µí†µì€ IBSë¥¼ ë¨¼ì € ìƒê°í•˜ë˜, **ì²´ì¤‘ ê°ì†Œë‚˜ í˜ˆë³€**ì´ ë³´ì´ë©´ ë°”ë¡œ IBDë‚˜ Malignancy workupìœ¼ë¡œ ë„˜ì–´ê°€ëŠ” Flowë¥¼ ë¨¸ë¦¿ì†ì— ê¼­ ê·¸ë ¤ë‘ì„¸ìš”! ë‹¤ìŒì—” Hepatobiliary íŒŒíŠ¸ë¡œ ë„˜ì–´ê°€ë³¼ê¹Œìš”?\n**0:00~0:30 Verification Dictation**\n\"All right, welcome back to the deep dive. We have a really clear uh objective today. We're dissecting the retroperitoneum and you know the left upper quadrant. A really important area. Absolutely. Specifically we're running the gauntlet from the pancreas all the way through to the spleen. We've got the source material right here and we're navigating strictly from section 6.1 through 7.1. It's a tight grouping but honestly it's arguably one of the highest yield areas for the boards.\"\n---\n**Verification Dictation (0:00~0:30)**\n> \"All right, welcome back to the deep dive. So if you're listening, you are probably staring down the barrel of Step 2 CK, specifically the GI system. And today isn't about just browsing. This is about mastery. We are zeroing in on the acute abdomen, that trifecta of appendicitis, its mimics, and obstruction. Exactly. And this is really the bread and butter of general surgery. The thing is, whether you end up in psych or derm or ortho, you are going to see these patients in the ER.\"\n>\n---\n# # Ep 8. The Acute Abdomen: Appendicitis & SBO","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-367"}
{"chunk_type":"transcript_chunk","text":"ì•ˆë…•í•˜ì„¸ìš”! ì˜¤ëŠ˜ì€ General Surgeryì˜ **Bread and Butter**ì¸ **Acute Abdomen**ì„ ë§ˆìŠ¤í„°í•´ë³´ê² ìŠµë‹ˆë‹¤. ë‹¨ìˆœíˆ ì§ˆë³‘ ë¦¬ìŠ¤íŠ¸ë¥¼ ì™¸ìš°ëŠ” ê²Œ ì•„ë‹ˆë¼, **Physiology**ë¥¼ ì´í•´í•´ì„œ ì§„ë‹¨ê³¼ ì¹˜ë£Œ ê³¼ì •ì„ ì§ê´€ì ìœ¼ë¡œ íŒŒì•…í•˜ëŠ” ê²ƒì´ ëª©í‘œì…ë‹ˆë‹¤.\n## ğŸŒ³ Big Picture: Acute Abdomen Classification\në¨¼ì € ì˜¤ëŠ˜ì˜ í° ê·¸ë¦¼ì„ ì¡ê³  ë“¤ì–´ê°ˆê²Œìš”.\n`Acute Abdomen\nâ”œâ”€â”€ Inflammation (Infectious)\nâ”‚   â”œâ”€â”€ Appendicitis (The Classic)\nâ”‚   â””â”€â”€ Pseudo-appendicitis (The Mimic: Yersinia/Campylobacter)\nâ””â”€â”€ Obstruction (Mechanical)\n    â”œâ”€â”€ Small Bowel Obstruction (SBO)\n    â”‚   â”œâ”€â”€ Simple (Non-strangulated)\n    â”‚   â””â”€â”€ Strangulated (Ischemic â†’ Emergency!)\n    â””â”€â”€ Ileus (Functional Paralysis)`\n---\n## 1. Appendicitis (ì¶©ìˆ˜ëŒê¸°ì—¼)\n### ğŸ§  Concept & Pathophysiology\nAppendicitis ì§„ë‹¨ì˜ í•µì‹¬ì€ **Pain Migration**ì…ë‹ˆë‹¤. ì´ ê¸°ì „ì„ ì´í•´í•˜ëŠ” ê²Œ ì¤‘ìš”í•´ìš”.\n1. **Visceral Pain (ë‚´ì¥í†µ):** ì´ˆê¸°ì—ëŠ” Appendicitisê°€ Mid-gut êµ¬ì¡°ë¬¼ì´ë¼ ì—¼ì¦ê³¼ íŒ½ì°½(stretch)ì´ ìƒê¸°ë©´ ììœ¨ì‹ ê²½ê³„(Autonomic nerves)ë¥¼ íƒ€ê³  **T10 dermatome (ë°°ê¼½ ì£¼ìœ„, Umbilicus)** ë¶€ê·¼ì— ëª¨í˜¸í•˜ê³  ë‘”í•œ í†µì¦(Vague, dull ache)ì„ ìœ ë°œí•©ë‹ˆë‹¤. í™˜ìëŠ” ì…ë§›ì´ ëš ë–¨ì–´ì§‘ë‹ˆë‹¤ (**Anorexia**).\n2. **Somatic Pain (ì²´ì„±í†µ):** ì—¼ì¦ì´ ì‹¬í•´ì ¸ì„œ ë³µë²½ì˜ ë³µë§‰(**Parietal Peritoneum**)ì„ ìê·¹í•˜ë©´, í†µì¦ì´ êµ­ì†Œí™”(Localized)ë˜ë©´ì„œ ë‚ ì¹´ë¡œì›Œì§‘ë‹ˆë‹¤. ì´ë•Œ í†µì¦ì´ **Right Lower Quadrant (RLQ)** ë¡œ ì´ë™í•©ë‹ˆë‹¤.\n    - ğŸ‘‰ **Clinical Pearl:** Visceral â†’ Somaticìœ¼ë¡œ ë°”ë€ŒëŠ” ì´ íƒ€ì„ë¼ì¸ì´ ë³‘ì˜ ì§„í–‰ì„ ë³´ì—¬ì£¼ëŠ” í•µì‹¬ ë‹¨ì„œì…ë‹ˆë‹¤!\n### ğŸ¯ Diagnosis: The Alvarado Score (MANTRELS)\në‹¨ìˆœí•œ \"ë°° ì•„í””\"ê³¼ ìˆ˜ìˆ ì´ í•„ìš”í•œ ìƒí™©ì„ êµ¬ë¶„í•˜ê¸° ìœ„í•´ ì ìˆ˜í™”í•©ë‹ˆë‹¤.\n| **Symptoms/Signs** | **Points** | **Note** |\n| --- | --- | --- |\n| **M**igration of pain | 1 | ë°°ê¼½ â†’ RLQ ì´ë™ |\n| **A**norexia | 1 | ì…ë§› ì—†ìŒ (Acetone ëƒ„ìƒˆ ë“±) |\n| **N**ausea/Vomiting | 1 |  |\n| **T**enderness in RLQ | **2** | ê°€ì¥ ì¤‘ìš”í•œ ì‹ ì²´ ì§„ì°° ì†Œê²¬ |\n| **R**ebound tenderness | 1 | ë—„ ë•Œ ì•„í”” (Peritoneal irritation) |\n| **E**levated Temperature | 1 | >37.3Â°C |\n| **L**eukocytosis | **2** | WBC > 10,000 (ì—¼ì¦ ìˆ˜ì¹˜) |\n| **S**hift to left | 1 | Neutrophils ì¦ê°€ (Segmented forms) |\n- **Scoring Strategy:**\n    - **Low score:** ì§‘ì— ë³´ëƒ„ (Discharge).\n    - **Middle score>4ì :** Imaging (CT or US)ë¡œ í™•ì¸.\n    - **High score:** ë°”ë¡œ ìˆ˜ìˆ  (Surgical Consult).\n### ğŸ©º Physical Exam Maneuvers (Anatomy Lessons)\në‹¨ìˆœí•œ ìˆ ê¸°ê°€ ì•„ë‹ˆë¼, **Appendixì˜ ìœ„ì¹˜**ë¥¼ ì¶”ë¦¬í•˜ëŠ” ê³¼ì •ì…ë‹ˆë‹¤.\n- **Psoas Sign:** í™˜ìë¥¼ ì™¼ìª½ìœ¼ë¡œ ëˆ•íˆê³  ì˜¤ë¥¸ìª½ ë‹¤ë¦¬ë¥¼ ë’¤ë¡œ ì –í˜(Extension).\n    - ğŸ‘‰ í†µì¦ ë°œìƒ ì‹œ: Appendixê°€ **Retrocecal** (Cecum ë’¤ìª½)ì— ìœ„ì¹˜í•˜ì—¬ Iliopsoas muscleì„ ìê·¹í•˜ê³  ìˆë‹¤ëŠ” ëœ».\n- **Obturator Sign:** ë¬´ë¦ê³¼ ê³ ê´€ì ˆì„ êµ½íˆê³  ë‹¤ë¦¬ë¥¼ ì•ˆìª½ìœ¼ë¡œ ëŒë¦¼(Internal Rotation).\n    - ğŸ‘‰ í†µì¦ ë°œìƒ ì‹œ: Appendixê°€ ê³¨ë°˜ ê¹Šìˆ™ì´ (**Pelvic**) ìœ„ì¹˜í•˜ì—¬ Obturator internus muscleì„ ìê·¹í•¨.\n- **Rovsing's Sign:** **LLQ**ë¥¼ ëˆŒë €ëŠ”ë° **RLQ**ê°€ ì•„í””.\n    - ğŸ‘‰ ê¸°ì „: ê°€ìŠ¤ë¥¼ ì—­ë¥˜ì‹œì¼œ Cecumì„ íŒ½ì°½ì‹œí‚¤ê³  ì—¼ì¦ ë¶€ìœ„ë¥¼ ìê·¹í•¨.\n- Rectal tenderness: DREì¤‘ì— ì˜¤ë¥¸ìª½ ëˆ„ë¥´ë‹ˆê¹Œ ì•„í”„ë‹¤.\n### ğŸ“¸ Imaging Strategy (Next Best Step)\n- **Adult (Non-pregnant):** â˜… **CT Abdomen/Pelvis** (Gold Standard).\n- **Child / Pregnant Woman:** â˜… **Ultrasound** (Radiation í”¼í•˜ê¸° ìœ„í•´ 1ìˆœìœ„).\n    - [Note] ì„ì‚°ë¶€ì—ì„œ ì´ˆìŒíŒŒë¡œ ì•ˆ ë³´ì´ë©´? â†’ **MRI** (CTëŠ” ë°©ì‚¬ì„  ë•Œë¬¸ì— ê¸ˆê¸°).\n    - ì„ì‚°ë¶€ëŠ” ìê¶ì´ ì»¤ì§€ë©´ì„œ Appendixê°€ **Right Upper Quadrant (RUQ)** ìª½ìœ¼ë¡œ ë°€ë ¤ ì˜¬ë¼ê°€ë¯€ë¡œ í†µì¦ ìœ„ì¹˜ê°€ ë‹¤ë¥¼ ìˆ˜ ìˆìŒì„ ì£¼ì˜! (Gallbladder painê³¼ í—·ê°ˆë¦´ ìˆ˜ ìˆìŒ).\n### ğŸ”ª Treatment\n- **Simple (Non-perforated):** Appendectomy + Antibiotics.\n- **Perforated (ì²œê³µ):**\n    - **Immediate Surgery? NO!** ğŸ›‘ ì—¼ì¦ì´ ë„ˆë¬´ ì‹¬í•˜ê³  ì¡°ì§ì´ ì•½í•´ì ¸(Friable) ìˆ˜ìˆ  ì‹œ í•©ë³‘ì¦ ìœ„í—˜ì´ í¼.\n    - **Phlegmon/Abscess í˜•ì„± ì‹œ: ë°”ë¡œ ìˆ˜ìˆ í•˜ë©´ì•ˆëœë‹¤!**\n        1. **IV Antibiotics + Bowel Rest** (Cool down first).\n        2. **Percutaneous Drainage** (ë†ì–‘ ë°°ì•¡, ì˜ìƒ ìœ ë„ í•˜).\n        3. **Interval Appendectomy:** ì—¼ì¦ ê°€ë¼ì•‰ê³  6-8ì£¼ ë’¤ì— ìˆ˜ìˆ .\n---","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-387"}
{"chunk_type":"transcript_chunk","text":"## 2. Pseudo-appendicitis (The Mimics)\n### ğŸ¦  The Culprits: *Yersinia* & *Campylobacter*\nì„ìƒ ì–‘ìƒì€ Appendicitisì™€ ë˜‘ê°™ìŠµë‹ˆë‹¤ (RLQ pain, fever). í•˜ì§€ë§Œ **ê²°ì •ì ì¸ ì°¨ì´**ê°€ ìˆìŠµë‹ˆë‹¤.\n- **Symptoms:** RLQ Pain + Fever + â˜… **Profuse Diarrhea** (ì„¤ì‚¬).\n    - ì§„ì§œ AppendicitisëŠ” ë³€ë¹„ê°€ ì˜¤ê±°ë‚˜ ê°€ë²¼ìš´ ì„¤ì‚¬ ì •ë„ì§€, ì½¸ì½¸ ìŸëŠ” ì„¤ì‚¬ëŠ” ë“œë­…ë‹ˆë‹¤.\n- **Pathophysiology:** Terminal Ileumê³¼ Cecumì„ ì¢‹ì•„í•˜ëŠ” ê· ë“¤ì´ë¼ ì—¼ì¦ ìœ„ì¹˜ê°€ Appendixì™€ ê²¹ì¹¨ (**Ileocecitis**).\n- **History Tip:** ëœ ìµì€ ë‹­ê³ ê¸°(Undercooked poultry)ë‚˜ ì˜¤ì—¼ëœ ìŒì‹ ì„­ì·¨ë ¥, \"Cookout\" ë“±ì˜ í‚¤ì›Œë“œ í™•ì¸.\n- Campylobacter extra GI sx: ì´ìƒí•œê±° ë¨¹ê³  ë°°ì•„í”„ê³  1ì£¼ì¼ìˆë‹¤ê°€ í˜ë¹ ì§€ê³  ê´€ì ˆì•„í”„ë©´?\n    1. GBS (Ascending paralysis)\n    2. reactive arthritis\n- **Treatment:** ìˆ˜ìˆ  ì•„ë‹˜! **Supportive Care** (ìˆ˜ì•¡, ëŒ€ì¦ ì¹˜ë£Œ). í•­ìƒì œëŠ” ì‹¬í•œ ê²½ìš°ì—ë§Œ ê³ ë ¤.\n---\n## 3. Small Bowel Obstruction (SBO) vs. Ileus\n### ğŸ—ï¸ Etiology (ì›ì¸)\n- **SBO (ê¸°ê³„ì  íìƒ‰):** ë¬´ì–¸ê°€ ë¬¼ë¦¬ì ìœ¼ë¡œ ë§‰ìŒ.\n    - #1 ì›ì¸: **Adhesions** (ìˆ˜ìˆ  í›„ ìœ ì°©, ê³¼ê±° Hysterectomy, Appendectomy ë“± í‰í„° ì¡°ì§).\n    - #2 ì›ì¸: **Hernia** (íƒˆì¥).\n    - Complete and Partial â˜…\n- **Ileus (ë§ˆë¹„ì„± ì¥íìƒ‰):** ì¥ì´ ì›€ì§ì´ì§€ ì•ŠìŒ (Functional paralysis).\n    - ì›ì¸: ìˆ˜ìˆ  ì§í›„(Post-op), Opiates ì‚¬ìš©, ì „í•´ì§ˆ ë¶ˆê· í˜•(Hypokalemia ë“±).\n### ğŸ” Diagnosis: SBO vs Ileus ê°ë³„ (Crucial!)\n| **Feature** | **SBO (Mechanical)** | **Ileus (Functional)** |\n| --- | --- | --- |\n| **Pain** | **Colicky** (ì¥ì–´ì§œëŠ” ë“¯í•œ íŒŒë™ì„± í†µì¦) | Vague discomfort, Bloating (ë”ë¶€ë£©í•¨) |\n| **Bowel Sounds** | ì´ˆê¸°: **High-pitched, Tinkling** (ëš«ìœ¼ë ¤ê³  ë‚œë¦¬ ë‚¨) \n í›„ê¸°: ê°ì†Œ | **Silent / Absent** (ì¡°ìš©í•¨) |\n| **Imaging (KUB/CT)** | **Transition Point** (ë§‰íŒ ê³³ ì „ì€ ëŠ˜ì–´ë‚˜ê³  í›„ëŠ” ìª¼ê·¸ë¼ë“¦) | Diffuse dilation (ì „ì²´ì ìœ¼ë¡œ ë‹¤ ëŠ˜ì–´ë‚¨) |\n| **Rectal Air** | **Absent** (ê°€ìŠ¤ê°€ ëª» ë‚´ë ¤ê°) | **Present** (ë§ˆë¹„ëœ ê±°ë¼ ê°€ìŠ¤ëŠ” ì°¨ ìˆìŒ air all the way down) |\n### ğŸš¨ Strangulated SBO (Emergency!)\në‹¨ìˆœ íìƒ‰ì„ ë„˜ì–´ ê³µê¸° ì••ë ¥ì´ ì°¨ì„œ ê³µê¸°ë¡œ ê½‰ì°¬ê±°ë•Œë¬¸ì— í˜ˆê´€ì„ ì••ë°•í•˜ê³  **í˜ˆë¥˜ê°€ ì°¨ë‹¨(Ischemia)** ë˜ëŠ” ìƒí™©ì…ë‹ˆë‹¤. ì‘ê¸‰ ìˆ˜ìˆ ì´ í•„ìš”í•©ë‹ˆë‹¤.\n- **Warning Signs:**\n    1. Fever\n    2. Tachycardia \n    3. Leukocytosis (WBC ì¦ê°€)\n    4. Metabolic Acidosis (Lactic acid ì¦ê°€)\n    5. **Peritoneal Signs** (Rebound tenderness) - ì¥ ê´´ì‚¬ ì‹œì‚¬.\n### ğŸ› ï¸ Management\n1. **Conservative (Initial):**\n    - **NPO** (ê¸ˆì‹).\n    - **NG Tube** (Nasogastric tube): ìœ„ ê°ì•• (Decompression) - êµ¬í† ì™€ íŒ½ë§Œê° ì™„í™”.\n    - **IV Fluids**: íƒˆìˆ˜ êµì • (ê°€ì¥ ë¨¼ì €!).\n2. **Surgical:**\n    - ë³´ì¡´ì  ì¹˜ë£Œ ì‹¤íŒ¨ ì‹œ or **Strangulation** ì§•í›„(ì—´, ë¹ˆë§¥, ë³µë§‰ìê·¹ì¦ìƒ)ê°€ ë³´ì´ë©´ ì¦‰ì‹œ ìˆ˜ìˆ ì‹¤ë¡œ!\n---","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-407"}
{"chunk_type":"recap_summary","text":"## ğŸ”¥ Rapid Fire Recap (High Yield Summary)\n| **Clinical Vignette (Korean)** | **Diagnosis (English)** | **Key Action / Trap âš ï¸** |\n| --- | --- | --- |\n| ì„ì‚°ë¶€, ìš°ì¸¡ ìƒë³µë¶€(RUQ) í†µì¦, ì••í†µ | **Appendicitis (in pregnancy)** | âš ï¸ **Trap:** ë‹´ë‚­ì—¼(Cholecystitis)ê³¼ í˜¼ë™ ì£¼ì˜. ìê¶ ë•Œë¬¸ì— ìœ„ì¹˜ ì´ë™í•¨. Next Step: **Ultrasound**. |\n| RLQ í†µì¦, ê³ ì—´, **í­ë°œì ì¸ ì„¤ì‚¬(Profuse diarrhea)** | **Pseudo-appendicitis (*Yersinia, Campylobacter*)** | âš ï¸ **Trap:** ìˆ˜ìˆ í•˜ë©´ ì•ˆ ë¨! ì¹˜ë£ŒëŠ” **Supportive care**. |\n| ê³¼ê±° ìê¶ì ì¶œìˆ ë ¥ 50ì„¸ ì—¬ì„±, ì‚°í†µ(Colicky pain), êµ¬í† , **High-pitched bowel sounds** | **Small Bowel Obstruction (SBO)** | **Next Step:** NPO, NG tube, IV fluids. ê°€ì¥ í”í•œ ì›ì¸ì€ **Adhesions**. |\n| SBO í™˜ì, ê°‘ìê¸° ì—´ë‚˜ê³  ë§¥ë°• ë¹¨ë¼ì§(Tachy), ë°° ë§Œì§€ë©´ ìì§€ëŸ¬ì§ | **Strangulated SBO** | **Next Step:** **Urgent Surgery**. (Ischemia ì˜ì‹¬). |\n| ìˆ˜ìˆ  í›„ 3ì¼ì§¸, ë°°ê°€ ë¹µë¹µí•¨, **Bowel sound ë“¤ë¦¬ì§€ ì•ŠìŒ**, ì§ì¥ì— ê°€ìŠ¤ ìˆìŒ | **Post-op Ileus** | **Tx:** ë³´ì¡´ì  ì¹˜ë£Œ, ì „í•´ì§ˆ êµì •, Opiate ì¤‘ë‹¨. |\n| CTìƒ Appendix ì£¼ìœ„ì— **Abscess** í˜•ì„±ë¨ | **Perforated Appendicitis** | âš ï¸ **Trap:** ë°”ë¡œ ìˆ˜ìˆ  ì•ˆ í•¨. **Drainage + Antibiotics** í›„ ë‚˜ì¤‘ì— ìˆ˜ìˆ (Interval Appy). |","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-423"}
{"chunk_type":"recap_quiz_seed","text":"## ğŸ”¥ Rapid Fire Recap (High Yield Summary)\n| Clinical Vignette (ìƒí™©) | Diagnosis (ì§„ë‹¨) | Key Action / Concept (í•µì‹¬) |\n| --- | --- | --- |\n| **Solid**ë¶€í„° ì‹œì‘í•´ì„œ **Liquid**ë¡œ ì§„í–‰ë˜ëŠ” ì‚¼í‚´ ê³¤ë€ | **Mechanical Obstruction** (Stricture/Cancer) | **Barium Swallow** ë¨¼ì € í•´ì„œ ìœ„ì¹˜/ëª¨ì–‘ í™•ì¸í•˜ê³  ë‚´ì‹œê²½(EGD). |\n| ì²˜ìŒë¶€í„° **Solid & Liquid** ë‘˜ ë‹¤ ì•ˆ ë„˜ì–´ê° | **Motility Disorder** (Achalasia/Spasm) | **Manometry**ê°€ Confirmatory test. (ì••ë ¥ ì¸¡ì • í•„ìˆ˜) |\n| Bariumì—ì„œ **Bird's beak** ì†Œê²¬ + ì²´ì¤‘ ê°ì†Œ ì‹¬í•¨ | **Pseudo-achalasia** (Cancer suspicion) | Achalasiaë¡œ ë‹¨ì • ê¸ˆì§€. ë°˜ë“œì‹œ **EGD**ë¡œ ì•”ì„ ë°°ì œí•  ê²ƒ(Rule out malignancy). |\n| ìê¸° ì „ ì•½ ë¨¹ê³  ë‚œ ë’¤ ê·¹ì‹¬í•œ í‰í†µ (Odynophagia) | **Pill-induced Esophagitis** | ì›ì¸: **Tetracycline, Bisphosphonates, NSAIDs**. ì¹˜ë£ŒëŠ” ì•½ ì¤‘ë‹¨/ë¬¼ ë§ì´ ë§ˆì‹œê¸°. |\n| 55ì„¸ ë‚¨ì„±, 10ë…„ ëœ ì†ì“°ë¦¼ (Heartburn) | **GERD** (Screening Candidate) | 50ì„¸ ì´ìƒ ë‚¨ì„± + 5ë…„ ì´ìƒ ì¦ìƒì€ **Barrett's** ìœ„í—˜êµ° â†’ **Endoscopy** ì‹œí–‰. |\n| ì Šì€ ì²œì‹ í™˜ì, ê³ ê¸° ë¨¹ë‹¤ ê±¸ë¦¼, PPI ë°˜ì‘ ì—†ìŒ | **Eosinophilic Esophagitis (EoE)** | Biopsyì—ì„œ **>15 Eosinophils**. ì¹˜ë£ŒëŠ” **Swallowed Steroid**. |\n| ICU í™˜ì, ì¸ê³µí˜¸í¡ê¸° 3ì¼ì§¸ ì ìš© ì¤‘ | **Stress Ulcer Risk** | Major risk factor(Vent > 48h) ìˆìŒ â†’ **PPI Prophylaxis** ì‹œì‘. |\n| ì•„ì¹¨ì— ê¹¨ë©´ ì…ì—ì„œ ì‹ ë§›ì´ ë‚¨, ê²½ê³  ì¦ìƒ ì—†ìŒ | **Uncomplicated GERD** | ê²€ì‚¬ ì—†ì´ **PPI 2ë‹¬** ì¹˜ë£Œ (Lifestyle + PPI trial). |\n| PPI ë¨¹ê³  ìˆëŠ”ë° ë°¤ì— ìë‹¤ê°€ ê°‘ìê¸° 3ì‹œì— ì†ì“°ë ¤ì„œ ê¹¸ | **Nocturnal Acid Breakthrough** | í™˜ìê°€ \"Refractory\"í•œì§€ í™•ì¸ í•„ìš”? ì•„ë‹ˆìš”, ì´ê±´ **Dosing** ë¬¸ì œì¼ ìˆ˜ë„. (ì˜¤ë””ì˜¤ì—ëŠ” ì—†ëŠ” ë‚´ìš©ì´ë‚˜ ì°¸ê³ : ì•¼ê°„ ì‚°ë¶„ë¹„ ê³ ë ¤) *ì˜¤ë””ì˜¤ ë‚´ìš© ê¸°ì¤€: 2ë‹¬ ì¹˜ë£Œ ì‹¤íŒ¨ ì‹œ ì¦ëŸ‰/êµì²´.* |\n---\n**[Next Step for User]**\nì„ ìƒë‹˜, Esophagus íŒŒíŠ¸ëŠ” **Algorithm** ì‹¸ì›€ì…ë‹ˆë‹¤. íŠ¹íˆ **\"Solid vs Liquid\"** êµ¬ë¶„ê³¼ **\"Alarm feature ìœ ë¬´ì— ë”°ë¥¸ Scope ê²°ì •\"** ì´ ë‘ ê°€ì§€ê°€ ì‹œí—˜ì˜ 70%ë¥¼ ì°¨ì§€í•©ë‹ˆë‹¤. ë‹¤ìŒ ì„¹ì…˜(Stomach/Small Bowel)ìœ¼ë¡œ ë„˜ì–´ê°€ê¸° ì „ì—, ìœ„ í‘œì˜ Rapid Fire ë‚´ìš©ì„ ê°€ë¦¬ê³  ë‹µí•  ìˆ˜ ìˆëŠ”ì§€ ìê°€ í…ŒìŠ¤íŠ¸ í•œë²ˆ í•´ë³´ì‹œê² ìŠµë‹ˆê¹Œ?\nHere is the comprehensive study guide based on the audio file provided.\n### ğŸ§ One Line Vibe & Summary\n**\"Stomach Pathology: From toxic erosions to paralyzed pumps â€“ distinguishing functional failure from mechanical blocks.\"**\nì´ë²ˆ ì—í”¼ì†Œë“œëŠ” ìœ„ì¥ê´€(Stomach)ì—ì„œ ë°œìƒí•  ìˆ˜ ìˆëŠ” ë³‘ë¦¬í•™ì  ìƒíƒœë¥¼ 3.1ë¶€í„° 3.5ê¹Œì§€ **Erosion(ë¯¸ë€), Motility(ìš´ë™ì„±), Obstruction(íì‡„)**ì˜ ê´€ì ì—ì„œ ì •ë¦¬í–ˆìŠµë‹ˆë‹¤. íŠ¹íˆ Functional disorderì™€ Mechanical obstructionì„ êµ¬ë¶„í•˜ëŠ” ê²ƒì´ í•µì‹¬ì…ë‹ˆë‹¤.\n---\n### ğŸ“ 0:00~0:30 Dictation (Verbatim Verification)","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-37"}
{"chunk_type":"recap_quiz_seed","text":"## ğŸ”¥ Rapid Fire Recap (High Yield Summary)\n1. **Clinical Vignette:** 70ì„¸ ë…¸ì¸, í†µì¦ ì—†ëŠ” í™©ë‹¬ (Painless Jaundice), Courvoisier's sign (ë§Œì ¸ì§€ëŠ” ë‹´ë‚­).\n    - **Diagnosis:** [Malignancy (Pancreatic head cancer, Cholangiocarcinoma)]\n    - **Key Action:** **CT Abdomen** or **US** first. **Do NOT** assume stones.\n2. **Clinical Vignette:** ì Šì€ í™˜ì, ìŠ¤íŠ¸ë ˆìŠ¤ ë°›ê±°ë‚˜ êµ¶ì—ˆë”ë‹ˆ ê²½ë¯¸í•œ í™©ë‹¬ (Mild unconjugated hyperbilirubinemia). ê°„ìˆ˜ì¹˜ ì •ìƒ.\n    - **Diagnosis:** [Gilbert Syndrome]\n    - **Key Action:** **Reassurance**. No treatment needed.\n3. **Clinical Vignette:** Cirrhosis í™˜ì, Confusion, Asterixis (Hand flapping).\n    - **Diagnosis:** [Hepatic Encephalopathy]\n    - **Key Action:** Check for triggers (Infection, GI bleed, Constipation). Start **Lactulose**.\n4. **Clinical Vignette:** Acute Liver Failure Triad?\n    - **Answer:** [Severe Liver Injury (High LFTs) + Coagulopathy (INR â‰¥ 1.5) + Encephalopathy]\n    - **Trap:** Mental statusê°€ ì •ìƒì´ë©´ Acute Hepatitisì´ì§€ ALFê°€ ì•„ë‹˜! â˜…\n    - Hep C ëŠ” ì›ì¸ì•„ë‹˜! íƒ€ì´ë ˆë†€ì€ ì›ì¸ì„\n5. SAAG >1.1 : High Hydrostatic portal Hypertension / SAAG <1.1 : Low Leaky albumin\n6. **Clinical Vignette:** Ascites í™˜ì, **ë¯¸ì—´ â˜…**  ë°œìƒ. Paracentesisì—ì„œ PMN > 250.\n    - **Diagnosis:** [Spontaneous Bacterial Peritonitis (SBP)]\n    - **Key Action:** Start **Ceftriaxone** immediately. Give **Albumin** to protect kidneys.\n## ğŸ“ Tutor's One-Liner\n\"JaundiceëŠ” **Pain**ì´ ìˆëŠ”ì§€ ë¨¼ì € ë³´ê³ , LFT íŒ¨í„´(**Hepatocellular vs Cholestatic**)ìœ¼ë¡œ ê¸¸ì„ ë‚˜ëˆˆ ë’¤, **Anatomy(Duct dilation)**ë¥¼ í™•ì¸í•˜ì„¸ìš”. CirrhosisëŠ” **Decompensated events**(Bleeding, Ascites, Encephalopathy)ë¥¼ ë§‰ê³  ê´€ë¦¬í•˜ëŠ” ê²ƒì´ ì „ë¶€ì…ë‹ˆë‹¤! íŒŒì´íŒ…! ğŸ’ª\"\n**Verbatim Dictation (0:00~0:30)**\n\"Welcome back to the deep dive. Today we are wading into the... the deep end of the GI block. We're strapping in for a real heavy hitter. We really are. We're talking about the metabolic engine of the body, the liver. And specifically we're looking at what happens when that engine, you know, just seizes up. It absolutely is the engine room. Yeah. You know I always tell the med students on rounds...\"\n---\n# ğŸ©º **Deep Dive: Liver Pathology (Cirrhosis & Complications)**\n**Section 4.2 - 4.7 Comprehensive Lecture Notes**\nì•ˆë…•í•˜ì„¸ìš”! ì˜¤ëŠ˜ ìš°ë¦¬ëŠ” ìš°ë¦¬ ëª¸ì˜ **Metabolic Engine**ì¸ **Liver**ê°€ ê³ ì¥ ë‚¬ì„ ë•Œ ì–´ë–¤ ì¼ì´ ë²Œì–´ì§€ëŠ”ì§€, ê·¸ë¦¬ê³  **USMLE Step 2 CK**ì—ì„œ ì–´ë–»ê²Œ ì¶œì œë˜ëŠ”ì§€ ì•„ì£¼ ê¹Šê²Œ íŒŒí—¤ì³ ë³¼ ê²ë‹ˆë‹¤. ì—”ì§„ì´ ë©ˆì¶”ë©´ ì‹œìŠ¤í…œ ì „ì²´ê°€ ë¶•ê´´ë˜ë“¯ì´, ê°„ì´ ë©ˆì¶”ë©´ Brain, Kidney, Lungê¹Œì§€ ëª¨ë‘ íƒ€ê²©ì„ ì…ìŠµë‹ˆë‹¤. ì, ì¤€ë¹„ë˜ì…¨ë‚˜ìš”? Let's dive in! ğŸ¤¿","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-146"}
{"chunk_type":"recap_quiz_seed","text":"## ğŸ”¥ **Rapid Fire Recap (High Yield Summary)**\nì˜¤ë””ì˜¤ì—ì„œ ê°•ì¡°í•œ í•µì‹¬ ì‹œë‚˜ë¦¬ì˜¤ ì •ë¦¬í‘œ!\n| **Clinical Vignette (ìƒí™©)** | **Diagnosis (ì§„ë‹¨)** | **Key Action / Trap (í•µì‹¬)** |\n| --- | --- | --- |\n| **Fatty meal** í›„ 30ë¶„ ë’¤ í†µì¦, 6ì‹œê°„ ë‚´ ì†Œì‹¤ | **Biliary Colic** | **Elective Lap Chole**. (ì‘ê¸‰ ì•„ë‹˜) |\n| RUQ pain, **Fever**, **Murphy's sign (+)** | **Acute Cholecystitis** | **HIDA scan** if US equivocal. **Surgery within 72h**. |\n| **Jaundice**, Alk Phos â†‘, Dilated CBD on US | **Choledocholithiasis** | **ERCP** first (Remove stone) â†’ then Cholecystectomy. |\n| **Fever + Jaundice + RUQ Pain** (Charcot) | **Acute Cholangitis** | **Emergent ERCP** (Drainage) + IV Abx + Fluids. |\n| **ICU Patient**, Sepsis, No stones on US | **Acalculous Cholecystitis** | **Cholecystostomy Tube** (Do NOT operate yet). |\n| **Diabetic Male**, Air in GB wall | **Emphysematous Cholecystitis** | **Emergency Surgery** (High risk of perforation). |\n| **Male with UC**, Jaundice, Itching | **PSC** | Screen for **Cholangiocarcinoma**. Look for \"Beads on string\". |\n| **Middle-aged Woman**, Itching, Fatigue | **PBC** | Check **Anti-Mitochondrial Ab (AMA)**. Tx: Ursodiol. |\n---\n**[Next Step for User]**\nWould you like me to generate specific Anki card content for the **\"PSC vs PBC\"** differentiation or the **\"Management Hierarchy of Cholangitis\"** to help you lock this into your long-term memory?\n**Verification Dictation (0:00~0:30)**\n\"Welcome back to the deep dive. Today we are strapping in for a serious session. We're opening the abdominal cavity but uh, we are staying out of the hollow viscus for a moment. Oh yeah. We are focusing on the solid organs that really define those upper quadrants. We have a lot of ground to cover specifically two organs that often get bundled together but have, well very different personalities. The pancreas and the spleen.\"\n---\n# ğŸ¥ USMLE Step 2 CK: The Angry Pancreas & The Silent Spleen","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-252"}
{"chunk_type":"recap_quiz_seed","text":"## ğŸ”¥ Rapid Fire Recap (High Yield Summary)\n1. **Epigastric pain radiating to back + Lipase > 3x** â†’ **Acute Pancreatitis** â†’ **Next Step:** Fluids (LR), Pain control, NPO. (Do NOT order CT first).\n2. **Acute Pancreatitis + ALT > 150** â†’ **Gallstone Pancreatitis** â†’ **Next Step:** RUQ Ultrasound.\n3. **Pancreatitis patient + Fever/Hypotension after 10 days + CT shows gas** â†’ **Infected Necrosis** â†’ **Next Step:** Antibiotics (Carbapenem) + Step-up drainage.\n4. **4 weeks after Pancreatitis + Early Satiety + Abdominal Mass** â†’ **Pancreatic Pseudocyst** â†’ **Next Step:** Symptomatic? Drainage (Cystogastrostomy). Asymptomatic? Observation.\n5. **Chronic Pancreatitis + Isolated Gastric Varices** â†’ **Splenic Vein Thrombosis** â†’ **Tx:** Splenectomy.\n6. **Sore throat (Mono) + Sudden LUQ pain/Shoulder pain** â†’ **Splenic Rupture** â†’ **Next Step:** Stable? CT. Unstable? OR.\n## ğŸ§ 0:00~0:30 Verbatim Dictation\n\"Welcome back to the deep dive. Today we are... uh, not just reading a textbook. No, definitely not. We are putting on our long white coats, we're grabbing our stethoscopes, and we are stepping directly onto the wards. I like it. We are tackling a veritable beast of a topic for the USMLE Step 2 CK: Gastroenterology. Mm-hm. And specifically we are zooming in on the small intestine. We're looking strictly at sections 8.0 through 8.6 of our table of contents.\"\n---\n# ğŸ¥ USMLE Step 2 CK: GI Deep Dive (Small Intestine)\n**Topic:** Malabsorption, IBS, IBD, Celiac, SIBO\nì•ˆë…•í•˜ì„¸ìš” ì„ ìƒë‹˜! USMLE Step 2 CK ì¤€ë¹„ë¥¼ ìœ„í•œ GI íŒŒíŠ¸ Deep Diveì…ë‹ˆë‹¤.\nì˜¤ëŠ˜ì˜ ì£¼ì œëŠ” ì†Œì¥(Small Intestine) íŒŒíŠ¸ì…ë‹ˆë‹¤. ì¦ìƒì€ ë¹„ìŠ·í•´ ë³´ì´ì§€ë§Œ(ì„¤ì‚¬, ë³µí†µ, bloating), ê´€ë¦¬ëŠ” ì²œì§€ì°¨ì´ì¸ ì§ˆí™˜ë“¤ì„ í™•ì‹¤í•˜ê²Œ êµ¬ë¶„í•˜ëŠ” ê²ƒì´ í•µì‹¬ì…ë‹ˆë‹¤.\në¨¼ì € ì „ì²´ì ì¸ ê·¸ë¦¼ì„ **Big Picture**ë¡œ ì¡ê³  ë“¤ì–´ê°€ê² ìŠµë‹ˆë‹¤.","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-317"}
{"chunk_type":"recap_quiz_seed","text":"## ğŸ”¥ Rapid Fire Recap (High Yield Summary)\n| **Clinical Vignette (Korean)** | **Diagnosis (English)** | **Key Action / Trap âš ï¸** |\n| --- | --- | --- |\n| ì„ì‚°ë¶€, ìš°ì¸¡ ìƒë³µë¶€(RUQ) í†µì¦, ì••í†µ | **Appendicitis (in pregnancy)** | âš ï¸ **Trap:** ë‹´ë‚­ì—¼(Cholecystitis)ê³¼ í˜¼ë™ ì£¼ì˜. ìê¶ ë•Œë¬¸ì— ìœ„ì¹˜ ì´ë™í•¨. Next Step: **Ultrasound**. |\n| RLQ í†µì¦, ê³ ì—´, **í­ë°œì ì¸ ì„¤ì‚¬(Profuse diarrhea)** | **Pseudo-appendicitis (*Yersinia, Campylobacter*)** | âš ï¸ **Trap:** ìˆ˜ìˆ í•˜ë©´ ì•ˆ ë¨! ì¹˜ë£ŒëŠ” **Supportive care**. |\n| ê³¼ê±° ìê¶ì ì¶œìˆ ë ¥ 50ì„¸ ì—¬ì„±, ì‚°í†µ(Colicky pain), êµ¬í† , **High-pitched bowel sounds** | **Small Bowel Obstruction (SBO)** | **Next Step:** NPO, NG tube, IV fluids. ê°€ì¥ í”í•œ ì›ì¸ì€ **Adhesions**. |\n| SBO í™˜ì, ê°‘ìê¸° ì—´ë‚˜ê³  ë§¥ë°• ë¹¨ë¼ì§(Tachy), ë°° ë§Œì§€ë©´ ìì§€ëŸ¬ì§ | **Strangulated SBO** | **Next Step:** **Urgent Surgery**. (Ischemia ì˜ì‹¬). |\n| ìˆ˜ìˆ  í›„ 3ì¼ì§¸, ë°°ê°€ ë¹µë¹µí•¨, **Bowel sound ë“¤ë¦¬ì§€ ì•ŠìŒ**, ì§ì¥ì— ê°€ìŠ¤ ìˆìŒ | **Post-op Ileus** | **Tx:** ë³´ì¡´ì  ì¹˜ë£Œ, ì „í•´ì§ˆ êµì •, Opiate ì¤‘ë‹¨. |\n| CTìƒ Appendix ì£¼ìœ„ì— **Abscess** í˜•ì„±ë¨ | **Perforated Appendicitis** | âš ï¸ **Trap:** ë°”ë¡œ ìˆ˜ìˆ  ì•ˆ í•¨. **Drainage + Antibiotics** í›„ ë‚˜ì¤‘ì— ìˆ˜ìˆ (Interval Appy). |","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-423"}